细胞株Cell Lines 99及完全培养基-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心http://www.biovector.net
- 价 格：¥19200
- 货 号：NTCC-CV99
- 产 地：北京
- BioVector NTCC典型培养物保藏中心
- 联系人：Dr.Xu, Biovector NTCC Inc.
电话：400-800-2947 工作QQ:1843439339 (微信同号)
邮件：Biovector@163.com
手机：18901268599
地址：北京
- 已注册
细胞株Cell Lines-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心
ID TE-FLY-A8
AC CVCL_9U63
SY TEFLY A8; TEFLYA8
CC Group: Retrovirus packaging cell line.
DI NCIt; C8971; Embryonal rhabdomyosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1756 ! TE 671
SX Female
CA Cancer cell line
//
ID TE-FLY-GALV
AC CVCL_9U64
SY TE-FLYGALV
RX PubMed=10022544;
CC Group: Retrovirus packaging cell line.
CC Transfected with: UniProtKB; P03355; Moloney murine leukemia virus (MoMLV) gag-pol.
CC Transfected with: UniProtKB; P21415; Gibbon ape leukemia virus (GALV) env.
DI NCIt; C8971; Embryonal rhabdomyosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1756 ! TE 671
SX Female
CA Cancer cell line
//
ID TE15
AC CVCL_F780
SY TE-15; 18G3.cl 1
DR CLO; CLO_0009311
DR ATCC; HB-206
RX PubMed=2578044;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID TE16
AC CVCL_F781
SY TE-16; 8F11.cl 2
DR CLO; CLO_0009312
DR ATCC; HB-210
RX PubMed=2578044;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID TE19
AC CVCL_F782
SY TE-19; 11G8.cl 2-1.8
DR CLO; CLO_0009313
DR ATCC; HB-211
RX PubMed=2578044;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID TE3
AC CVCL_F783
SY TE3A; TE-3A
DR CLO; CLO_0009314
DR ATCC; HB-209
RX PubMed=6205074;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID Te39
AC CVCL_3801
SY Te-39
DR CLO; CLO_0009315
DR ATCC; HB-8577
RX Patent=US4695538;
OX NCBI_TaxID=9606; ! Homo sapiens
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID TE4
AC CVCL_F784
SY TE-4
DR CLO; CLO_0009316
DR ATCC; HB-207
RX PubMed=6200562;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3411 ! P3X63Ag8
CA Hybridoma
//
ID TE7
AC CVCL_F785
SY TE-7
DR CLO; CLO_0009319
DR ATCC; HB-208
RX PubMed=6200562;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID TE8
AC CVCL_F786
SY TE-8; 10A3.cl 1
DR CLO; CLO_0009320
DR ATCC; HB-212
RX PubMed=2578044;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID TEC
AC CVCL_J026
SY Turbot Embryonic Cell line
RX CelloPub=CLPUB00053;
RX DOI=10.1016/j.aquaculture.2005.01.031;
CC Group: Fish cell line.
OX NCBI_TaxID=52904; ! Scophthalmus maximus
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID TEC61
AC CVCL_7167
DR BioSample; SAMN03151803
DR ECACC; 06031505
RX PubMed=12388152;
RX PubMed=19625678;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a JEG-3 derivative (PubMed=20143388).
CC Caution: PubMed=19625678 is a retractation of PubMed=12388152.
CC Discontinued: ECACC; 06031505; true.
CC Derived from metastatic site: Brain.
DI NCIt; C4646; Gestational choriocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0363 ! JEG-3
SX Male
CA Cancer cell line
//
ID TEK
AC CVCL_F245
DR CLO; CLO_0009321
DR CLDB; cl4502
WW http://www.rccc.cytspb.rssi.ru/ecellbank/animal/atek.htm
OX NCBI_TaxID=9913; ! Bos taurus
SX Sex undetermined
CA Finite cell line
//
ID Tel12
AC CVCL_EE25
SY Tel#12; Telomerase 12; HFF TEL 12
RX PubMed=11044129;
CC Transfected with: HGNC; 11730; TERT.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Telomerase immortalized cell line
//
ID TELac2
AC CVCL_9U65
SY TElac2
RX PubMed=7494248;
RX PubMed=10022544;
CC Group: Retrovirus packaging cell line.
CC Transfected with: UniProtKB; P00722; E.coli lacZ.
DI NCIt; C8971; Embryonal rhabdomyosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1756 ! TE 671
SX Female
CA Cancer cell line
//
ID TELCeB6
AC CVCL_9U66
RX PubMed=7494248;
RX PubMed=10022544;
CC Group: Retrovirus packaging cell line.
CC Transfected with: UniProtKB; P03355; Moloney murine leukemia virus (MoMLV) gag-pol.
CC Transfected with: UniProtKB; P00722; E.coli lacZ.
DI NCIt; C8971; Embryonal rhabdomyosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_9U65 ! TELac2
SX Female
CA Cancer cell line
//
ID TelCOFS02MA
AC CVCL_U606
DR ATCC; CRL-4005
DR BioSample; SAMN03471716
RX PubMed=10739753;
CC Transfected with: HGNC; 11730; TERT.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 10,12
ST D16S539: 9,11
ST D5S818: 7,13
ST D7S820: 10,12
ST TH01: 7,9.3
ST TPOX: 11,12
ST vWA: 16,17
DI NCIt; C9460; Cockayne syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Telomerase immortalized cell line
//
ID TelCOFS03MA
AC CVCL_U607
DR ATCC; CRL-4006
DR BioSample; SAMN03471717
RX PubMed=10739753;
CC Transfected with: HGNC; 11730; TERT.
CC Discontinued: ATCC; CRL-4006; true.
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 10
ST D13S317: 9,10
ST D16S539: 10,11
ST D5S818: 11
ST D7S820: 10,12
ST TH01: 7
ST TPOX: 8,12
ST vWA: 17
DI NCIt; C9460; Cockayne syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Telomerase immortalized cell line
//
ID TeLFBASAF
AC CVCL_9U67
SY TELFBASAF
RX PubMed=10022544;
CC Group: Retrovirus packaging cell line.
CC Transfected with: UniProtKB; P00722; E.coli lacZ.
DI NCIt; C8971; Embryonal rhabdomyosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1756 ! TE 671
SX Female
CA Cancer cell line
//
ID TeloHAEC
AC CVCL_Z065
DR ATCC; CRL-4052
CC Transfected with: HGNC; 11730; TERT.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 9,12
ST D16S539: 12,13
ST D5S818: 12
ST D7S820: 10,11
ST TH01: 6,8
ST TPOX: 8
ST vWA: 15,16
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Telomerase immortalized cell line
//
ID TeloHAEC-GFP
AC CVCL_Z066
DR ATCC; CRL-4054
CC Transfected with: HGNC; 11730; TERT.
CC Transfected with: UniProtKB; P42212; GFP.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 9,12
ST D16S539: 12,13
ST D5S818: 12
ST D7S820: 10,11
ST TH01: 6,8
ST TPOX: 8
ST vWA: 15,16
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_Z065 ! TeloHAEC
SX Female
CA Telomerase immortalized cell line
//
ID TEM
AC CVCL_E844
DR dbMHC; 49036
DR ECACC; 88052057
DR IHW; IHW9057
DR IMGT/HLA; 11438
WW http://bioinformatics.hsanmartino.it/ecbr/cl57.html
CC Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID TEN
AC CVCL_E063
DR CLO; CLO_0050884
DR BioSample; SAMN03472138
DR CCLE; TEN_ENDOMETRIUM
DR GEO; GSM887703
DR GEO; GSM888796
DR RCB; RCB1433
RX PubMed=9436040;
RX PubMed=22460905;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 10,12
ST D16S539: 11,12
ST D5S818: 11,12
ST D7S820: 10,12
ST TH01: 7,8
ST TPOX: 8
ST vWA: 14,17
DI NCIt; C7558; Endometrial carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID Ten12
AC CVCL_4765
SY TEN12; TEN/12
DR Cosmic; 2585154
RX CelloPub=CLPUB00117;
RX PubMed=9316653;
WW http://capcelllines.ca/details.asp?id=110
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID TEN12C
AC CVCL_K060
RX PubMed=14673948;
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_4765 ! Ten12
SX Male
CA Cancer cell line
//
ID TEN12F
AC CVCL_K061
RX PubMed=14673948;
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_4765 ! Ten12
SX Male
CA Cancer cell line
//
ID tEnd.1
AC CVCL_6272
SY thymus-derived End cells.1
RX PubMed=3345558;
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID TENN
AC CVCL_Y378
DR Cosmic; 1131689
RX PubMed=17363507;
RX PubMed=23623571;
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Tep Be
AC CVCL_3802
DR CLO; CLO_0009322
DR ATCC; CRL-1336
DR BioSample; SAMN03471353
DR JCRB; KURB1915
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 8
ST D16S539: 12
ST D5S818: 11,12
ST D7S820: 11,12
ST TH01: 6,9.3
ST TPOX: 8,9
ST vWA: 14,18
DI NCIt; C9460; Cockayne syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID Ter Loy
AC CVCL_X716
DR ATCC; CRL-1147
CC Discontinued: ATCC; CRL-1147; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID TER-119
AC CVCL_8432
DR JCRB; JCRB1353
RX PubMed=8660794;
RX PubMed=10848813;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=TER-119
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID TER-259
AC CVCL_E845
DR dbMHC; 49037
DR IHW; IHW9401
DR IMGT/HLA; 26005
CC Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID TER-3
AC CVCL_U375
RX PubMed=12064461;
RX PubMed=19344951;
DI NCIt; C3247; Myelodysplastic syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID TER-ND
AC CVCL_E846
SY TER ND; RAIN-TER; RAI
DR dbMHC; 49038
DR ECACC; 88072602
DR IHW; IHW9303
DR IMGT/HLA; 11449
WW http://bioinformatics.hsanmartino.it/ecbr/cl303.html
CC Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID Tera-1
AC CVCL_2776
SY TERA-1
DR CLO; CLO_0009323
DR ATCC; HTB-105
DR BioSample; SAMN03471091
DR Cosmic; 687053
DR Cosmic; 971769
DR Cosmic; 2163763
DR GDSC; 1331043
DR KCLB; 30105
RX DOI=10.1007/978-1-4757-1647-4_5;
RX PubMed=833871;
RX PubMed=6244232;
RX PubMed=24812411;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
ST Source(s): ATCC; KCLB
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 12
ST D16S539: 10,12
ST D3S1358: 15
ST D5S818: 11,13
ST D7S820: 9,10
ST FGA: 21,25
ST TH01: 7,8
ST TPOX: 8
ST vWA: 14
DI NCIt; C3752; Embryonal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Tera-2
AC CVCL_2777
SY TERA-2; Tera 2; Tera II
DR BTO; BTO:0002573
DR CLO; CLO_0009324
DR ATCC; HTB-106
DR Cosmic; 971770
DR Wikidata; Q28248633
RX DOI=10.1007/978-1-4757-1647-4_5;
RX PubMed=833871;
RX PubMed=3293662;
RX PubMed=6169654;
RX PubMed=6244232;
RX PubMed=6694356;
RX PubMed=6935474;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
CC Derived from metastatic site: Lung.
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 13
ST D16S539: 11,12,13
ST D5S818: 9,12
ST D7S820: 10,12
ST TH01: 9.3
ST TPOX: 8
ST vWA: 18,19
DI NCIt; C3752; Embryonal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID TERA-C3H
AC CVCL_AV91
DR CLS; 400360/p567_TERA-C3H
CC Breed/subspecies: C3H.
DI NCIt; C30037; Mouse malignant ovarian neoplasm
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Cancer cell line
//
ID TerC
AC CVCL_DE18
SY Teratoma C; TerC74
RX CelloPub=CLPUB00342;
RX PubMed=379868;
RX PubMed=4365513;
RX PubMed=6958907;
RX PubMed=7135164;
CC Breed/subspecies: 129/Sv.
DI NCIt; C128123; Mouse testicular teratoma
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Cancer cell line
//
ID Tes Man
AC CVCL_Y128
DR ATCC; CRL-1154
CC Discontinued: ATCC; CRL-1154; true.
DI NCIt; C2975; Cystic fibrosis
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID Tesi
AC CVCL_IN51
DR GEO; GSE10508
RX PubMed=9420268;
RX PubMed=18276843;
CC Characteristics: Immortalized using a tetracycline-repressible HTLV-1 Tax gene.
CC Characteristics: IL2 dependent.
CC Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1) [Tax].
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID Tet-iNOS-293
AC CVCL_8117
SY Tet-iNOS 293; Tet-iNOS293
DR BTO; BTO:0003282
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID Tet2
AC CVCL_HF70
SY TET2; SHEP-2; SHEP2
DR GEO; GSM692875
RX PubMed=8761302;
RX PubMed=22213050;
CC Transfected with: UniProtKB; P04483; E.coli Tn10 tetR.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Bone marrow.
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2A38 ! SHEP-SF
SX Female
CA Cancer cell line
//
ID Tet21N
AC CVCL_9812
SY TET21/N; Tet21/N; Tet-21/N; SHEP-21/N; SHEP21N
DR BTO; BTO:0004654
DR GEO; GSM692858
RX PubMed=8761302;
RX PubMed=22213050;
CC Transfected with: HGNC; 7559; MYCN.
CC Transfected with: UniProtKB; P04483; E.coli Tn10 tetR.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Bone marrow.
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2A38 ! SHEP-SF
SX Female
CA Cancer cell line
//
ID TF
AC CVCL_8274
SY Turbo Fin
RX PubMed=20502962;
CC Group: Fish cell line.
OX NCBI_TaxID=52904; ! Scophthalmus maximus
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID TF-1
AC CVCL_0559
SY TF1
DR BTO; BTO:0004760
DR CLO; CLO_0009325
DR CLO; CLO_0009326
DR MCCL; MCC:0000460
DR CLDB; cl4503
DR CLDB; cl7163
DR ATCC; CRL-2003
DR BCRC; 60323
DR BCRJ; 0233
DR BioSample; SAMN03470850
DR CCLE; TF1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
DR CCRID; 3111C0001CCC000118
DR CCRID; 3131C0001000700139
DR ChEMBL-Cells; CHEMBL3307972
DR ChEMBL-Targets; CHEMBL612552
DR CLS; 300434/p538_TF-1
DR Cosmic; 787479
DR Cosmic; 919129
DR Cosmic; 924041
DR Cosmic; 975302
DR Cosmic; 1012123
DR Cosmic; 1127259
DR Cosmic; 1281355
DR Cosmic; 2089658
DR Cosmic; 2306240
DR DSMZ; ACC-334
DR ECACC; 93022307
DR GDSC; 1331044
DR GEO; GSM887704
DR GEO; GSM888797
DR GEO; GSM1374961
DR ICLC; HTL05001
DR NCBI_Iran; C602
RX PubMed=2656885;
RX PubMed=2663885;
RX PubMed=11021758;
RX PubMed=11414198;
RX PubMed=16408098;
RX PubMed=22460905;
RX PubMed=23955599;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=TF-1
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Characteristics: Proliferatively responsive to many growth factors.
CC Doubling time: ~70 hours (DSMZ).
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Discontinued: BCRJ; 0233; probable.
ST Source(s): ATCC; CLS; DSMZ; ECACC; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 13,14 (ATCC; PubMed=25877200)
ST CSF1PO: 13 (CLS; DSMZ; ECACC)
ST D13S317: 8,9
ST D16S539: 9,12
ST D18S51: 13
ST D21S11: 30
ST D3S1358: 15
ST D5S818: 13
ST D7S820: 12
ST D8S1179: 11,15
ST FGA: 18,19
ST Penta D: 10,13
ST Penta E: 5,17
ST TH01: 7,9
ST TPOX: 8
ST vWA: 15,17
DI NCIt; C7152; Erythroleukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID TF-1 BCR/ABL
AC CVCL_J294
SY TF-1 BCR-ABL
DR BTO; BTO:0004761
RX PubMed=18829496;
DI NCIt; C7152; Erythroleukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0559 ! TF-1
SX Male
CA Cancer cell line
//
ID TF-1.CN5a.1
AC CVCL_3607
DR CLO; CLO_0009327
DR ATCC; CRL-2512
CC Transfected with: HGNC; 2170; CNTFR.
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 13
ST D13S317: 8,9
ST D16S539: 9,12
ST D5S818: 13
ST D7S820: 12
ST TH01: 7,9
ST TPOX: 8
ST vWA: 15,17
DI NCIt; C7152; Erythroleukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0559 ! TF-1
SX Male
CA Cancer cell line
//
ID TF-1a
AC CVCL_3608
DR CLO; CLO_0009328
DR ATCC; CRL-2451
DR BCRC; 60440
DR BioSample; SAMN03471582
RX PubMed=9716013;
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 13
ST D13S317: 8,9
ST D16S539: 9,12
ST D5S818: 13
ST D7S820: 12
ST TH01: 7,9
ST TPOX: 8
ST vWA: 15,17
DI NCIt; C7152; Erythroleukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0559 ! TF-1
SX Male
CA Cancer cell line
//
ID TF228.1.16
AC CVCL_1G52
DR NIH-ARP; 11481-330
RX PubMed=8094000;
CC Characteristics: EBV-negative.
DI NCIt; C2912; Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_5711 ! BJAB
SX Female
CA Cancer cell line
//
ID TFA-11
AC CVCL_H250
RX PubMed=6932214;
CC Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV).
CC Breed/subspecies: DBA/2.
DI NCIt; C21895; Mouse erythroid leukemia
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID TFK-1
AC CVCL_2214
SY TFK1
DR CLO; CLO_0009330
DR CLO; CLO_0050010
DR BioSample; SAMN03471922
DR BioSample; SAMN03473356
DR Cosmic; 927187
DR Cosmic; 1122354
DR Cosmic; 1373550
DR DSMZ; ACC-344
DR RCB; RCB2537
DR TKG; TKG 0367
RX CelloPub=CLPUB00275;
RX PubMed=8693487;
RX PubMed=9290701;
CC Doubling time: ~40 hours (DSMZ).
ST Source(s): DSMZ; RCB; TKG
ST Amelogenin: X,Y
ST CSF1PO: 10
ST D13S317: 14
ST D16S539: 9
ST D5S818: 9,12
ST D7S820: 10 (DSMZ)
ST D7S820: 10,11 (RCB; TKG)
ST TH01: 6
ST TPOX: 8
ST vWA: 14,17
DI NCIt; C4436; Cholangiocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID TFP-10
AC CVCL_H251
SY TFP10; TFP 10
RX PubMed=6932214;
CC Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV).
CC Breed/subspecies: DBA/2.
DI NCIt; C21895; Mouse erythroid leukemia
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID TFS-2
AC CVCL_J858
DR CLO; CLO_0050356
DR RCB; RCB2203
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3412 ! P3X63Ag8U.1
CA Hybridoma
//
ID TFS-4
AC CVCL_J859
DR CLO; CLO_0050357
DR RCB; RCB2204
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3412 ! P3X63Ag8U.1
CA Hybridoma
//
ID TFTA1
AC CVCL_D036
SY TFT A1; 3721.95.161.4
DR CLO; CLO_0009331
DR ATCC; CRL-1771
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_D037 ! Sp2/5
CA Hybridoma
//
ID TFTB1
AC CVCL_2732
SY TFT B1; 3916.120.15
DR CLO; CLO_0009332
DR ATCC; CRL-1759
DR ECACC; 94102701
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_D037 ! Sp2/5
CA Hybridoma
//
ID TG-1
AC CVCL_0P34
SY TG1
RX PubMed=1378830;
RX PubMed=2424598;
DI NCIt; C8000; Testicular yolk sac tumor
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0P33 ! JTG-1
SX Male
CA Cancer cell line
//
ID TG1
AC CVCL_8555
DR JCRB; JCRB0626
CC Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_2234 ! V79
SX Male
CA Spontaneously immortalized cell line
//
ID Tg1.K
AC CVCL_S182
DR ATCC; CRL-6263
CC Group: Cetacean cell line.
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6263; true.
OX NCBI_TaxID=9739; ! Tursiops truncatus
OI CVCL_S183 ! Tg1.Sp
OI CVCL_S184 ! Tg1.Thy
SX Female
CA Finite cell line
//
ID Tg1.Sp
AC CVCL_S183
DR ATCC; CRL-6264
CC Group: Cetacean cell line.
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6264; true.
OX NCBI_TaxID=9739; ! Tursiops truncatus
OI CVCL_S182 ! Tg1.K
OI CVCL_S184 ! Tg1.Thy
SX Female
CA Finite cell line
//
ID Tg1.Thy
AC CVCL_S184
DR ATCC; CRL-6265
CC Group: Cetacean cell line.
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6265; true.
OX NCBI_TaxID=9739; ! Tursiops truncatus
OI CVCL_S182 ! Tg1.K
OI CVCL_S183 ! Tg1.Sp
SX Female
CA Finite cell line
//
ID TG2
AC CVCL_F231
SY TG-2; GM00345
DR CLO; CLO_0025561
DR Coriell; GM00345
RX PubMed=5062896;
OX NCBI_TaxID=10036; ! Mesocricetus auratus
HI CVCL_1915 ! BHK-21 clone 13
SX Male
CA Spontaneously immortalized cell line
//
ID TGBC-47
AC CVCL_H709
RX CelloPub=CLPUB00275;
RX PubMed=14532968;
RX PubMed=15645130;
CC Derived from metastatic site: Lymph node.
DI NCIt; C4436; Cholangiocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID TGBC11TKB
AC CVCL_1768
SY TGBC-11-TKB; TGBC11T
DR CLO; CLO_0050801
DR BioSample; SAMN03472160
DR CCLE; TGBC11TKB_STOMACH
DR ChEMBL-Cells; CHEMBL3308557
DR ChEMBL-Targets; CHEMBL2366374
DR Cosmic; 909770
DR Cosmic; 1187297
DR Cosmic; 1518259
DR Cosmic-CLP; 909770
DR GDSC; 909770
DR GEO; GSM887705
DR GEO; GSM888798
DR GEO; GSM1670539
DR RCB; RCB1148
RX PubMed=22460905;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Lymph node.
ST Source(s): Cosmic-CLP; PubMed=11416159; RCB
ST Amelogenin: X
ST CSF1PO: 9,12
ST D13S317: 8,9
ST D16S539: 9
ST D18S51: 11,19
ST D21S11: 29,30
ST D5S818: 8,12
ST D7S820: 10,11
ST D8S1179: 15,16
ST FGA: 20,21
ST TH01: 6,9
ST TPOX: 8
ST vWA: 18,20,21 (Cosmic-CLP; PubMed=11416159)
ST vWA: 18,19,20 (RCB)
DI NCIt; C4911; Gastric carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID TGBC14TKB
AC CVCL_3340
SY TGBC-14-TKB; TGBC-14
DR CLO; CLO_0050016
DR BioSample; SAMN03472174
DR RCB; RCB1186
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 12
ST D16S539: 9
ST D5S818: 12
ST D7S820: 10
ST TH01: 6,7
ST TPOX: 8,13
ST vWA: 14
DI NCIt; C3844; Gallbladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID TGBC18TKB
AC CVCL_3338
SY TGBC-18-TKB; TGBC-18TKB
DR CLO; CLO_0051538
DR BioSample; SAMN03472165
DR RCB; RCB1169
ST Source(s): PubMed=11416159; RCB
ST Amelogenin: X
ST CSF1PO: 12,14
ST D13S317: 8
ST D16S539: 9
ST D18S51: 15
ST D21S11: 31.2,32.2
ST D5S818: 12,14
ST D7S820: 11,12
ST D8S1179: 13,15
ST FGA: 21,23
ST TH01: 9,9.3
ST TPOX: 8
ST vWA: 18
DI NCIt; C6650; Ampulla of Vater adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID TGBC1TKB
AC CVCL_1769
SY TGBC-1-TKB; TGBC-1TKB; TGBC1-TKB; TGBC-1
DR CLO; CLO_0050019
DR BioSample; SAMN03472156
DR ChEMBL-Cells; CHEMBL3308852
DR ChEMBL-Targets; CHEMBL2366089
DR Cosmic; 909769
DR Cosmic-CLP; 909769
DR GDSC; 909769
DR GEO; GSM1670540
DR RCB; RCB1129
RX PubMed=9824643;
RX PubMed=21533411;
RX PubMed=27397505;
CC Doubling time: 41 hours (PubMed=9824643).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Derived from metastatic site: Lymph node.
ST Source(s): Cosmic-CLP; RCB
ST Amelogenin: X
ST CSF1PO: 14
ST D13S317: 8,11
ST D16S539: 9,11
ST D5S818: 11
ST D7S820: 9,13
ST TH01: 9
ST TPOX: 8
ST vWA: 14,17
DI NCIt; C9167; Undifferentiated gallbladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_3339 ! TGBC2TKB
SX Female
CA Cancer cell line
//
ID TGBC24TKB
AC CVCL_1770
SY TGBC-24-TKB
DR CLO; CLO_0050018
DR BioSample; SAMN03472177
DR ChEMBL-Cells; CHEMBL3308856
DR ChEMBL-Targets; CHEMBL2366093
DR Cosmic; 910695
DR Cosmic-CLP; 910695
DR GDSC; 910695
DR GEO; GSM1670541
DR RCB; RCB1196
RX PubMed=27397505;
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Derived from metastatic site: Ascites.
ST Source(s): Cosmic-CLP; RCB
ST Amelogenin: X
ST CSF1PO: 12,13
ST D13S317: 12
ST D16S539: 9,10
ST D5S818: 11
ST D7S820: 10,11
ST TH01: 6
ST TPOX: 8
ST vWA: 16
DI NCIt; C3844; Gallbladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID TGBC2TKB
AC CVCL_3339
SY TGBC-2-TKB; TGBC-2TKB; TGBC-2
DR CLO; CLO_0050015
DR RCB; RCB1130
RX PubMed=21533411;
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 14
ST D13S317: 8,11
ST D16S539: 9,11
ST D5S818: 11
ST D7S820: 9,13
ST TH01: 9
ST TPOX: 8
ST vWA: 14,17
DI NCIt; C9167; Undifferentiated gallbladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1769 ! TGBC1TKB
SX Female
CA Cancer cell line
//
ID TGBC41TKB
AC CVCL_E144
SY TGBC-41-TKB
DR RCB; RCB1254
CC Discontinued: RCB; RCB1254; true.
DI NCIt; C3844; Gallbladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID TGBC44TKB
AC CVCL_E145
SY TGBC-44-TKB; TGBC-44TKB; TGBC-44
DR RCB; RCB1259
RX PubMed=9824643;
RX PubMed=14532968;
RX PubMed=21533411;
CC Doubling time: 30 hours (PubMed=9824643).
CC Discontinued: RCB; RCB1259; true.
CC Derived from metastatic site: Lymph node.
DI NCIt; C7356; Gallbladder adenosquamous carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID TGBC50TKB
AC CVCL_H693
DR CLO; CLO_0050114
DR BioSample; SAMN03472123
DR PRIDE; PXD002657
DR RCB; RCB1280
RX PubMed=26951071;
CC Omics: Deep proteome analysis.
CC Derived from metastatic site: Liver.
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 8
ST D16S539: 10
ST D5S818: 9,11
ST D7S820: 10,11
ST TH01: 7,8
ST TPOX: 8,9
ST vWA: 14,16
DI NCIt; C27418; Ampulla of Vater adenosquamous carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_H694 ! TGBC51TKB
OI CVCL_H695 ! TGBC52TKB
SX Male
CA Cancer cell line
//
ID TGBC51TKB
AC CVCL_H694
SY TGBC-51TKB; TGBC-51
DR CLO; CLO_0050116
DR RCB; RCB1281
RX CelloPub=CLPUB00275;
RX PubMed=9824643;
RX PubMed=15645130;
CC Doubling time: 96 hours (PubMed=9824643).
CC Derived from metastatic site: Liver.
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 8
ST D16S539: 10
ST D5S818: 9,11
ST D7S820: 10,11
ST TH01: 7,8
ST TPOX: 8,9
ST vWA: 14,16
DI NCIt; C27418; Ampulla of Vater adenosquamous carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_H693 ! TGBC50TKB
OI CVCL_H695 ! TGBC52TKB
SX Male
CA Cancer cell line
//
ID TGBC52TKB
AC CVCL_H695
DR CLO; CLO_0050115
DR RCB; RCB1282
CC Derived from metastatic site: Lymph node.
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 8
ST D16S539: 10
ST D5S818: 9,11
ST D7S820: 10,11
ST TH01: 7,8
ST TPOX: 8,9
ST vWA: 14,16
DI NCIt; C27418; Ampulla of Vater adenosquamous carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_H693 ! TGBC50TKB
OI CVCL_H694 ! TGBC51TKB
SX Male
CA Cancer cell line
//
ID TGBG3
AC CVCL_B472
RX CelloPub=CLPUB00145;
WW http://www.lib.yamagata-u.ac.jp/medical/ymj/19-2-4.html
DI NCIt; C3844; Gallbladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID TGE-R
AC CVCL_0I63
SY TGE
DR CCLV; CCLV-RIE 0256
RX PubMed=19941903;
CC Group: Bird cell line.
OX NCBI_TaxID=8932; ! Columba livia
CA Finite cell line
//
ID TGI
AC CVCL_F584
SY TER53; TER218; TER282; TER344
DR IMGT/HLA; 11452
CC Part of: International Histocompatibility Workshop cell lines.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID tGM24
AC CVCL_7703
SY hTERT-GM00024; HTERT-GM00024
RX PubMed=16140041;
CC Transfected with: HGNC; 11730; TERT.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_7269 ! GM00024
SX Male
CA Telomerase immortalized cell line
//
ID TGP47
AC CVCL_4318
SY TGP 47
DR CLO; CLO_0009338
DR ATCC; CRL-2141
RX PubMed=7904904;
RX PubMed=12006552;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: Tg(E1a-1-SV40E)Bri18 transgenic.
DI NCIt; C34036; Mouse pancreatic acinar neoplasm
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Cancer cell line
//
ID TGP48
AC CVCL_IV01
RX PubMed=7904904;
RX PubMed=12006552;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: Tg(E1a-1-SV40E)Bri18 transgenic.
DI NCIt; C34036; Mouse pancreatic acinar neoplasm
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Cancer cell line
//
ID TGP49
AC CVCL_4319
SY TGP 49
DR CLO; CLO_0009334
DR CLO; CLO_0009339
DR CLDB; cl4504
DR ATCC; CRL-2136
DR ECACC; 94022427
RX PubMed=7904904;
RX PubMed=12006552;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: Tg(E1a-1-SV40E)Bri18 transgenic.
DI NCIt; C34036; Mouse pancreatic acinar neoplasm
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Cancer cell line
//
ID TGP50
AC CVCL_IV02
RX PubMed=7904904;
RX PubMed=12006552;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: Tg(E1a-1-SV40E)Bri18 transgenic.
DI NCIt; C34036; Mouse pancreatic acinar neoplasm
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Cancer cell line
//
ID TGP51
AC CVCL_IV03
RX PubMed=7904904;
RX PubMed=12006552;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: Tg(E1a-1-SV40E)Bri18 transgenic.
DI NCIt; C34036; Mouse pancreatic acinar neoplasm
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Cancer cell line
//
ID TGP52
AC CVCL_4320
SY TGP 52
DR CLO; CLO_0009335
DR CLO; CLO_0009340
DR CLDB; cl4505
DR ATCC; CRL-2140
DR ECACC; 94022429
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: Tg(E1a-1-SV40E)Bri18 transgenic.
DI NCIt; C34036; Mouse pancreatic acinar neoplasm
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Cancer cell line
//
ID TGP54
AC CVCL_4307
SY TGP 54
DR CLO; CLO_0009336
DR CLDB; cl4506
DR ECACC; 94022430
RX PubMed=7904904;
RX PubMed=12006552;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: Tg(E1a-1-SV40E)Bri18 transgenic.
DI NCIt; C34036; Mouse pancreatic acinar neoplasm
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID TGP55
AC CVCL_4322
SY TGP 55
DR CLO; CLO_0009337
DR CLO; CLO_0009341
DR CLDB; cl4507
DR ATCC; CRL-2150
DR ECACC; 95062833
RX PubMed=7904904;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: Tg(E1a-1-SV40E)Bri18 transgenic.
DI NCIt; C34036; Mouse pancreatic acinar neoplasm
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Cancer cell line
//
ID TGP61
AC CVCL_4323
SY TGP 61
DR CLO; CLO_0009342
DR ATCC; CRL-2135
RX PubMed=7904904;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: Tg(E1a-1-SV40E)Bri18 transgenic.
DI NCIt; C34036; Mouse pancreatic acinar neoplasm
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Cancer cell line
//
ID TGR-1
AC CVCL_T955
DR TOKU-E; 3592
RX PubMed=8455944;
CC Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG).
CC Breed/subspecies: Fischer 344.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_0492 ! Rat1
CA Spontaneously immortalized cell line
//
ID TgSVA
AC CVCL_U966
RX PubMed=8389915;
CC Transfected with: HGNC; 9705; PVR.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: ICR.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID TgSVB
AC CVCL_U967
RX PubMed=8389915;
CC Transfected with: HGNC; 9705; PVR.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: ICR.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID TGW
AC CVCL_1771
SY TOG; TGW-nu; TGW-I-nu; TGW-nu-1
DR BioSample; SAMN03471635
DR ChEMBL-Cells; CHEMBL3308792
DR ChEMBL-Targets; CHEMBL1075600
DR Cosmic; 801749
DR Cosmic; 910780
DR Cosmic; 920238
DR Cosmic; 947703
DR Cosmic; 1037349
DR Cosmic; 1099146
DR Cosmic; 1153801
DR Cosmic; 2131589
DR Cosmic-CLP; 910780
DR GDSC; 910780
DR GEO; GSM314028
DR GEO; GSM333815
DR GEO; GSM1670542
DR JCRB; JCRB0618
RX PubMed=2335222;
RX PubMed=18923524;
RX PubMed=27397505;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/t/cell-lines-detail-424.html
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
ST Source(s): Cosmic-CLP; JCRB
ST Amelogenin: X
ST CSF1PO: 15
ST D13S317: 8,11
ST D16S539: 9,13
ST D5S818: 13
ST D7S820: 12
ST TH01: 6,7
ST TPOX: 10,11
ST vWA: 14,18
DI NCIt; C4827; Adrenal gland neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID TGW.P3
AC CVCL_3180
DR BioSample; SAMN03471636
DR JCRB; JCRB0618.1
DR JCRB; NIHS0371
CC Discontinued: JCRB; NIHS0371; true.
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 15
ST D13S317: 8,11
ST D16S539: 9,13
ST D5S818: 13
ST D7S820: 12
ST TH01: 6,7
ST TPOX: 11
ST vWA: 14,18
DI NCIt; C4827; Adrenal gland neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1771 ! TGW
SX Male
CA Cancer cell line
//
ID TH
AC CVCL_M528
DR Cosmic; 720794
DR Cosmic; 760395
DR Cosmic; 2302419
RX PubMed=1958480;
RX PubMed=8943038;
RX PubMed=10087940;
RX PubMed=10936422;
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID TH-1
AC CVCL_G000
DR TKG; TKG 0270
RX PubMed=2562090;
ST Source(s): TKG
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 8,11
ST D16S539: 9
ST D5S818: 11,12
ST D7S820: 10,11
ST TH01: 7,9
ST TPOX: 11
ST vWA: 14,16
DI NCIt; C3728; Hepatoblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID TH-1 subline B1
AC CVCL_4324
SY TH-1, Subline B1; TH-1, Sub B1; TH-1
DR CLO; CLO_0009343
DR CLDB; cl4508
DR CLDB; cl4509
DR ATCC; CCL-50
DR CCLV; CCLV-RIE 1131
DR ECACC; 90102528
RX PubMed=4295486;
RX PubMed=19941903;
CC Group: Reptilian cell line.
CC Discontinued: ECACC; 90102528; probable.
OX NCBI_TaxID=158814; ! Terrapene carolina
CA Spontaneously immortalized cell line
//
ID TH1
AC CVCL_5J51
RX Patent=US20050136539;
RX PubMed=15208689;
WW https://www.kerafast.com/product/1167/human-renal-proximal-tubule-epithelial-th1-cell-line
CC Transfected with: HGNC; 11730; TERT.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_5J52 ! TH7
CA Transformed cell line
//
ID TH202
AC CVCL_AS73
WW https://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-str-profiles
CC Part of: Wistar Institute melanoma cell line collection.
ST Source(s): Wistar
ST Amelogenin: X
ST CSF1PO: 10,13
ST D13S317: 12,14
ST D16S539: 12
ST D18S51: 13,17
ST D19S433: 15,15.2
ST D21S11: 28,29
ST D2S1338: 20,25
ST D3S1358: 14,18
ST D5S818: 7,10
ST D7S820: 8,10
ST D8S1179: 11,14
ST FGA: 20
ST TH01: 8,9
ST TPOX: 8,11
ST vWA: 16
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID TH7
AC CVCL_5J52
RX Patent=US20050136539;
RX PubMed=15208689;
CC Transfected with: HGNC; 11730; TERT.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_5J51 ! TH1
CA Transformed cell line
//
ID THA
AC CVCL_E847
SY TER332; TER425
DR dbMHC; 49039
DR ECACC; 94050318
DR IHW; IHW9327
DR IMGT/HLA; 11456
WW http://bioinformatics.hsanmartino.it/ecbr/cl327.html
CC Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID THAI742
AC CVCL_E848
SY THAI 742; TER336
DR dbMHC; 49040
DR ECACC; 94022548
DR IHW; IHW9253
DR IMGT/HLA; 11472
WW http://bioinformatics.hsanmartino.it/ecbr/cl253.html
CC Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID THB-5
AC CVCL_2215
SY HB-5; HB5
DR CLO; CLO_0009344
DR CLDB; cl4510
DR ATCC; HB-135
DR DSMZ; ACC-88
CC Doubling time: ~50 hours (DSMZ).
CC Monoclonal antibody target: UniProtKB; P20023; Human CR2/CD21.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID THB-7
AC CVCL_D038
SY HB-7; HB7
DR CLO; CLO_0009345
DR ATCC; HB-136
RX PubMed=6440308;
CC Monoclonal antibody target: UniProtKB; P28907; Human CD38.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID THC-252
AC CVCL_6732
SY THC 252
DR BTO; BTO:0004336
RX PubMed=2990676;
CC Transformant: ChEBI; CHEBI:17356; 2-acetamidofluorene (2AAF).
CC Breed/subspecies: ACI.
DI NCIt; C60416; Rat hepatocellular carcinoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Cancer cell line
//
ID THC-253
AC CVCL_6733
SY THC 253; THC253
RX PubMed=2990676;
CC Transformant: ChEBI; CHEBI:17356; 2-acetamidofluorene (2AAF).
CC Breed/subspecies: ACI.
DI NCIt; C60416; Rat hepatocellular carcinoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Cancer cell line
//
ID THC-H5D
AC CVCL_6734
SY H5D
DR BTO; BTO:0004337
DI NCIt; C60416; Rat hepatocellular carcinoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Cancer cell line
//
ID THG1-24
AC CVCL_J775
DR ECACC; 87120202
CC Discontinued: ECACC; 87120202; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3949 ! J558L
CA Hybridoma
//
ID THG3-B5-13
AC CVCL_J094
DR ECACC; 88022402
RX PubMed=3500259;
CC Monoclonal antibody target: ChEBI; CHEBI:53793; (4-hydroxy-3-nitrophenyl)acetyl group (NP).
OX NCBI_TaxID=9606; ! Homo sapiens
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3949 ! J558L
CA Hybridoma
//
ID THG3-MP-2-19-3-8
AC CVCL_J095
DR ECACC; 88012701
RX PubMed=3500259;
CC Monoclonal antibody target: ChEBI; CHEBI:53793; (4-hydroxy-3-nitrophenyl)acetyl group (NP).
OX NCBI_TaxID=9606; ! Homo sapiens
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3949 ! J558L
CA Hybridoma
//
ID THJ-11T
AC CVCL_W919
SY THJ11T
DR Cosmic; 2054093
RX PubMed=20810568;
RX PubMed=23724124;
RX PubMed=23833040;
CC Doubling time: 30 hours (PubMed=20810568).
CC Miscellaneous: STR profile from personal communication of Marlow L.A.
CC Caution: Cell line wrongly indicated as being female in figure 2A of PubMed=20810568.
ST Source(s): Direct_author_submission
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 8,13
ST D16S539: 12,13
ST D18S51: 12,14
ST D3S1358: 14,17
ST D5S818: 13
ST D7S820: 9
ST D8S1179: 13
ST FGA: 21,24
ST TH01: 5,6
ST TPOX: 8,11
ST vWA: 16,17
DI NCIt; C3878; Thyroid gland undifferentiated (anaplastic) carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID THJ-16T
AC CVCL_W920
SY THJ16T
DR Cosmic; 2054100
RX PubMed=20810568;
RX PubMed=23724124;
RX PubMed=23833040;
CC Doubling time: 27 hours (PubMed=20810568).
CC Miscellaneous: STR profile from personal communication of Marlow L.A.
ST Source(s): Direct_author_submission
ST Amelogenin: X
ST CSF1PO: 11,14
ST D13S317: 10,11
ST D16S539: 9,12
ST D18S51: 17,19
ST D3S1358: 15,16
ST D5S818: 11,12
ST D7S820: 10,12
ST D8S1179: 12,13
ST FGA: 23,27
ST TH01: 8,9
ST TPOX: 8,11
ST vWA: 16,17
DI NCIt; C3878; Thyroid gland undifferentiated (anaplastic) carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID THJ-21T
AC CVCL_W921
SY THJ21T
DR Cosmic; 2054082
RX PubMed=20810568;
RX PubMed=23724124;
RX PubMed=23833040;
CC Doubling time: 43 hours (PubMed=20810568).
CC Miscellaneous: STR profile from personal communication of Marlow L.A.
ST Source(s): Direct_author_submission
ST Amelogenin: X,Y
ST CSF1PO: 11,15
ST D13S317: 11
ST D16S539: 12
ST D18S51: 13,15
ST D3S1358: 15,17
ST D5S818: 12,13
ST D7S820: 10
ST D8S1179: 14
ST FGA: 24
ST TH01: 6
ST TPOX: 8,12
ST vWA: 16
DI NCIt; C3878; Thyroid gland undifferentiated (anaplastic) carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID THJ-29T
AC CVCL_W922
SY THJ29T
DR Cosmic; 2054113
RX PubMed=20810568;
RX PubMed=23724124;
RX PubMed=23833040;
CC Doubling time: 35 hours (PubMed=20810568).
CC Miscellaneous: STR profile from personal communication of Marlow L.A.
ST Source(s): Direct_author_submission
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 12
ST D16S539: 12,13
ST D18S51: 15
ST D3S1358: 16,18
ST D5S818: 11,14
ST D7S820: 10
ST D8S1179: 14,16
ST FGA: 22,26
ST TH01: 7
ST TPOX: 8,9
ST vWA: 16,18
DI NCIt; C3878; Thyroid gland undifferentiated (anaplastic) carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID THK [Hamster]
AC CVCL_U475
SY Transformed Hamster Kidney
DR CLO; CLO_0051402
DR RCB; RCB1832
RX PubMed=7288919;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10036; ! Mesocricetus auratus
CA Transformed cell line
//
ID THK [Tilapia]
AC CVCL_DE02
SY Tilapia Head Kidney
RX PubMed=26806163;
CC Group: Fish cell line.
OX NCBI_TaxID=8128; ! Oreochromis niloticus
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID THK-1
AC CVCL_DE00
SY Transformed Hamster Kidney-1
RX PubMed=14077486;
RX PubMed=14206435;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [777].
OX NCBI_TaxID=10036; ! Mesocricetus auratus
CA Transformed cell line
//
ID THLE-2
AC CVCL_3803
SY THLE2; Transformed Human Liver Epithelial-2
DR CLO; CLO_0009346
DR ATCC; CRL-2706
DR ATCC; CRL-10149
DR BioSample; SAMN03471297
DR Cosmic; 2162542
DR IZSLER; BS CL 194
RX DOI=10.1007/978-1-4612-0411-4_31;
RX Patent=US5759765;
RX PubMed=7685115;
RX PubMed=23887712;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 11,13
ST D13S317: 8,12
ST D16S539: 11,13
ST D5S818: 11,13
ST D7S820: 10,12
ST TH01: 7,9.3
ST TPOX: 8,11
ST vWA: 16,17
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID THLE-3
AC CVCL_3804
SY Transformed Human Liver Epithelial-3
DR CLO; CLO_0009347
DR ATCC; CRL-11233
DR BioSample; SAMN03471331
DR Cosmic; 2162543
RX DOI=10.1007/978-1-4612-0411-4_31;
RX Patent=US5759765;
RX PubMed=7685115;
RX PubMed=23887712;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 13
ST D16S539: 11,12
ST D5S818: 13
ST D7S820: 8,10
ST TH01: 8,9.3
ST TPOX: 6,9
ST vWA: 17,18
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID THLE-5B
AC CVCL_M209
SY THLE-5b; THLE-5; Transformed Human Liver Epithelial-5B
DR BTO; BTO:0005782
DR ATCC; CRL-11113
RX DOI=10.1007/978-1-4612-0411-4_31;
RX Patent=US5506131;
RX PubMed=16962796;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Discontinued: ATCC; CRL-11113; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID THLE-5B-1A1
AC CVCL_IQ12
RX Patent=US5506131;
CC Transfected with: HGNC; 2595; CYP1A1.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_M209 ! THLE-5B
CA Transformed cell line
//
ID THLE-5B-1A2
AC CVCL_IQ13
RX Patent=US5506131;
RX PubMed=22851615;
CC Transfected with: HGNC; 2596; CYP1A2.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_M209 ! THLE-5B
CA Transformed cell line
//
ID THLE-5B-2A6
AC CVCL_IQ14
RX Patent=US5506131;
CC Transfected with: HGNC; 2610; CYP2A6.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_M209 ! THLE-5B
CA Transformed cell line
//
ID THLE-5B-2B6
AC CVCL_IQ15
RX Patent=US5506131;
CC Transfected with: HGNC; 2615; CYP2B6.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_M209 ! THLE-5B
CA Transformed cell line
//
ID THLE-5B-2C19
AC CVCL_IQ16
RX PubMed=22851615;
CC Transfected with: HGNC; 2621; CYP2C19.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_M209 ! THLE-5B
CA Transformed cell line
//
ID THLE-5B-2C9
AC CVCL_IQ17
RX Patent=US5506131;
RX PubMed=22851615;
CC Transfected with: HGNC; 2623; CYP2C9.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_M209 ! THLE-5B
CA Transformed cell line
//
ID THLE-5B-2D6
AC CVCL_IQ18
RX Patent=US5506131;
RX PubMed=22851615;
CC Transfected with: HGNC; 2625; CYP2D6.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_M209 ! THLE-5B
CA Transformed cell line
//
ID THLE-5B-2E1
AC CVCL_IQ19
RX Patent=US5506131;
CC Transfected with: HGNC; 2631; CYP2E1.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_M209 ! THLE-5B
CA Transformed cell line
//
ID THLE-B5-3A4
AC CVCL_IQ20
RX Patent=US5506131;
RX PubMed=22851615;
CC Transfected with: HGNC; 2637; CYP3A4.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_M209 ! THLE-5B
CA Transformed cell line
//
ID THM 7.3.5
AC CVCL_J092
DR ECACC; 87120201
CC Discontinued: ECACC; 87120201; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3949 ! J558L
CA Hybridoma
//
ID tHmf-e
AC CVCL_0A61
RX PubMed=3515628;
CC Breed/subspecies: Sprague-Dawley.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_0A60 ! tHmf-f
SX Male
CA Spontaneously immortalized cell line
//
ID tHmf-f
AC CVCL_0A60
RX PubMed=3515628;
CC Breed/subspecies: Sprague-Dawley.
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Male
CA Spontaneously immortalized cell line
//
ID THO
AC CVCL_E849
DR IHW; IHW1406
WW http://bioinformatics.hsanmartino.it/ecbr/cl382.html
CC Part of: 9th International Histocompatibility Workshop (9IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID THO,MA
AC CVCL_E850
SY THO, MA
DR dbMHC; 49041
DR ECACC; 94082258
DR IHW; IHW9158
DR IMGT/HLA; 11701
RX PubMed=8307784;
WW http://bioinformatics.hsanmartino.it/ecbr/cl158.html
CC Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID ThoCu
AC CVCL_U958
RX PubMed=14490970;
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID THP-1
AC CVCL_0006
SY THP1; THP 1; THPI; THP-1(ATCC)
DR BTO; BTO:0001370
DR CLO; CLO_0009348
DR CLO; CLO_0050999
DR EFO; EFO_0001253
DR MCCL; MCC:0000461
DR CLDB; cl4513
DR CLDB; cl4514
DR CLDB; cl4515
DR CLDB; cl4517
DR ATCC; TIB-202
DR BCRC; 60430
DR BCRJ; 0234
DR BioSample; SAMN03470795
DR BioSample; SAMN03473256
DR BioSample; SAMN03473419
DR CCLE; THP1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
DR CCRID; 3111C0001CCC000057
DR CCRID; 3111C0002000000058
DR CCRID; 3131C0001000700057
DR CCRID; 3142C0001000000114
DR ChEMBL-Cells; CHEMBL3307574
DR ChEMBL-Targets; CHEMBL614245
DR CLS; 300356/p804_THP-1
DR Cosmic; 717684
DR Cosmic; 724818
DR Cosmic; 787480
DR Cosmic; 909771
DR Cosmic; 919122
DR Cosmic; 924051
DR Cosmic; 975303
DR Cosmic; 991556
DR Cosmic; 996316
DR Cosmic; 998748
DR Cosmic; 1012124
DR Cosmic; 1037666
DR Cosmic; 1070694
DR Cosmic; 1078722
DR Cosmic; 1089517
DR Cosmic; 1150901
DR Cosmic; 1176587
DR Cosmic; 1181604
DR Cosmic; 1187864
DR Cosmic; 1197931
DR Cosmic; 1278779
DR Cosmic; 1281356
DR Cosmic; 1319551
DR Cosmic; 1476425
DR Cosmic; 1519163
DR Cosmic; 1524842
DR Cosmic; 1601064
DR Cosmic; 2089655
DR Cosmic; 2131559
DR Cosmic; 2306241
DR Cosmic; 2392976
DR Cosmic-CLP; 909771
DR DSMZ; ACC-16
DR ECACC; 88081201
DR GDSC; 909771
DR GEO; GSM236807
DR GEO; GSM236843
DR GEO; GSM482495
DR GEO; GSM887706
DR GEO; GSM888799
DR GEO; GSM1374962
DR GEO; GSM1670543
DR ICLC; HTL97014
DR IGRhCellID; THP1
DR IZSLER; BS TCL 138
DR JCRB; JCRB0112
DR JCRB; JCRB0112.1
DR KCB; KCB 200549YJ
DR KCLB; 40202
DR LINCS; 50861
DR NCBI_Iran; C563
DR NIH-ARP; 9942-142
DR PRIDE; PXD000328
DR RCB; RCB1189
DR TKG; TKG 0267
DR Wikidata; Q7670282
RX PubMed=6091813;
RX PubMed=6970727;
RX PubMed=9290701;
RX PubMed=9738977;
RX PubMed=11414198;
RX PubMed=15843827;
RX PubMed=16408098;
RX PubMed=19377474;
RX PubMed=22460905;
RX PubMed=23955599;
RX PubMed=25130606;
RX PubMed=25485619;
RX PubMed=25984343;
RX PubMed=27397505;
RX PubMed=28196595;
WW https://en.wikipedia.org/wiki/THP-1_cell_line
WW http://www.proteinatlas.org/learn/cellines
WW https://strap.nci.nih.gov/celline_detail.php?sample_id=78
WW http://www.infarktforschung.de/macrophages_cell_lines.html
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/t/cell-lines-detail-444.html
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Part of: RAS genetic alteration cell panel (ATCC TCP-1031).
CC Characteristics: Can differentiate from monocytes into macrophage-like cells upon stimulation with PMA.
CC Doubling time: 26 hours (PubMed=25984343); ~35-50 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep antibody staining analysis.
CC Omics: Deep exome analysis.
CC Omics: Deep promoter analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; CLS; Cosmic-CLP; DSMZ; ECACC; ICLC; JCRB; KCLB; PubMed=11416159; PubMed=25877200; RCB; TKG
ST Amelogenin: X,Y
ST CSF1PO: 11,13
ST D13S317: 13 (ATCC; CLS; Cosmic-CLP; ECACC; JCRB; KCLB; PubMed=25877200)
ST D13S317: 8,13 (DSMZ; RCB; TKG)
ST D16S539: 11,12
ST D18S51: 13,14
ST D21S11: 30,31.2
ST D3S1358: 15,17
ST D5S818: 11,12
ST D7S820: 10
ST D8S1179: 10,14
ST FGA: 24,25
ST Penta D: 10,12
ST Penta E: 11,15
ST TH01: 8,9.3 (ATCC; CLS; Cosmic-CLP; DSMZ; ECACC; ICLC; KCLB; PubMed=11416159; PubMed=25877200; RCB; TKG)
ST TH01: 8,10 (JCRB)
ST TPOX: 8,11
ST vWA: 16 (ATCC; CLS; Cosmic-CLP; ECACC; ICLC; JCRB; KCLB; PubMed=11416159; PubMed=25877200)
ST vWA: 16,17 (DSMZ; RCB; TKG)
DI NCIt; C9163; Childhood acute monocytic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID THP-1 NucLight Red
AC CVCL_DF52
WW http://www.essenbioscience.com/essen-products/reagents-and-consumables/thp-1-nuclight-red-cells-cat-no-4612/
CC Characteristics: Stably expresses a non-perturbing nuclear restricted red fluorescent label.
CC Transfected with: mKate2; a bright red fluorescent protein derived from eqFP578.
DI NCIt; C9163; Childhood acute monocytic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0006 ! THP-1
SX Male
CA Cancer cell line
//
ID THP-1/ara-C
AC CVCL_4V22
RX PubMed=21290089;
CC Selected for resistance to: ChEBI; CHEBI:28680; Cytarabine (Arabinosylcytosine; Ara-C).
DI NCIt; C9163; Childhood acute monocytic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0006 ! THP-1
SX Male
CA Cancer cell line
//
ID THP-1/DC-SIGN
AC CVCL_0R21
SY THP-1(ATCC)/DC-SIGN; THP-1ATCC/DC-SIGN
DR NIH-ARP; 9943-457
RX PubMed=14972530;
CC Transfected with: HGNC; 1641; CD209.
DI NCIt; C9163; Childhood acute monocytic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0006 ! THP-1
SX Male
CA Cancer cell line
//
ID THP-1(NCI)
AC CVCL_0R25
SY THP-1NCI
DR NIH-ARP; 9949-380
RX PubMed=14972530;
DI NCIt; C9163; Childhood acute monocytic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0006 ! THP-1
SX Male
CA Cancer cell line
//
ID THP-1(NCI)/DC-SIGN
AC CVCL_0R26
SY THP-1NCI/DC-SIGN
DR NIH-ARP; 9950-48
RX PubMed=14972530;
CC Doubling time: ~24 hours (NIH-ARP).
CC Transfected with: HGNC; 1641; CD209.
DI NCIt; C9163; Childhood acute monocytic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0R25 ! THP-1(NCI)
SX Male
CA Cancer cell line
//
ID THP-1h
AC CVCL_3426
SY THP-1 h
DR CLDB; cl7171
DR ICLC; HTL05008
ST Source(s): ICLC
ST Amelogenin: X,Y
ST D18S51: 13,14
ST D21S11: 30,31.2
ST D8S1179: 10,14
ST FGA: 24,25
ST TH01: 8,9.3
ST vWA: 16
DI NCIt; C9163; Childhood acute monocytic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0006 ! THP-1
SX Male
CA Cancer cell line
//
ID THP-1l
AC CVCL_3427
SY THP-1 l
DR CLDB; cl7172
DR ICLC; HTL05009
ST Source(s): ICLC
ST Amelogenin: X,Y
ST D18S51: 13,14
ST D21S11: 30,31.2
ST D8S1179: 10,14
ST FGA: 24,25
ST TH01: 8,9.3
ST vWA: 16
DI NCIt; C9163; Childhood acute monocytic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0006 ! THP-1
SX Male
CA Cancer cell line
//
ID THP-2
AC CVCL_9252
RX PubMed=6314596;
CC Characteristics: EBV-negative.
DI NCIt; C2912; Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID THP-3-1
AC CVCL_9250
RX PubMed=6605598;
DI NCIt; C3168; Childhood acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_9251 ! THP-3-2
SX Female
CA Cancer cell line
//
ID THP-3-2
AC CVCL_9251
RX PubMed=6605598;
DI NCIt; C3168; Childhood acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_9250 ! THP-3-1
SX Female
CA Cancer cell line
//
ID THP-4
AC CVCL_9247
DR Cosmic; 1037728
RX PubMed=2954268;
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID THP-5
AC CVCL_A441
DR Cosmic; 1037729
DI NCIt; C8644; B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID THP-6
AC CVCL_4686
DR BTO; BTO:0004926
DR Cosmic; 721719
DR Cosmic; 801718
DR Cosmic; 998732
DR Cosmic; 1037684
DR Cosmic; 1375584
RX PubMed=2954268;
RX PubMed=3130528;
RX PubMed=10071127;
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID THP-7
AC CVCL_9248
DR Cosmic; 1037730
RX PubMed=2954268;
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID THP-8
AC CVCL_4687
DR BTO; BTO:0004927
DR Cosmic; 710462
DR Cosmic; 801719
DR Cosmic; 998705
DR Cosmic; 1037731
RX PubMed=2954268;
RX PubMed=7727782;
DI NCIt; C9140; Childhood B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID THP-9
AC CVCL_9249
RX PubMed=2954268;
DI NCIt; C5165; Childhood lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID THP1-Blue ISG
AC CVCL_X588
RX PubMed=25130606;
WW http://www.invivogen.com/thp1-blue-isg
CC Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an ISG54 promoter enhanced by a multimeric ISRE.
CC Transfected with: HGNC; 439; ALPP.
DI NCIt; C9163; Childhood acute monocytic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0006 ! THP-1
SX Male
CA Cancer cell line
//
ID THP1-Blue ISG-KD-STING
AC CVCL_X589
WW http://www.invivogen.com/thp1-blue-isg-kd-sting
CC Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an ISG54 promoter enhanced by a multimeric ISRE.
CC Knockout cell: Method=shRNA knockdown; HGNC; 27962; TMEM173.
CC Transfected with: HGNC; 439; ALPP.
DI NCIt; C9163; Childhood acute monocytic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0006 ! THP-1
SX Male
CA Cancer cell line
//
ID THP1-Blue NF-kappaB
AC CVCL_X585
RX PubMed=25130606;
WW http://www.invivogen.com/thp1-blue-nfkb
CC Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 copies of the NF-kappaB consensus TRE and 3 copies of the c-Rel binding site.
CC Transfected with: HGNC; 439; ALPP.
DI NCIt; C9163; Childhood acute monocytic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0006 ! THP-1
SX Male
CA Cancer cell line
//
ID THP1-defASC
AC CVCL_X598
WW http://www.invivogen.com/thp1-defasc
DI NCIt; C9163; Childhood acute monocytic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0006 ! THP-1
SX Male
CA Cancer cell line
//
ID THP1-defCASP1
AC CVCL_5I76
WW http://www.invivogen.com/thp1-defcasp1
DI NCIt; C9163; Childhood acute monocytic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0006 ! THP-1
SX Male
CA Cancer cell line
//
ID THP1-defNLRP3
AC CVCL_X600
WW http://www.invivogen.com/thp1-defnlrp3
DI NCIt; C9163; Childhood acute monocytic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0006 ! THP-1
SX Male
CA Cancer cell line
//
ID THP1-Dual
AC CVCL_X599
WW http://www.invivogen.com/thp1-dual
CC Transfected with: HGNC; 439; ALPP.
CC Transfected with: Lucia luciferase; a synthetic gene designed on natural secreted luciferase genes from marine copepods.
DI NCIt; C9163; Childhood acute monocytic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0006 ! THP-1
SX Male
CA Cancer cell line
//
ID THP1-Dual KO-MyD
AC CVCL_5J54
WW http://www.invivogen.com/thp1-dual-komyd
CC Knockout cell: Method=Not specified; HGNC; 7562; MYD88.
CC Transfected with: HGNC; 439; ALPP.
CC Transfected with: Lucia luciferase; a synthetic gene designed on natural secreted luciferase genes from marine copepods.
DI NCIt; C9163; Childhood acute monocytic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_X599 ! THP1-Dual
SX Male
CA Cancer cell line
//
ID THP1-Lucia ISG
AC CVCL_X587
WW http://www.invivogen.com/thp1-lucia-isg
CC Transfected with: Lucia luciferase; a synthetic gene designed on natural secreted luciferase genes from marine copepods.
DI NCIt; C9163; Childhood acute monocytic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0006 ! THP-1
SX Male
CA Cancer cell line
//
ID THP1-Lucia NF-kappaB
AC CVCL_X590
WW http://www.invivogen.com/thp1-lucia-nfkb
CC Transfected with: Lucia luciferase; a synthetic gene designed on natural secreted luciferase genes from marine copepods.
DI NCIt; C9163; Childhood acute monocytic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0006 ! THP-1
SX Male
CA Cancer cell line
//
ID THP1-NLRC4
AC CVCL_5I77
WW http://www.invivogen.com/thp1-nlrc4
DI NCIt; C9163; Childhood acute monocytic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0006 ! THP-1
SX Male
CA Cancer cell line
//
ID THP1-Null
AC CVCL_X601
WW http://www.invivogen.com/thp1-null
DI NCIt; C9163; Childhood acute monocytic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0006 ! THP-1
SX Male
CA Cancer cell line
//
ID THP1-Xblue
AC CVCL_X582
RX PubMed=25130606;
WW http://www.invivogen.com/thp1-xblue-cell
CC Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of a NF-KappaB/AP-1 promoter.
CC Transfected with: HGNC; 439; ALPP.
DI NCIt; C9163; Childhood acute monocytic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0006 ! THP-1
SX Male
CA Cancer cell line
//
ID THP1-Xblue-CD14
AC CVCL_X583
RX PubMed=25130606;
WW http://www.invivogen.com/thp1-xblue-cd14-cell
CC Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of a NF-KappaB/AP-1 promoter.
CC Transfected with: HGNC; 439; ALPP.
CC Transfected with: HGNC; 1628; CD14.
DI NCIt; C9163; Childhood acute monocytic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_X582 ! THP1-Xblue
SX Male
CA Cancer cell line
//
ID THP1-XBlue-defMyD
AC CVCL_X586
RX PubMed=25130606;
WW http://www.invivogen.com/thp1-xblue-defmyd-cell
CC Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of a NF-KappaB/AP-1 promoter.
CC Transfected with: HGNC; 439; ALPP.
DI NCIt; C9163; Childhood acute monocytic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_X582 ! THP1-Xblue
SX Male
CA Cancer cell line
//
ID THP1-Xblue-MD2-CD14
AC CVCL_X584
RX PubMed=25130606;
WW http://www.invivogen.com/thp1-xblue-md2cd14-cell
CC Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of a NF-KappaB/AP-1 promoter.
CC Transfected with: HGNC; 439; ALPP.
CC Transfected with: HGNC; 1628; CD14.
CC Transfected with: HGNC; 17156; LY96.
DI NCIt; C9163; Childhood acute monocytic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_X582 ! THP1-Xblue
SX Male
CA Cancer cell line
//
ID THR
AC CVCL_1M76
SY GM06820
DR CLO; CLO_0036526
DR Coriell; GM06820
CC Part of: International Histocompatibility Workshop cell lines.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID Thr.C1-PI 33
AC CVCL_9V38
DR NCBI_Iran; C443
RX PubMed=17254797;
ST Source(s): PubMed=17254797
ST Amelogenin: X
ST CSF1PO: 9,11
ST D13S317: 11
ST D16S539: 11
ST D18S51: 13
ST D21S11: 27,30
ST D3S1358: 16
ST D5S818: 9,12
ST D7S820: 8,11
ST D8S1179: 13
ST FGA: 24
ST TH01: 6,9
ST TPOX: 8,10
ST vWA: 16,18
DI NCIt; C4815; Thyroid gland carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID THS119
AC CVCL_5435
SY THS-119; THS 119
RX CelloPub=CLPUB00291;
RX PubMed=10378898;
RX PubMed=11520047;
RX PubMed=17233813;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=THS119
CC Characteristics: Requires feeder cells. Maintenance of THS119 depends on the presence of cell line TBR59 (CVCL_5372).
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX NCBI_TaxID=10090; ! Mus musculus
CA Conditionally immortalized cell line
//
ID THX
AC CVCL_D556
DR Cosmic; 922395
RX PubMed=3491924;
DI NCIt; C3802; Amelanotic melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Thy0517
AC CVCL_2Z85
RX PubMed=26273358;
CC Doubling time: 37 hours (PubMed=26273358).
DI NCIt; C60989; Myasthenia gravis
DI NCIt; C3411; Thymoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Thy16
AC CVCL_2Z87
SY Thymoma line No. 16.3
RX PubMed=219598;
RX PubMed=6543243;
CC Breed/subspecies: BALB/c.
DI NCIt; C21602; Mouse lymphoma
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID Thy19
AC CVCL_J304
SY Thy-19; Thy 19
RX PubMed=219598;
RX PubMed=6543243;
CC Breed/subspecies: BALB/c.
DI NCIt; C21602; Mouse lymphoma
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID THY28
AC CVCL_HF48
RX PubMed=27811013;
CC Doubling time: 56 hours (PubMed=27811013).
CC Derived from metastatic site: Spinal column.
DI NCIt; C4035; Thyroid gland papillary carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID ThyL-6
AC CVCL_2Z86
RX PubMed=18691242;
DI NCIt; C7569; Thymic carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID TI-1 [Human leukemia]
AC CVCL_L806
DR BioSample; SAMN03151817
RX PubMed=1611097;
RX PubMed=11871388;
RX PubMed=12592342;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a K-562 derivative (PubMed=11871388, PubMed=12592342, PubMed=20143388).
DI NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0004 ! K-562
SX Female
CA Cancer cell line
//
ID TI-1 [Mouse hybridoma]
AC CVCL_2216
DR CLO; CLO_0009349
DR DSMZ; ACC-285
CC Doubling time: ~50 hours (DSMZ).
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3940 ! NS0
CA Hybridoma
//
ID TI-1 [Thysanoplusia]
AC CVCL_Z344
RX DOI=10.1303/aez.2000.245;
CC Group: Insect cell line.
OX NCBI_TaxID=254425; ! Thysanoplusia intermixta
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID TI-4
AC CVCL_2217
DR CLO; CLO_0009350
DR DSMZ; ACC-286
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3940 ! NS0
CA Hybridoma
//
ID TiB7-4
AC CVCL_IS69
SY TiB7.4
RX PubMed=17724450;
CC Breed/subspecies: C57BL/6 x 129S4/SvJae.
OX NCBI_TaxID=10090; ! Mus musculus
CA Induced pluripotent stem cell
//
ID TIG-1
AC CVCL_0560
SY Tokyio Institute of Gerontology-1; AG06173
DR CLO; CLO_0035248
DR MCCL; MCC:0000462
DR Coriell; AG06173
RX PubMed=7389832;
RX PubMed=7421303;
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_IU09 ! TIG-1H
OI CVCL_IU10 ! TIG-1L
SX Female
CA Finite cell line
//
ID TIG-1 iPSC clone K1
AC CVCL_U502
RX PubMed=21562774;
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0560 ! TIG-1
SX Female
CA Induced pluripotent stem cell
//
ID TIG-1 iPSC clone K2
AC CVCL_U503
RX PubMed=21562774;
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0560 ! TIG-1
SX Female
CA Induced pluripotent stem cell
//
ID TIG-1 iPSC clone K3
AC CVCL_U504
RX PubMed=21562774;
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0560 ! TIG-1
SX Female
CA Induced pluripotent stem cell
//
ID TIG-1 iPSC clone K4
AC CVCL_U505
RX PubMed=21562774;
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0560 ! TIG-1
SX Female
CA Induced pluripotent stem cell
//
ID TIG-1-20
AC CVCL_3181
DR ChEMBL-Cells; CHEMBL3307469
DR ChEMBL-Targets; CHEMBL615014
DR JCRB; JCRB0501
DR TKG; TKG 0276
ST Source(s): TKG
ST Amelogenin: X
ST CSF1PO: 12,13
ST D13S317: 11,12
ST D16S539: 11,12
ST D5S818: 9,10
ST D7S820: 8,11
ST TH01: 7
ST TPOX: 11
ST vWA: 14,17
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0560 ! TIG-1
SX Female
CA Finite cell line
//
ID TIG-1-30
AC CVCL_3182
DR JCRB; JCRB0502
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0560 ! TIG-1
SX Female
CA Finite cell line
//
ID TIG-1-40
AC CVCL_3183
DR JCRB; JCRB0503
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0560 ! TIG-1
SX Female
CA Finite cell line
//
ID TIG-1-50
AC CVCL_3184
DR JCRB; JCRB0504
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0560 ! TIG-1
SX Female
CA Finite cell line
//
ID TIG-1-60
AC CVCL_3185
SY TIG-1 (PDL62)
DR JCRB; JCRB0505
RX PubMed=9290701;
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0560 ! TIG-1
SX Female
CA Finite cell line
//
ID TIG-101
AC CVCL_3186
SY Tokyio Institute of Gerontology-101
DR JCRB; JCRB0526
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID TIG-102
AC CVCL_3187
SY Tokyio Institute of Gerontology-102
DR JCRB; JCRB0527
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID TIG-103
AC CVCL_3188
SY TIG103; Tokyio Institute of Gerontology-103
DR JCRB; JCRB0528
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID TIG-104
AC CVCL_3189
SY Tokyio Institute of Gerontology-104
DR JCRB; JCRB0529
RX PubMed=7556460;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID TIG-105
AC CVCL_3190
SY Tokyio Institute of Gerontology-105
DR JCRB; JCRB0530
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID TIG-106
AC CVCL_3191
SY Tokyio Institute of Gerontology-106
DR JCRB; JCRB0531
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID TIG-107
AC CVCL_3192
SY TIG107; Tokyio Institute of Gerontology-107
DR GEO; GSM1493707
DR GEO; GSM1899754
DR JCRB; JCRB0532
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID TIG-108
AC CVCL_3193
SY TIG108; Tokyio Institute of Gerontology-108
DR JCRB; JCRB0537
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID TIG-109
AC CVCL_3194
SY TIG109; Tokyio Institute of Gerontology-109
DR JCRB; JCRB0538
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID TIG-110
AC CVCL_3195
SY Tokyio Institute of Gerontology-110
DR JCRB; JCRB0543
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID TIG-111
AC CVCL_3196
SY Tokyio Institute of Gerontology-111
DR JCRB; JCRB0541
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID TIG-112
AC CVCL_3197
SY Tokyio Institute of Gerontology-112
DR JCRB; JCRB0533
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID TIG-113
AC CVCL_3198
SY Tokyio Institute of Gerontology-113
DR JCRB; JCRB0539
RX PubMed=7556460;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID TIG-114
AC CVCL_3199
SY TIG114; Tokyio Institute of Gerontology-114
DR JCRB; JCRB0534
DR JCRB; NIHS0207
RX PubMed=7556460;
CC Discontinued: JCRB; NIHS0207; true.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID TIG-118
AC CVCL_3200
SY TIG118; Tokyio Institute of Gerontology-118
DR JCRB; JCRB0535
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID TIG-119
AC CVCL_3201
SY Tokyio Institute of Gerontology-119
DR JCRB; JCRB0540
RX PubMed=7556460;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID TIG-120
AC CVCL_3202
SY TIG120; Tig120; Tokyio Institute of Gerontology-120
DR GEO; GSM1493703
DR JCRB; JCRB0542
DR PRIDE; PXD000071
RX PubMed=7556460;
RX PubMed=23210603;
CC Omics: Deep proteome analysis.
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 10
ST D16S539: 12
ST D5S818: 9,11
ST D7S820: 10,12
ST TH01: 9,9.3
ST TPOX: 8,11
ST vWA: 14,20
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID TIG-121
AC CVCL_3203
SY TIG121; Tokyio Institute of Gerontology-121
DR JCRB; JCRB0536
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID TIG-1H
AC CVCL_IU09
SY Tokyio Institute of Gerontology-1 Heart
RX PubMed=7421303;
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0560 ! TIG-1
OI CVCL_IU10 ! TIG-1L
SX Female
CA Finite cell line
//
ID TIG-1L
AC CVCL_IU10
SY Tokyio Institute of Gerontology-1 Liver
RX PubMed=7421303;
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0560 ! TIG-1
OI CVCL_IU09 ! TIG-1H
SX Female
CA Finite cell line
//
ID TIG-2
AC CVCL_IU07
SY Tokyio Institute of Gerontology-2
RX PubMed=7421303;
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_3204 ! TIG-2M-30
OI CVCL_IU08 ! TIG-2S
SX Female
CA Finite cell line
//
ID TIG-2M-30
AC CVCL_3204
SY TIG-2M; Tokyio Institute of Gerontology-2 Muscle
DR JCRB; JCRB0525
RX PubMed=7421303;
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_IU07 ! TIG-2
OI CVCL_IU08 ! TIG-2S
SX Female
CA Finite cell line
//
ID TIG-2S
AC CVCL_IU08
SY Tokyio Institute of Gerontology-2 Skin
RX PubMed=7421303;
RX PubMed=7556460;
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_IU07 ! TIG-2
OI CVCL_3204 ! TIG-2M-30
SX Female
CA Finite cell line
//
ID TIG-3
AC CVCL_E939
SY TIG3; Tig3; Tokyio Institute of Gerontology-3
DR PRIDE; PXD000523
DR PRIDE; PXD001068
DR PRIDE; PXD001499
RX PubMed=7053395;
RX PubMed=9548301;
WW http://proteome.tmig.or.jp/2D/Fibro/humfb_menu.html
CC Omics: Deep proteome analysis.
CC Omics: Proteome analysis by 2D-DE.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_3210 ! TIG-3S
SX Male
CA Finite cell line
//
ID TIG-3 iPSC #10-2
AC CVCL_IN43
DR GEO; GSM1519867
RX PubMed=25390333;
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_E939 ! TIG-3
SX Male
CA Induced pluripotent stem cell
//
ID TIG-3 TD
AC CVCL_V617
SY TIG3 TD
DR CCLE; TIG3TD_LUNG
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Transfected with: HGNC; 11730; TERT.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_E939 ! TIG-3
SX Male
CA Telomerase immortalized cell line
//
ID TIG-3-20
AC CVCL_3205
SY TIG 3-20; TIG3-20; TIG-3 (PDL23)
DR BTO; BTO:0004521
DR JCRB; JCRB0506
DR TKG; TKG 0488
RX PubMed=9290701;
ST Source(s): TKG
ST Amelogenin: X,Y
ST D13S317: 9,12
ST D16S539: 10
ST D5S818: 13
ST TH01: 7,9
ST vWA: 14,17
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_E939 ! TIG-3
SX Male
CA Finite cell line
//
ID TIG-3-30
AC CVCL_3206
DR JCRB; JCRB0507
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_E939 ! TIG-3
SX Male
CA Finite cell line
//
ID TIG-3-40
AC CVCL_3207
DR JCRB; JCRB0508
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_E939 ! TIG-3
SX Male
CA Finite cell line
//
ID TIG-3-50
AC CVCL_3208
DR JCRB; JCRB0509
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_E939 ! TIG-3
SX Male
CA Finite cell line
//
ID TIG-3-60
AC CVCL_3209
SY TIG-3 (PDL60)
DR JCRB; JCRB0510
RX PubMed=9290701;
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_E939 ! TIG-3
SX Male
CA Finite cell line
//
ID TIG-3S
AC CVCL_3210
SY Tokyio Institute of Gerontology-3 Skin
DR JCRB; JCRB0544
RX PubMed=7421303;
RX PubMed=7556460;
CC Characteristics: Senesces at 67 PDL.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_E939 ! TIG-3
SX Male
CA Finite cell line
//
ID TIG-7
AC CVCL_E940
SY Tokyio Institute of Gerontology-7
DR BTO; BTO:0005634
RX PubMed=1800129;
CC Characteristics: Senesces at 73 +-7 PDL.
CC Doubling time: 23 hours (at 65th passage), 62 hours (at 75th passage) (PubMed=1800129).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID TIG-7-20
AC CVCL_3211
DR JCRB; JCRB0511
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_E940 ! TIG-7
SX Male
CA Finite cell line
//
ID TIG-7-30
AC CVCL_3212
DR JCRB; JCRB0512
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_E940 ! TIG-7
SX Male
CA Finite cell line
//
ID TIG-7-40
AC CVCL_3213
DR JCRB; JCRB0513
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_E940 ! TIG-7
SX Male
CA Finite cell line
//
ID TIG-7-50
AC CVCL_3214
DR JCRB; JCRB0514
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_E940 ! TIG-7
SX Male
CA Finite cell line
//
ID TIG-7-60
AC CVCL_3215
DR JCRB; JCRB0515
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_E940 ! TIG-7
SX Male
CA Finite cell line
//
ID TIGKs
AC CVCL_M095
SY TIGK; Telomerase Immortalized Gingival Keratinocytes
RX PubMed=23441958;
CC Transfected with: HGNC; 11730; TERT.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Telomerase immortalized cell line
//
ID TIGMEC-1
AC CVCL_5374
SY TIGMEC1; T-antigen Immortalized Goat Milk Epithelial Cells-1
RX PubMed=11592613;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: Saanen.
OX NCBI_TaxID=9925; ! Capra hircus
SX Female
CA Transformed cell line
//
ID TIGMEC-2
AC CVCL_5375
SY TIGMEC2; T-antigen Immortalized Goat Milk Epithelial Cells-2
RX PubMed=11592613;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: Saanen.
OX NCBI_TaxID=9925; ! Capra hircus
SX Female
CA Transformed cell line
//
ID TIGMEC-3
AC CVCL_5376
SY TIGMEC3; T-antigen Immortalized Goat Milk Epithelial Cells-3
RX PubMed=11592613;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: Saanen.
OX NCBI_TaxID=9925; ! Capra hircus
SX Female
CA Transformed cell line
//
ID TIME
AC CVCL_0047
SY Telomerase-Immortalized human Microvascular Endothelial cells
DR ATCC; CRL-4025
DR BioSample; SAMN03471728
DR Wikidata; Q27653709
RX PubMed=11795943;
WW http://www.proteinatlas.org/learn/cellines
CC Transfected with: HGNC; 11730; TERT.
CC Omics: Deep antibody staining analysis.
CC Omics: Deep RNAseq analysis.
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 9,11
ST D16S539: 9,12
ST D5S818: 11
ST D7S820: 8,9
ST TH01: 6,7
ST TPOX: 8
ST vWA: 16,18
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Telomerase immortalized cell line
//
ID TIME-GFP
AC CVCL_S878
DR ATCC; CRL-4045
CC Transfected with: HGNC; 11730; TERT.
CC Transfected with: UniProtKB; P42212; GFP.
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 9,11
ST D16S539: 9,12
ST D5S818: 11
ST D7S820: 8,9
ST TH01: 6,7
ST TPOX: 8
ST vWA: 16,18
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0047 ! TIME
SX Male
CA Telomerase immortalized cell line
//
ID TIMI.4
AC CVCL_3609
DR CLO; CLO_0009351
DR ATCC; TIB-37
CC Breed/subspecies: C57BL/6.
DI NCIt; C21602; Mouse lymphoma
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID TIMI.4G.1.3
AC CVCL_5900
DR CLO; CLO_0009352
DR ATCC; TIB-38
CC Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG).
CC Breed/subspecies: C57BL/6.
DI NCIt; C21602; Mouse lymphoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3609 ! TIMI.4
CA Cancer cell line
//
ID TIMJ2-C15
AC CVCL_0P79
RX PubMed=1879973;
CC Transformant: Recombinant retrovirus J2.
CC Breed/subspecies: C57BL/6J.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Transformed cell line
//
ID TIMJ2-C4
AC CVCL_0P80
RX PubMed=1879973;
CC Transformant: Recombinant retrovirus J2.
CC Breed/subspecies: C57BL/6J.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Transformed cell line
//
ID TIMJ2-C7
AC CVCL_0P81
RX PubMed=1879973;
CC Transformant: Recombinant retrovirus J2.
CC Breed/subspecies: C57BL/6J.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Transformed cell line
//
ID TISI
AC CVCL_E851
DR dbMHC; 49042
DR ECACC; 88052042
DR IHW; IHW9042
DR IMGT/HLA; 11649
RX PubMed=8307784;
WW http://bioinformatics.hsanmartino.it/ecbr/cl42.html
CC Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID TIVE
AC CVCL_2G60
SY Telomerase-Immortalized human umbilical Vein Endothelial cells
DR EFO; EFO_0002086
RX PubMed=16641275;
CC Transfected with: HGNC; 11730; TERT.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Telomerase immortalized cell line
//
ID TJ-GBC2
AC CVCL_IU75
RX PubMed=28194091;
DI NCIt; C3844; Gallbladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID TJ8510
AC CVCL_B265
RX CelloPub=CLPUB00118;
DI NCIt; C60781; Astrocytoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_B266 ! TJ861
SX Male
CA Cancer cell line
//
ID TJ861
AC CVCL_B266
RX CelloPub=CLPUB00118;
DI NCIt; C60781; Astrocytoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_B265 ! TJ8510
SX Male
CA Cancer cell line
//
ID TJ899
AC CVCL_B264
SY Tj-899
RX CelloPub=CLPUB00119;
RX PubMed=19781350;
CC Omics: Proteome analysis by 2D-DE.
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID TJ905
AC CVCL_6975
SY Tj-905
DR CCRID; 3111C0001CCC000267
RX CelloPub=CLPUB00119;
RX PubMed=19781350;
CC Omics: Proteome analysis by 2D-DE.
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID TK [Human B-cell lymphoma]
AC CVCL_3216
SY Tk
DR Cosmic-CLP; 1331045
DR GDSC; 1331045
DR GEO; GSM827272
DR GEO; GSM1670544
DR JCRB; JCRB0157
DR JCRB; NIHS0245
RX PubMed=10354143;
RX PubMed=25485619;
RX PubMed=27397505;
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Discontinued: JCRB; NIHS0245; true.
ST Source(s): Cosmic-CLP
ST Amelogenin: X
ST CSF1PO: 12,13
ST D13S317: 8
ST D16S539: 9,11
ST D5S818: 10,12
ST D7S820: 11
ST TH01: 6,9
ST TPOX: 8
ST vWA: 16,18
DI NCIt; C3457; B-cell non-Hodgkin lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID TK [Human brain lymphoma]
AC CVCL_E941
SY Tk
DR BioSample; SAMN03472435
DR JCRB; JCRB1206
DR JCRB; NIHS0524
RX PubMed=6450513;
RX PubMed=7059907;
CC Anecdotal: Cell name corresponds to the initials of the patient.
CC Discontinued: JCRB; NIHS0524; true.
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 8,13
ST D16S539: 9,10
ST D5S818: 9,10
ST D7S820: 10,11
ST TH01: 6
ST TPOX: 8,11
ST vWA: 17,19
DI NCIt; C7611; Cerebral lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID TK [Human cholangiocarcinoma]
AC CVCL_4Z42
SY Tankan-gann
RX CelloPub=CLPUB00275;
RX PubMed=10718366;
CC Derived from metastatic site: Ascites.
DI NCIt; C4436; Cholangiocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID TK [Turbot]
AC CVCL_R815
SY Turbot Kidney
RX PubMed=20496112;
CC Group: Fish cell line.
OX NCBI_TaxID=52904; ! Scophthalmus maximus
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID TK-1 [Human astrocytoma]
AC CVCL_B325
DR BioSample; SAMN03151978
DR Cosmic; 687587
DR JCRB; JCRB0128
DR JCRB; NIHS0181
RX PubMed=9183640;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a U-251MG derivative.
CC Discontinued: JCRB; NIHS0181; true.
ST Source(s): JCRB
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 10,11
ST D16S539: 12
ST D5S818: 11,12
ST D7S820: 10,12
ST TH01: 9.3
ST TPOX: 8
ST vWA: 16,18
DI NCIt; C60781; Astrocytoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0021 ! U-251MG
SX Male
CA Cancer cell line
//
ID TK-1 [Human myeloid leukemia]
AC CVCL_B326
RX PubMed=3457771;
DI NCIt; C9154; Adult acute myeloid leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID TK-1 [Mouse lymphoma]
AC CVCL_3217
DR CLO; CLO_0009356
DR ATCC; CRL-2396
CC Breed/subspecies: AKR/Cum.
DI NCIt; C21602; Mouse lymphoma
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID TK-1 [Tilapia]
AC CVCL_R879
SY Tilapia Kidney-1
RX CelloPub=CLPUB00008;
CC Group: Fish cell line.
OX NCBI_TaxID=304579; ! Oreochromis mossambicus x Oreochromis niloticus
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID TK-10
AC CVCL_1773
SY TK.10; TK 10; TK10
DR BTO; BTO:0004283
DR EFO; EFO_0006765
DR BioSample; SAMN03473277
DR ChEMBL-Cells; CHEMBL3308453
DR ChEMBL-Targets; CHEMBL614056
DR Cosmic; 687944
DR Cosmic; 845925
DR Cosmic; 905980
DR Cosmic; 974308
DR Cosmic; 1092642
DR Cosmic; 1305378
DR Cosmic; 1312366
DR Cosmic; 1998485
DR Cosmic-CLP; 905980
DR GDSC; 905980
DR GEO; GSM50231
DR GEO; GSM50295
DR GEO; GSM750807
DR GEO; GSM799440
DR GEO; GSM847165
DR GEO; GSM844717
DR GEO; GSM1153450
DR GEO; GSM1181308
DR GEO; GSM1181326
DR GEO; GSM1670545
DR SKY/M-FISH/CGH; 2807
RX PubMed=2041050;
RX PubMed=3594443;
RX PubMed=10723130;
RX PubMed=17088437;
RX PubMed=19372543;
RX PubMed=23856246;
RX PubMed=23933261;
RX PubMed=25485619;
RX PubMed=27397505;
RX PubMed=27807467;
RX PubMed=27993170;
RX PubMed=28196595;
WW https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
WW https://strap.nci.nih.gov/celline_detail.php?sample_id=42
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Part of: NCI60 cancer cell line panel.
CC Doubling time: 25 hours, at 155th passage (PubMed=3594443); 51.3 hours (DTP).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep proteome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; PubMed=19372543; PubMed=25877200
ST Amelogenin: X (PubMed=19372543)
ST Amelogenin: X,Y (Cosmic-CLP; PubMed=25877200)
ST CSF1PO: 12
ST D13S317: 9
ST D16S539: 12
ST D18S51: 16 (PubMed=19372543)
ST D18S51: 16,17 (PubMed=25877200)
ST D19S433: 14,15
ST D21S11: 29
ST D2S1338: 17
ST D3S1358: 15,17
ST D5S818: 11,12
ST D7S820: 10,11
ST D8S1179: 15,16
ST FGA: 18,22
ST Penta D: 10
ST Penta E: 10
ST TH01: 8
ST TPOX: 11
ST vWA: 18,19
DI NCIt; C4033; Clear cell renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID TK-164
AC CVCL_8324
SY TK 164; TK164
DR BTO; BTO:0004284
DR Cosmic; 845928
RX PubMed=3594443;
RX PubMed=27993170;
CC Doubling time: 43 hours (PubMed=3594443).
DI NCIt; C4033; Clear cell renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID TK-1B
AC CVCL_B331
DR Cosmic; 787481
DR Cosmic; 975304
RX PubMed=3457771;
DI NCIt; C9154; Adult acute myeloid leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_B326 ! TK-1 [Human myeloid leukemia]
SX Male
CA Cancer cell line
//
ID TK-1D
AC CVCL_B327
RX PubMed=3457771;
DI NCIt; C9154; Adult acute myeloid leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_B326 ! TK-1 [Human myeloid leukemia]
SX Male
CA Cancer cell line
//
ID TK-6
AC CVCL_X907
SY TK6
DR BioSample; SAMN03473400
DR CGH-DB; 9213-4
DR Cosmic; 1483366
DR DSMZ; ACC-723
RX PubMed=7475285;
CC Doubling time: ~60-72 hours (DSMZ).
ST Source(s): DSMZ
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 8,13
ST D16S539: 9,12
ST D5S818: 11,12
ST D7S820: 8,11
ST TH01: 6,9
ST TPOX: 8
ST vWA: 15,16
DI NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID TK-TS 13
AC CVCL_4325
SY TK TS 13; tk-ts13; tk. ts13; tk- ts13; tk^(-)ts13
DR CLO; CLO_0009353
DR CLO; CLO_0009354
DR CLO; CLO_0009360
DR CLO; CLO_0051412
DR CLDB; cl4521
DR CLDB; cl4522
DR ATCC; CRL-1632
DR BCRC; 60208
DR ECACC; 93120838
DR IZSLER; BS CL 85
DR RCB; RCB0286
RX PubMed=6294505;
OX NCBI_TaxID=10036; ! Mesocricetus auratus
HI CVCL_1915 ! BHK-21 clone 13
SX Male
CA Spontaneously immortalized cell line
//
ID TK#1
AC CVCL_6528
DR CLO; CLO_0009355
DR ATCC; CRL-11383
RX Patent=US5675059;
CC Knockout cell: Method=Homologous recombination; MGI; MGI:96591; Irf2.
CC Breed/subspecies: 129S2/SvPas.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4378 ! ES-D3
SX Male
CA Embryonic stem cell
//
ID TK6
AC CVCL_0561
SY TK-6; H2BT
DR BTO; BTO:0003707
DR CLO; CLO_0009357
DR MCCL; MCC:0000463
DR CLDB; cl4519
DR ATCC; CRL-8015
DR BCRC; 60107
DR BioSample; SAMN03471129
DR CLS; 300357/p582_TK6
DR ECACC; 95111735
RX DOI=10.1016/j.mrgentox.2016.08.001;
RX Patent=US4302535;
RX PubMed=214074;
RX PubMed=7744731;
RX PubMed=8316623;
CC Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG).
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST Source(s): ATCC; CLS; ECACC; JCRB
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 11
ST D16S539: 11,12
ST D18S51: 11,16
ST D21S11: 29
ST D3S1358: 16
ST D5S818: 12,13
ST D7S820: 9,11
ST D8S1179: 10,13
ST FGA: 22,24
ST Penta D: 11,12
ST Penta E: 5,7
ST TH01: 8,9.3
ST TPOX: 8,11
ST vWA: 17,20
DI NCIt; C97074; Hereditary spherocytosis
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_X906 ! HH4
SX Male
CA Transformed cell line
//
ID TK6 (IVGT)
AC CVCL_AR68
SY TK6(IVGT)
DR ECACC; 13051501
DR JCRB; JCRB1435
RX DOI=10.1016/j.mrgentox.2016.08.001;
CC Part of: In Vitro Genetic Toxicity (IVGT) cell line panel.
CC Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG).
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST Source(s): ECACC
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 11
ST D16S539: 11,12
ST D5S818: 12,13
ST D7S820: 9,11
ST TH01: 8,9.3
ST TPOX: 8,11
ST vWA: 17,20
DI NCIt; C97074; Hereditary spherocytosis
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0561 ! TK6
SX Male
CA Transformed cell line
//
ID TK6TGR
AC CVCL_2733
SY TK6 TGr.p1
DR CLO; CLO_0009358
DR CLDB; cl4520
DR ECACC; 87020507
RX PubMed=22359172;
CC Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG).
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST Source(s): ECACC
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 11
ST D16S539: 11,12
ST D5S818: 12,13
ST D7S820: 9,11
ST TH01: 8,9.3
ST TPOX: 8,11
ST vWA: 17,20
DI NCIt; C97074; Hereditary spherocytosis
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0561 ! TK6
SX Male
CA Transformed cell line
//
ID TK765
AC CVCL_F544
SY TER109; TER250
DR IMGT/HLA; 11480
CC Part of: International Histocompatibility Workshop cell lines.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID TKB-1
AC CVCL_S125
SY TKB1
DR CCRID; 3111C0002000000066
RX PubMed=10365094;
DI NCIt; C4450; Large cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID TKB-12
AC CVCL_S126
SY TKB12
RX PubMed=10365094;
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID TKB-14
AC CVCL_S140
SY TKB14
RX PubMed=10365094;
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID TKB-15
AC CVCL_S127
SY TKB15
RX PubMed=10365094;
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID TKB-16
AC CVCL_S128
SY TKB16
RX PubMed=10365094;
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID TKB-17
AC CVCL_S129
SY TKB17
RX PubMed=10365094;
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID TKB-2
AC CVCL_S130
SY TKB2
RX PubMed=2430695;
RX PubMed=2548713;
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID TKB-20
AC CVCL_S131
SY TKB20
RX PubMed=10365094;
DI NCIt; C3493; Squamous cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID TKB-21
AC CVCL_S139
SY TKB21
RX PubMed=10365094;
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID TKB-3
AC CVCL_S138
SY TKB3
RX PubMed=2548713;
DI NCIt; C4450; Large cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID TKB-34
AC CVCL_S137
SY TKB34
RX PubMed=10365094;
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID TKB-4
AC CVCL_S132
SY TKB4
RX PubMed=2548713;
RX PubMed=10365094;
DI NCIt; C3493; Squamous cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID TKB-5
AC CVCL_S133
SY TKB5
RX PubMed=10365094;
DI NCIt; C4450; Large cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID TKB-6
AC CVCL_S134
SY TKB6
RX PubMed=2548713;
RX PubMed=10365094;
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID TKB-7
AC CVCL_S135
SY TKB7
RX PubMed=10365094;
DI NCIt; C3493; Squamous cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID TKB-8
AC CVCL_S136
SY TKB8
RX PubMed=10365094;
DI NCIt; C4450; Large cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID TKC2
AC CVCL_5597
SY TKC-2
DR IFO; IFO50373
DR TKG; TKG 0354
RX PubMed=1663919;
RX PubMed=7641784;
RX PubMed=9224657;
RX PubMed=11520047;
RX PubMed=17233813;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX NCBI_TaxID=10090; ! Mus musculus
CA Conditionally immortalized cell line
//
ID TkCB7-2
AC CVCL_DP88
SY TKCB7-2
DR GEO; GSM1040273
DR GEO; GSM1040343
RX PubMed=22802639;
RX PubMed=24259714;
CC From: Center for iPS Cell Research and Application; Kyoto University; Kyoto; Japan.
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_DP89 ! TkCBV4-2
OI CVCL_DP90 ! TkCBV5-6
SX Male
CA Induced pluripotent stem cell
//
ID TkCBV4-2
AC CVCL_DP89
SY TKCBV4-2
DR GEO; GSM1040271
DR GEO; GSM1040341
RX PubMed=22802639;
RX PubMed=24259714;
CC From: Center for iPS Cell Research and Application; Kyoto University; Kyoto; Japan.
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_DP88 ! TkCB7-2
OI CVCL_DP90 ! TkCBV5-6
SX Male
CA Induced pluripotent stem cell
//
ID TkCBV5-6
AC CVCL_DP90
SY TKCBV5-6
DR GEO; GSM1040272
DR GEO; GSM1040342
RX PubMed=22802639;
RX PubMed=24259714;
CC From: Center for iPS Cell Research and Application; Kyoto University; Kyoto; Japan.
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_DP88 ! TkCB7-2
OI CVCL_DP89 ! TkCBV4-2
SX Male
CA Induced pluripotent stem cell
//
ID TKD2
AC CVCL_5598
DR CLO; CLO_0050786
DR IFO; IFO50374
DR RCB; RCB0752
RX PubMed=1663919;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX NCBI_TaxID=10090; ! Mus musculus
CA Conditionally immortalized cell line
//
ID TKE2
AC CVCL_AR53
DR ECACC; 11033107
RX PubMed=18318692;
CC Breed/subspecies: CD-1.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Spontaneously immortalized cell line
//
ID TKHMY
AC CVCL_J604
RX PubMed=7822823;
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_6416 ! LTR228
CA Hybrid cell line
//
ID TKKK
AC CVCL_5599
DR CLO; CLO_0050852
DR BioSample; SAMN03472090
DR RCB; RCB1907
DR TKG; TKG 0456
ST Source(s): RCB; TKG
ST Amelogenin: X,Y
ST CSF1PO: 11
ST D13S317: 8,12
ST D16S539: 11
ST D5S818: 13
ST D7S820: 10,11
ST TH01: 6
ST TPOX: 8
ST vWA: 14,16
DI NCIt; C35417; Intrahepatic cholangiocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID TKS-1
AC CVCL_8465
RX PubMed=7967745;
RX PubMed=10803505;
CC Miscellaneous: Cell line has been lost (PubMed=10803505).
DI NCIt; C82217; Natural killer cell lymphoblastic leukemia/lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID TL
AC CVCL_E852
DR dbMHC; 49043
DR ECACC; 94050310
DR IHW; IHW9270
DR IMGT/HLA; 11481
WW http://bioinformatics.hsanmartino.it/ecbr/cl270.html
CC Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID TL-1
AC CVCL_B371
DR CLO; CLO_0050020
DR BioSample; SAMN03472078
DR RCB; RCB1871
DR TKG; TKG 0607
RX PubMed=2486610;
RX PubMed=6268866;
CC Characteristics: EBV-negative.
CC Doubling time: ~36 hours (PubMed=6268866).
ST Source(s): RCB; TKG
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 8,11
ST D16S539: 12
ST D5S818: 10,12
ST D7S820: 10,12
ST TH01: 6,7
ST TPOX: 9,11
ST vWA: 14,19
DI NCIt; C2912; Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID TL-Hir
AC CVCL_G014
DR TKG; TKG 0288
RX PubMed=6088403;
CC Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID TL-Mat
AC CVCL_G015
DR TKG; TKG 0287
RX PubMed=6088403;
CC Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_A782 ! ILT-Mat
SX Male
CA Transformed cell line
//
ID TL-Mor
AC CVCL_0074
DR CLO; CLO_0050080
DR BioSample; SAMN03472082
DR RCB; RCB1881
DR TKG; TKG 0369
CC Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
ST Source(s): RCB; TKG
ST Amelogenin: X,Y
ST CSF1PO: 7,12
ST D13S317: 11,12
ST D16S539: 12,13
ST D5S818: 11,12
ST D7S820: 11,12
ST TH01: 6,9
ST TPOX: 9,11
ST vWA: 14,17
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_F910 ! ILT-Mor
OI CVCL_G011 ! TCL-Mor
SX Male
CA Transformed cell line
//
ID TL-OML
AC CVCL_B473
SY TL-Om1; TL-om1; TL-OM1; TLom1; TLOM1
DR TKG; TKG 0289
RX PubMed=6088403;
CC Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID TL-Su
AC CVCL_G013
DR TKG; TKG 0290
RX PubMed=6088403;
CC Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_F913 ! ILT-Su
SX Male
CA Transformed cell line
//
ID TLBR-1
AC CVCL_L177
DR ATCC; CRL-3027
RX PubMed=21425149;
CC Discontinued: ATCC; CRL-3027; probable.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 11,14
ST D16S539: 12
ST D5S818: 11,13
ST D7S820: 8,10
ST TH01: 7,9
ST TPOX: 8
ST vWA: 16,17
DI NCIt; C37194; Anaplastic large cell lymphoma, ALK-negative
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID TLM1
AC CVCL_0C83
SY TLM-1
RX PubMed=9539362;
RX PubMed=11467477;
RX PubMed=12944992;
WW https://www.kerafast.com/product/2258/canine-melanoma-cell-line-tlm-1
CC Doubling time: ~20 hours (Kerafast).
CC Breed/subspecies: Gordon Setter.
DI NCIt; C120298; Canine melanoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Male
CA Cancer cell line
//
ID TLNC-1
AC CVCL_6F00
SY Transformed Lymph Node Cells-1
RX PubMed=4098902;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: Sprague-Dawley.
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Transformed cell line
//
ID TLNC-2
AC CVCL_6E98
SY Transformed Lymph Node Cells-2
RX PubMed=4098902;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: Sprague-Dawley.
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Transformed cell line
//
ID TLNC-3
AC CVCL_6E99
SY Transformed Lymph Node Cells-3
RX PubMed=4098902;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: Sprague-Dawley.
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Transformed cell line
//
ID TLNC-4
AC CVCL_6F01
SY Transformed Lymph Node Cells-4
RX PubMed=4098902;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: Sprague-Dawley.
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Transformed cell line
//
ID TLR1
AC CVCL_F955
DR TKG; TKG 0351
RX PubMed=1655502;
RX PubMed=9224657;
RX PubMed=11520047;
RX PubMed=17233813;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX NCBI_TaxID=10090; ! Mus musculus
CA Conditionally immortalized cell line
//
ID TLR2
AC CVCL_5600
DR CLO; CLO_0050768
DR IFO; IFO50379
DR RCB; RCB0750
RX PubMed=1655502;
RX PubMed=9224657;
RX PubMed=11520047;
RX PubMed=17233813;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX NCBI_TaxID=10090; ! Mus musculus
CA Conditionally immortalized cell line
//
ID TLR3
AC CVCL_5601
DR IFO; IFO50380
DR TKG; TKG 0352
RX PubMed=1655502;
RX PubMed=9224657;
RX PubMed=11520047;
RX PubMed=17233813;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX NCBI_TaxID=10090; ! Mus musculus
CA Conditionally immortalized cell line
//
ID TLR4
AC CVCL_F956
DR TKG; TKG 0353
RX PubMed=1655502;
RX PubMed=9224657;
RX PubMed=11520047;
RX PubMed=17233813;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX NCBI_TaxID=10090; ! Mus musculus
CA Conditionally immortalized cell line
//
ID TLR4-/- D299G
AC CVCL_5L03
SY TLR4-/- 299
RX PubMed=19085953;
WW https://www.kerafast.com/product/1913/tlr4-snp-expressing-mouse-hepatic-stellate-cell-lines
CC Knockout cell: Method=KO mouse; MGI; MGI:108005; Myd88.
CC Knockout cell: Method=KO mouse; MGI; MGI:96824; Tlr4.
CC Transfected with: HGNC; 11850; TLR4 (with G-299).
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID TLR4-/- D299G/T399I
AC CVCL_5L05
SY TLR4-/- 299/399; TLR4-/- Dual SNP
RX PubMed=19085953;
WW https://www.kerafast.com/product/1913/tlr4-snp-expressing-mouse-hepatic-stellate-cell-lines
CC Knockout cell: Method=KO mouse; MGI; MGI:108005; Myd88.
CC Knockout cell: Method=KO mouse; MGI; MGI:96824; Tlr4.
CC Transfected with: HGNC; 11850; TLR4 (with G-299 and I-399).
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID TLR4-/- T399I
AC CVCL_5L04
SY TLR4-/- 399
RX PubMed=19085953;
WW https://www.kerafast.com/product/1913/tlr4-snp-expressing-mouse-hepatic-stellate-cell-lines
CC Knockout cell: Method=KO mouse; MGI; MGI:108005; Myd88.
CC Knockout cell: Method=KO mouse; MGI; MGI:96824; Tlr4.
CC Transfected with: HGNC; 11850; TLR4 (with I-399).
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID TLR4-/- WT
AC CVCL_5L02
RX PubMed=19085953;
WW https://www.kerafast.com/product/1913/tlr4-snp-expressing-mouse-hepatic-stellate-cell-lines
CC Knockout cell: Method=KO mouse; MGI; MGI:108005; Myd88.
CC Knockout cell: Method=KO mouse; MGI; MGI:96824; Tlr4.
CC Transfected with: HGNC; 11850; TLR4.
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID TLT
AC CVCL_6C16
RX DOI=10.3390/foods1010040;
RX PubMed=20444515;
RX PubMed=24454965;
OX NCBI_TaxID=9606; ! Homo sapiens
CA Spontaneously immortalized cell line
//
ID TLX5
AC CVCL_N032
SY TLX-5; TLX/5
DR ChEMBL-Cells; CHEMBL3307470
DR ChEMBL-Targets; CHEMBL615015
RX PubMed=5487248;
CC Breed/subspecies: CBA.
DI NCIt; C21602; Mouse lymphoma
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID TM
AC CVCL_E853
SY T.M.
DR dbMHC; 49044
DR IHW; IHW9355
DR IMGT/HLA; 11415
WW http://bioinformatics.hsanmartino.it/ecbr/cl355.html
CC Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID TM 902
AC CVCL_F246
SY TM902
DR CLO; CLO_0009362
DR CLDB; cl4525
RX PubMed=1429033;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3412 ! P3X63Ag8U.1
CA Hybridoma
//
ID TM 903
AC CVCL_F247
SY TM903
DR CLO; CLO_0009363
DR CLDB; cl4526
RX PubMed=1429033;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3412 ! P3X63Ag8U.1
CA Hybridoma
//
ID TM-1 [Human astrocytoma]
AC CVCL_M032
RX PubMed=1917778;
DI NCIt; C9477; Anaplastic astrocytoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID TM-1 [Human trabecular meshwork]
AC CVCL_5G36
SY TM1
RX PubMed=11773026;
RX PubMed=12789541;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID TM-28
AC CVCL_4979
SY TM-28 [Mutatect]
DR CLO; CLO_0009365
DR ATCC; CRL-2803
RX PubMed=11228549;
CC Discontinued: ATCC; CRL-2803; true.
CC Breed/subspecies: C57BL/10.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4978 ! MT-6
SX Male
CA Cancer cell line
//
ID TM-31
AC CVCL_6735
SY TM31
DR CLO; CLO_0050635
DR BCRJ; 0379
DR BioSample; SAMN03472072
DR CCLE; TM31_CENTRAL_NERVOUS_SYSTEM
DR GEO; GSM887707
DR GEO; GSM888800
DR RCB; RCB1731
RX PubMed=11213969;
RX PubMed=11213978;
RX PubMed=22460905;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 11,14
ST D16S539: 9,12
ST D5S818: 10
ST D7S820: 11,12
ST TH01: 9
ST TPOX: 8,11
ST vWA: 19
DI NCIt; C60781; Astrocytoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID TM-34
AC CVCL_4980
SY TM-34 [Mutatect]
DR CLO; CLO_0009367
DR ATCC; CRL-2801
RX PubMed=11228549;
CC Discontinued: ATCC; CRL-2801; probable.
CC Breed/subspecies: C57BL/10.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4978 ! MT-6
SX Male
CA Cancer cell line
//
ID TM-7
AC CVCL_4981
SY TM-7 [Mutatect]
DR CLO; CLO_0009369
DR ATCC; CRL-2798
RX PubMed=11228549;
CC Discontinued: ATCC; CRL-2798; true.
CC Breed/subspecies: C57BL/10.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4978 ! MT-6
SX Male
CA Cancer cell line
//
ID TM-791
AC CVCL_5939
SY TM 791; TM791
DR CLS; 300358/NA
CC Discontinued: CLS; 300358; true.
DI NCIt; C9145; Osteosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID TM-BBB1
AC CVCL_6C09
RX PubMed=11741243;
RX PubMed=17233813;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX NCBI_TaxID=10090; ! Mus musculus
CA Conditionally immortalized cell line
//
ID TM-BBB2
AC CVCL_6C10
RX PubMed=11741243;
RX PubMed=17233813;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX NCBI_TaxID=10090; ! Mus musculus
CA Conditionally immortalized cell line
//
ID TM-BBB3
AC CVCL_6C11
RX PubMed=11741243;
RX PubMed=17233813;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX NCBI_TaxID=10090; ! Mus musculus
CA Conditionally immortalized cell line
//
ID TM-BBB4
AC CVCL_6C12
RX PubMed=11741243;
RX PubMed=17233813;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX NCBI_TaxID=10090; ! Mus musculus
CA Conditionally immortalized cell line
//
ID TM-BBB5
AC CVCL_6C13
RX PubMed=11741243;
RX PubMed=17233813;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX NCBI_TaxID=10090; ! Mus musculus
CA Conditionally immortalized cell line
//
ID TM#1
AC CVCL_N781
DR ATCC; CRL-11380
RX Patent=US5731490;
CC Knockout cell: Method=Homologous recombination; MGI; MGI:96590; Irf1.
CC Breed/subspecies: 129S2/SvPas.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4378 ! ES-D3
SX Male
CA Embryonic stem cell
//
ID TM01
AC CVCL_6A96
SY TM 01
RX PubMed=9706400;
RX PubMed=11520047;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX NCBI_TaxID=10090; ! Mus musculus
CA Conditionally immortalized cell line
//
ID TM02-3
AC CVCL_6A97
SY TM 02-3
RX PubMed=9706400;
RX PubMed=11520047;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX NCBI_TaxID=10090; ! Mus musculus
CA Conditionally immortalized cell line
//
ID TM1
AC CVCL_F787
DR CLO; CLO_0009364
DR ATCC; HB-169
DR ECACC; 92100624
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID TM10
AC CVCL_HE75
SY TM 10
RX PubMed=2888776;
RX PubMed=4084981;
CC Breed/subspecies: C57BL/6J.
OX NCBI_TaxID=10090; ! Mus musculus
CA Spontaneously immortalized cell line
//
ID TM3
AC CVCL_4326
SY TM-3
DR BTO; BTO:0004523
DR CLO; CLO_0009366
DR CLDB; cl4527
DR ATCC; CRL-1714
DR BCRC; 60475
DR CCRID; 3111C0001CCC000297
DR ECACC; 91060526
DR KCLB; 21714
DR NCBI_Iran; C514
RX PubMed=6774781;
RX PubMed=15541572;
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Spontaneously immortalized cell line
//
ID TM4
AC CVCL_4327
SY TM-4
DR BTO; BTO:0004230
DR CLO; CLO_0009368
DR CLDB; cl4528
DR ATCC; CRL-1715
DR BCRC; 60254
DR CCRID; 3111C0001CCC000298
DR ECACC; 88111401
DR KCLB; 21715
DR NCBI_Iran; C513
RX PubMed=6774781;
RX PubMed=15541572;
RX PubMed=26900862;
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Spontaneously immortalized cell line
//
ID Tm87-16
AC CVCL_8001
SY TM87-16; TM
DR Cosmic; 801769
DR Cosmic; 802049
DR Cosmic; 802247
DR Cosmic; 1063887
DR Cosmic; 2144782
DR TOKU-E; 4151
RX PubMed=1747867;
RX PubMed=8385567;
RX PubMed=11557780;
RX PubMed=16557275;
RX PubMed=24418192;
CC Doubling time: 45 hours (PubMed=1747867).
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C6586; Extrarenal rhabdoid tumor
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID TMA-1
AC CVCL_1R69
DR RCB; AES0055
DR RCB; RCB2542
CC Discontinued: RCB; RCB2542; true.
CC Breed/subspecies: 129/Sv.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Embryonic stem cell
//
ID TMA-16
AC CVCL_1R71
RX PubMed=7514525;
CC Breed/subspecies: 129/Sv.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Embryonic stem cell
//
ID TMA-2
AC CVCL_1R70
DR RCB; AES0056
DR RCB; RCB2543
RX PubMed=7514525;
CC Discontinued: RCB; RCB2543; true.
CC Breed/subspecies: C3H/He x T37H.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Embryonic stem cell
//
ID TMA-29
AC CVCL_1R72
RX PubMed=7514525;
CC Breed/subspecies: 129/Sv.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Embryonic stem cell
//
ID TMA-30
AC CVCL_1R73
RX PubMed=7514525;
CC Breed/subspecies: 129/Sv.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Embryonic stem cell
//
ID TMA-32
AC CVCL_1R74
RX PubMed=7514525;
CC Breed/subspecies: 129/Sv.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Embryonic stem cell
//
ID TMA-45
AC CVCL_1R75
RX PubMed=7514525;
CC Breed/subspecies: 129/Sv x C3H/HeHa.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Embryonic stem cell
//
ID TMA-46
AC CVCL_1R76
RX PubMed=7514525;
CC Breed/subspecies: 129/Sv x C3H/HeHa.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Embryonic stem cell
//
ID TmB
AC CVCL_6F95
SY Tilapia mossambica Bulbus arteriosus
RX DOI=10.1111/j.1365-2761.1985.tb01283.x;
CC Group: Fish cell line.
OX NCBI_TaxID=8127; ! Oreochromis mossambicus
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID TMC-1
AC CVCL_9475
SY TMC1
DR BTO; BTO:0003284
RX PubMed=15237194;
DI NCIt; C4911; Gastric carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID TMCC-1
AC CVCL_IM28
RX PubMed=8631546;
RX PubMed=8931502;
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C9039; Cervical carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID TMCC-2
AC CVCL_6736
RX PubMed=1890355;
CC Doubling time: 24 hours (PubMed=1890355).
DI NCIt; C6344; Cervical clear cell adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID TMCC-2.U
AC CVCL_6737
RX PubMed=1888705;
DI NCIt; C6344; Cervical clear cell adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_6736 ! TMCC-2
SX Female
CA Cancer cell line
//
ID TMD2
AC CVCL_5377
RX PubMed=1912566;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=TMD2
DI NCIt; C3163; Chronic lymphocytic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID TMD5
AC CVCL_3218
DR BioSample; SAMN03472802
DR IFO; IFO50516
RX PubMed=10071078;
CC Doubling time: 50 hours (PubMed=10071078).
ST Source(s): JCRB
ST Amelogenin: X,Y
ST CSF1PO: 10,13
ST D13S317: 8
ST D16S539: 10,12
ST D5S818: 9,13
ST D7S820: 10,11
ST TH01: 9
ST TPOX: 8
ST vWA: 17,18
DI NCIt; C114819; Adult B acute lymphoblastic leukemia with t(9;22)(q34;q11.2) BCR-ABL1
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID TMD7
AC CVCL_5378
SY TMD-7
DR Cosmic; 975305
RX PubMed=11972520;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=TMD7
DI NCIt; C7600; Acute myeloid leukemia with myelodysplasia-related changes
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID TMD8
AC CVCL_A442
SY TMD-8
DR EFO; EFO_0006496
DR Cosmic; 1486587
DR Cosmic; 1945194
DR Cosmic; 2129635
DR GEO; GSM1059801
DR GEO; GSM1374963
DR GEO; GSM1890021
DR GEO; GSM1890022
DR GEO; GSM1890023
DR GEO; GSM1890024
DR GEO; GSM2037048
DR GEO; GSM2037049
RX PubMed=16780947;
RX PubMed=23292937;
RX PubMed=25485619;
CC Doubling time: ~30 hours (PubMed=16780947).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Misspelling: 'TDM8' in PubMed=23292937.
DI NCIt; C8851; Diffuse large B-cell lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID TMG-L
AC CVCL_W391
RX PubMed=12971623;
DI NCIt; C7558; Endometrial carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID TMH-1
AC CVCL_3219
DR BioSample; SAMN03151799
DR BioSample; SAMN03472499
DR JCRB; JCRB1078
DR JCRB; NIHS0267
RX PubMed=11686581;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a IHH-4 derivative (PubMed=20143388).
CC Discontinued: JCRB; NIHS0267; true.
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 10,13
ST D16S539: 9,11
ST D5S818: 9,13
ST D7S820: 9,10
ST TH01: 9
ST TPOX: 11
ST vWA: 16,18
DI NCIt; C4035; Thyroid gland papillary carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2960 ! IHH-4
SX Male
CA Cancer cell line
//
ID TMK-1
AC CVCL_4384
SY TMK1
DR BTO; BTO:0003219
DR EFO; EFO_0002867
DR Cosmic; 887251
DR Cosmic; 888829
DR Cosmic; 897537
DR Cosmic; 922689
DR Cosmic; 926110
DR Cosmic; 1122341
DR Cosmic; 1187298
DR Cosmic; 1223585
DR Cosmic; 1460701
DR Cosmic; 1482078
DR Cosmic; 1518245
DR Cosmic; 1571762
DR Cosmic-CLP; 1299069
DR GDSC; 1299069
DR GEO; GSM562397
DR TOKU-E; 4022
RX PubMed=11107048;
RX PubMed=27397505;
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
ST Source(s): Cosmic-CLP
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 10,13
ST D16S539: 9
ST D5S818: 10,13
ST D7S820: 8,12
ST TH01: 9
ST TPOX: 8,10
ST vWA: 14
DI NCIt; C4004; Gastric adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID TMM
AC CVCL_1894
DR CLO; CLO_0009376
DR CLDB; cl4533
DR BioSample; SAMN03151631
DR BioSample; SAMN03473406
DR DSMZ; ACC-95
RX PubMed=3478106;
RX PubMed=10516762;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Misidentified. Originally thought to be a leukemia cell line but is a B-lymphoblastoid cell line (PubMed=10516762, PubMed=20143388).
CC Doubling time: ~20-40 hours (DSMZ).
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST Source(s): DSMZ
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 12,14
ST D16S539: 10,12
ST D5S818: 11
ST D7S820: 10,11
ST TH01: 8,9.3
ST TPOX: 8,9
ST vWA: 14,18
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID TMNK-1
AC CVCL_4W79
DR JCRB; JCRB1564
RX PubMed=15167590;
CC Transfected with: HGNC; 11730; TERT.
CC Transfected with: UniProtKB; P42212; GFP.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 11
ST D16S539: 10,11
ST D5S818: 11
ST D7S820: 11,13
ST TH01: 6,7
ST TPOX: 9
ST vWA: 15,16
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID TMO-399
AC CVCL_V385
DR IMGT/HLA; 14458
RX PubMed=16948657;
CC Part of: International Histocompatibility Workshop cell lines.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID TMT-081MS
AC CVCL_L174
SY TMT-081-MS; TMT-081.MS
DR KCLB; 60021
RX PubMed=6662551;
CC Breed/subspecies: Wistar Furth.
DI NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX NCBI_TaxID=10116; ! Rattus norvegicus
OI CVCL_L175 ! TMT-081NM
SX Female
CA Cancer cell line
//
ID TMT-081NM
AC CVCL_L175
SY TMT-081-NM; NM-081
DR KCLB; 60023
RX PubMed=6662551;
CC Breed/subspecies: Wistar Furth.
DI NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX NCBI_TaxID=10116; ! Rattus norvegicus
OI CVCL_L174 ! TMT-081MS
SX Female
CA Cancer cell line
//
ID TMT-50
AC CVCL_Y664
RX PubMed=2096989;
CC Breed/subspecies: Wistar Furth.
DI NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Female
CA Cancer cell line
//
ID TMUU-08
AC CVCL_W376
RX PubMed=19222609;
DI NCIt; C4031; Bladder squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID TN-1
AC CVCL_6738
DR CLO; CLO_0051418
DR BioSample; SAMN03472008
DR RCB; RCB2107
DR TKG; TKG 0277
RX PubMed=2486611;
ST Source(s): RCB; TKG
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 8,13
ST D16S539: 11,12
ST D5S818: 10,11
ST D7S820: 11,12
ST TH01: 6
ST TPOX: 8,11
ST vWA: 14,19
DI NCIt; C4827; Adrenal gland neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID TN-2
AC CVCL_5602
DR CLO; CLO_0051415
DR BioSample; SAMN03472085
DR RCB; RCB1896
DR TKG; TKG 0278
RX PubMed=2486612;
ST Source(s): RCB; TKG
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 8
ST D16S539: 10,11
ST D5S818: 11,12
ST D7S820: 11,12
ST TH01: 6,7
ST TPOX: 8,11
ST vWA: 14,18
DI NCIt; C4827; Adrenal gland neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID TN-3
AC CVCL_W517
RX PubMed=2486613;
DI NCIt; C4827; Adrenal gland neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID TN-368
AC CVCL_C412
SY Tn-368; Tn 368; TN368; Tn368; Trichoplusia ni 368
DR CLO; CLO_0009377
DR CLDB; cl4534
DR DSMZ; ACC-177
RX DOI=10.1016/B978-0-12-429740-1.50033-3;
RX DOI=10.1139/z85-337;
RX PubMed=1104895;
RX PubMed=1367489;
RX PubMed=1561320;
RX PubMed=4471170;
RX PubMed=8314732;
RX PubMed=12623313;
RX PubMed=15926859;
RX PubMed=16057320;
RX PubMed=16346059;
RX PubMed=16593348;
CC Group: Insect cell line.
CC Group: Recombinant protein production insect cell line.
CC Doubling time: ~24 hours (DSMZ).
OX NCBI_TaxID=7111; ! Trichoplusia ni
SX Female
CA Spontaneously immortalized cell line
//
ID TN-368-10
AC CVCL_Z078
SY TN368-10; TN-368 clone 10
RX DOI=10.1016/B978-0-12-429740-1.50032-1;
RX PubMed=357682;
RX PubMed=1104895;
CC Group: Insect cell line.
CC Group: Recombinant protein production insect cell line.
OX NCBI_TaxID=7111; ! Trichoplusia ni
HI CVCL_C412 ! TN-368
SX Female
CA Spontaneously immortalized cell line
//
ID TN-368-13
AC CVCL_Z079
SY TN368-13; TN-368 clone 13
RX DOI=10.1016/B978-0-12-429740-1.50032-1;
RX PubMed=357682;
RX PubMed=1104895;
CC Group: Insect cell line.
CC Group: Recombinant protein production insect cell line.
OX NCBI_TaxID=7111; ! Trichoplusia ni
HI CVCL_C412 ! TN-368
SX Female
CA Spontaneously immortalized cell line
//
ID TN-368A
AC CVCL_C413
SY Tn-368A
RX DOI=10.1007/BF02618167;
CC Group: Insect cell line.
CC Group: Recombinant protein production insect cell line.
OX NCBI_TaxID=7111; ! Trichoplusia ni
HI CVCL_C412 ! TN-368
SX Female
CA Spontaneously immortalized cell line
//
ID Tn-4h
AC CVCL_Z431
SY Tn4h; BTI-Tn-5B1-4h
RX Patent=US6472175;
RX PubMed=10933841;
RX PubMed=11587569;
RX PubMed=20574041;
CC Group: Insect cell line.
CC Group: Recombinant protein production insect cell line.
OX NCBI_TaxID=7111; ! Trichoplusia ni
HI CVCL_C190 ! BTI-Tn-5B1-4
SX Female
CA Spontaneously immortalized cell line
//
ID Tn-4s
AC CVCL_Z432
RX PubMed=12573025;
RX PubMed=12790633;
CC Group: Insect cell line.
CC Group: Recombinant protein production insect cell line.
OX NCBI_TaxID=7111; ! Trichoplusia ni
HI CVCL_Z431 ! Tn-4h
SX Female
CA Spontaneously immortalized cell line
//
ID TN-CL1
AC CVCL_Z257
SY TN-368 CL1; TN-368 clone 1
RX DOI=10.1016/0022-2011(89)90145-6;
RX DOI=10.1016/0022-2011(91)90151-F;
RX DOI=10.3923/jas.2007.4040.4043;
RX PubMed=1522049;
RX PubMed=4471170;
RX PubMed=8799737;
RX PubMed=10777062;
CC Group: Insect cell line.
CC Group: Recombinant protein production insect cell line.
OX NCBI_TaxID=7111; ! Trichoplusia ni
HI CVCL_C412 ! TN-368
SX Female
CA Spontaneously immortalized cell line
//
ID TN1.Lu
AC CVCL_S393
DR ATCC; CRL-6563
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6563; true.
OX NCBI_TaxID=9361; ! Dasypus novemcinctus
SX Sex undetermined
CA Finite cell line
//
ID TNB1
AC CVCL_A443
SY TNB-1
DR CLO; CLO_0050265
DR BioSample; SAMN03472325
DR Cosmic; 920254
DR RCB; RCB0481
RX PubMed=2335222;
RX PubMed=2577250;
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 11,15
ST D13S317: 8,11
ST D16S539: 9,13
ST D5S818: 13
ST D7S820: 12
ST TH01: 6,7
ST TPOX: 10,11
ST vWA: 18
DI NCIt; C4827; Adrenal gland neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1771 ! TGW
SX Male
CA Cancer cell line
//
ID TND-1
AC CVCL_DP22
RX PubMed=3891604;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID TND-2
AC CVCL_DP23
RX PubMed=3891604;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID TND-3
AC CVCL_DP24
RX PubMed=3891604;
RX PubMed=10074495;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3895; Bare lymphocyte syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID TND-4
AC CVCL_DP25
RX PubMed=3891604;
RX PubMed=10074495;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID TNMY1
AC CVCL_M836
RX PubMed=11564213;
DI NCIt; C4247; Unclassified pleomorphic sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID TNR-2
AC CVCL_6739
RX PubMed=6971296;
CC Breed/subspecies: Swiss albino.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0120 ! 3T3-Swiss albino
SX Male
CA Spontaneously immortalized cell line
//
ID TNR-9
AC CVCL_6740
RX PubMed=6971296;
CC Breed/subspecies: Swiss albino.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0120 ! 3T3-Swiss albino
SX Male
CA Spontaneously immortalized cell line
//
ID TO [Human B-cell]
AC CVCL_E854
SY TO-PP
DR dbMHC; 49045
DR ECACC; 94022549
DR IHW; IHW9218
DR IMGT/HLA; 11482
WW http://bioinformatics.hsanmartino.it/ecbr/cl218.html
CC Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID TO [Salmon]
AC CVCL_D140
DR GEO; GSM1564238
DR GEO; GSM1564239
DR GEO; GSM1564240
RX PubMed=11383566;
RX PubMed=19162334;
RX PubMed=25765343;
CC Group: Fish cell line.
CC Omics: Deep RNAseq analysis.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=8030; ! Salmo salar
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID TO 165.T
AC CVCL_N528
DR ATCC; CRL-7775
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-7775; true.
DI NCIt; C3043; Fibrosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_3805 ! TO 166.M
SX Female
CA Cancer cell line
//
ID TO 166.M
AC CVCL_3805
DR CLO; CLO_0009379
DR ATCC; CRL-7776
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_N528 ! TO 165.T
SX Female
CA Finite cell line
//
ID TO 167.T
AC CVCL_N530
DR ATCC; CRL-7777
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-7777; true.
DI NCIt; C2946; Chondrosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID TO 173.T
AC CVCL_N529
DR ATCC; CRL-7778
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-7778; true.
DI NCIt; C3262; Neoplasm
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID TO 175.T
AC CVCL_3806
DR CLO; CLO_0009380
DR ATCC; CRL-7779
DR BioSample; SAMN03471152
DR CCLE; TO175T_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
DR GEO; GSM887708
DR GEO; GSM888801
DR IGRhCellID; TO175T
RX PubMed=22460905;
RX PubMed=25355872;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Omics: Virome analysis using RNAseq.
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 10,14
ST D16S539: 10,11
ST D5S818: 10,11
ST D7S820: 11,12
ST TH01: 7,8
ST TPOX: 10,12
ST vWA: 17
DI NCIt; C9357; Hodgkin lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID TO 183.T
AC CVCL_S257
DR ATCC; CRL-7952
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-7952; true.
DI NCIt; C3272; Neurofibroma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID TO 184.T
AC CVCL_S258
DR ATCC; CRL-7953
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-7953; true.
DI NCIt; C3194; Liposarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID TO 203.T
AC CVCL_3610
SY TO-203-T
DR CLO; CLO_0009381
DR ATCC; CRL-7780
DR BioSample; SAMN03471153
DR Cosmic; 687933
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-7780; true.
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 12,14
ST D16S539: 9,13
ST D5S818: 11
ST D7S820: 8,9
ST TH01: 8,9.3
ST TPOX: 9,11
ST vWA: 16,17
DI NCIt; C9145; Osteosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID To Ser
AC CVCL_U692
DR ATCC; CRL-1111
CC Discontinued: ATCC; CRL-1111; true.
DI NCIt; C61255; Lesch-Nyhan syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID To War
AC CVCL_U794
DR ATCC; CRL-1244
CC Discontinued: ATCC; CRL-1244; true.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID TO-2
AC CVCL_R880
SY Tilapia Ovary-2
DR Wikidata; Q28471145
RX DOI=10.3147/jsfp.18.13;
RX PubMed=2592443;
CC Group: Fish cell line.
CC Doubling time: 12 hours (in 20% FCS), 27 hours (in 10% FCS), 30 hours (in 5% FCS), 50 hours (in 2% FCS) (DOI=10.3147/jsfp.18.13).
OX NCBI_TaxID=304579; ! Oreochromis mossambicus x Oreochromis niloticus
SX Female
CA Spontaneously immortalized cell line
//
ID TO-37c
AC CVCL_R881
RX PubMed=2592443;
CC Group: Fish cell line.
OX NCBI_TaxID=304579; ! Oreochromis mossambicus x Oreochromis niloticus
HI CVCL_R880 ! TO-2
SX Female
CA Spontaneously immortalized cell line
//
ID TO14
AC CVCL_2734
SY T014
DR ECACC; 10081203
DR GEO; GSM726082
DR Ximbio; 151680
RX PubMed=3167863;
DI NCIt; C5228; Ovarian cystadenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2687 ! PEO14
OI CVCL_2689 ! PEO23
SX Female
CA Cancer cell line
//
ID TO4 Y56A
AC CVCL_GT19
DR ATCC; CRL-6580
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6580; true.
OX NCBI_TaxID=9615; ! Canis lupus familiaris
CA Cancer cell line
//
ID TOC-2
AC CVCL_Y478
RX PubMed=7671230;
CC From: Sato N.; Sapporo Medical College; Sapporo; Japan.
DI NCIt; C7700; Ovarian adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID TOC-4 iPSC
AC CVCL_GQ05
RX PubMed=27558612;
DI NCIt; C88411; Obsessive compulsive disorder
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID TOGB
AC CVCL_AZ92
SY Trachinotus Ovatus Golden Brain
RX PubMed=26822430;
CC Group: Fish cell line.
OX NCBI_TaxID=173339; ! Trachinotus ovatus
SX Male
CA Spontaneously immortalized cell line
//
ID TOK
AC CVCL_IQ76
SY Trachinotus Ovatus Kidney
RX PubMed=27981423;
CC Group: Fish cell line.
OX NCBI_TaxID=173339; ! Trachinotus ovatus
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID TOKUNAGA
AC CVCL_E855
SY TOK
DR dbMHC; 49046
DR ECACC; 85102916
DR IHW; IHW1202
DR IHW; IHW9304
DR IMGT/HLA; 11493
WW http://bioinformatics.hsanmartino.it/ecbr/cl380.html
WW http://bioinformatics.hsanmartino.it/ecbr/cl304.html
CC Part of: 9th International Histocompatibility Workshop (9IHW) cell line panel.
CC Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID Tol/F
AC CVCL_W140
SY Tol/FL; TOL/F; Tolstolob/Fin
RX PubMed=17497237;
CC Group: Fish cell line.
OX NCBI_TaxID=13095; ! Hypophthalmichthys molitrix
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID Toledo
AC CVCL_3611
SY TOLEDO
DR CLO; CLO_0009382
DR EFO; EFO_0002383
DR ATCC; CRL-2631
DR BCRC; 60544
DR BCRJ; 0235
DR BioSample; SAMN03472953
DR CCLE; TOLEDO_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
DR Cosmic; 1541917
DR Cosmic; 1670183
DR Cosmic; 1945195
DR Cosmic; 2022502
DR Cosmic; 2276337
DR GDSC; 1331046
DR GEO; GSM380151
DR GEO; GSM552462
DR GEO; GSM887709
DR GEO; GSM888802
DR GEO; GSM907526
DR IGRhCellID; Toledo
RX PubMed=10485273;
RX PubMed=19278952;
RX PubMed=19358282;
RX PubMed=22460905;
RX PubMed=23292937;
RX PubMed=25355872;
RX PubMed=25485619;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Omics: Array-based CGH.
CC Omics: CNV analysis.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: miRNA expression profiling.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Omics: Virome analysis using RNAseq.
ST Source(s): ATCC; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 11
ST D16S539: 9
ST D18S51: 12
ST D21S11: 28,32.2
ST D3S1358: 16,18
ST D5S818: 10,12
ST D7S820: 9,10
ST D8S1179: 13
ST FGA: 19,22
ST Penta D: 11,13
ST Penta E: 10,12
ST TH01: 8,9.3
ST TPOX: 8,11
ST vWA: 16,17
DI NCIt; C8851; Diffuse large B-cell lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID TOM-1
AC CVCL_1895
SY TOM1
DR BioSample; SAMN03473484
DR Cosmic; 1012125
DR Cosmic; 1026577
DR Cosmic; 1524825
DR Cosmic; 2491093
DR DSMZ; ACC-578
DR GEO; GSM236808
DR GEO; GSM236844
DR Lonza; 716
RX PubMed=3103721;
RX PubMed=3332852;
RX PubMed=9067587;
RX PubMed=16408098;
CC Doubling time: ~60-70 hours (DSMZ).
ST Source(s): DSMZ
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 8,11
ST D16S539: 9,10
ST D5S818: 11,13
ST D7S820: 10,12
ST TH01: 7,9
ST TPOX: 8,11
ST vWA: 17,18
DI NCIt; C9143; Adult B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID TOM-2
AC CVCL_5603
DR CLO; CLO_0050880
DR BioSample; SAMN03472155
DR RCB; RCB1125
RX PubMed=9590502;
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 8,12
ST D16S539: 10,14
ST D5S818: 11,13
ST D7S820: 10,11
ST TH01: 7
ST TPOX: 8
ST vWA: 17
DI NCIt; C40212; Cervical adenosquamous carcinoma, glassy cell variant
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID TonB210.1
AC CVCL_K246
SY Baf3/TonB210.1
RX PubMed=9573031;
CC Characteristics: IL3 dependent.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0161 ! Ba/F3
CA Factor-dependent cell line
//
ID Tong/HCC
AC CVCL_V640
SY Tong; TONG; TONG/PHC; TONG PHC
RX PubMed=2445644;
RX PubMed=8050184;
DI NCIt; C3099; Hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID TOS-1
AC CVCL_A753
RX PubMed=10775053;
CC Derived from metastatic site: Subcutaneous soft tissue.
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID TOS-2
AC CVCL_A754
RX PubMed=10775053;
CC Derived from metastatic site: Axillary subcutaneous soft tissue.
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID TOS-3
AC CVCL_A755
RX PubMed=10775053;
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_A756 ! TOS-3LN
SX Male
CA Cancer cell line
//
ID TOS-3LN
AC CVCL_A756
RX PubMed=10775053;
CC Derived from metastatic site: Lymph node.
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_A755 ! TOS-3
SX Male
CA Cancer cell line
//
ID Tot2
AC CVCL_0564
DR MCCL; MCC:0000466
DR Lonza; 443
RX PubMed=10981959;
CC Characteristics: CSF2 dependent.
OX NCBI_TaxID=10090; ! Mus musculus
CA Factor-dependent cell line
//
ID TOTL-1
AC CVCL_S612
RX PubMed=2476248;
DI NCIt; C7541; Retinoblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID TOU (TOU I-2)
AC CVCL_2735
SY TOU; TOU I-2
DR CLO; CLO_0009383
DR CLDB; cl4536
DR ECACC; 93093001
RX PubMed=6438434;
WW http://www.imgt.org/IMGTrepertoire/LocusGenes/locus/human/IGH/Hu_IGHcellines.html
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID TOV-112D
AC CVCL_3612
SY TOV-112d; TOV112D; TOV-112; TOV112
DR BTO; BTO:0005182
DR CLO; CLO_0009384
DR EFO; EFO_0005263
DR ATCC; CRL-11731
DR BCRC; 60408
DR BioSample; SAMN03471348
DR CCLE; TOV112D_OVARY
DR Cosmic; 875292
DR Cosmic; 1066219
DR Cosmic; 1102818
DR Cosmic; 1113278
DR Cosmic; 1139220
DR Cosmic; 1305335
DR Cosmic; 1709264
DR Cosmic; 2186587
DR Cosmic-CLP; 1299070
DR GDSC; 1299070
DR GEO; GSE35972
DR GEO; GSM289383
DR GEO; GSM289384
DR GEO; GSM289387
DR GEO; GSM289388
DR GEO; GSM313690
DR GEO; GSM659407
DR GEO; GSM784575
DR GEO; GSM851944
DR GEO; GSM887710
DR GEO; GSM888803
DR GEO; GSM1001425
DR GEO; GSM1001426
DR GEO; GSM1001489
DR GEO; GSM1374964
DR GEO; GSM1670546
RX Patent=US5710038;
RX PubMed=10949993;
RX PubMed=11641787;
RX PubMed=19288585;
RX PubMed=22328975;
RX PubMed=22460905;
RX PubMed=22710073;
RX PubMed=22931248;
RX PubMed=24023729;
RX PubMed=25230021;
RX PubMed=25485619;
RX PubMed=25984343;
RX PubMed=27235858;
RX PubMed=27397505;
RX PubMed=27561551;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: KuDOS 95 cell line panel.
CC Part of: MD Anderson Cell Lines Project.
CC Part of: OCCP ovarian cancer cell line panel.
CC Doubling time: 22 hours (PubMed=25984343).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep proteome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; Cosmic-CLP; PubMed=25230021; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 8
ST D16S539: 9,12 (ATCC; Cosmic-CLP; PubMed=25877200)
ST D16S539: 11,12 (PubMed=25230021)
ST D18S51: 17
ST D21S11: 31
ST D3S1358: 15
ST D5S818: 10
ST D7S820: 9,10
ST D8S1179: 9,13
ST FGA: 20
ST Penta D: 9
ST Penta E: 11
ST TH01: 6
ST TPOX: 8,11
ST vWA: 18
DI NCIt; C7979; Ovarian endometrioid adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID TOV-112DR
AC CVCL_IQ56
SY TOV112DR
RX PubMed=27561551;
CC Selected for resistance to: ChEBI; CHEBI:31355; Carboplatin (CBP; Paraplatin).
CC Omics: Deep proteome analysis.
DI NCIt; C7979; Ovarian endometrioid adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3612 ! TOV-112D
SX Female
CA Cancer cell line
//
ID TOV-1369
AC CVCL_9T17
SY TOV1369
RX PubMed=22931248;
DI NCIt; C105555; High grade ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_9T12 ! OV-1369(R2)
SX Female
CA Cancer cell line
//
ID TOV-1946
AC CVCL_4062
SY TOV1946
DR Cosmic; 1122314
RX PubMed=18507860;
RX PubMed=22931248;
WW http://colt.ccbr.utoronto.ca/cancer/get_cellline.pl?cellline=TOV-1946
DI NCIt; C105555; High grade ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4375 ! OV-1946
SX Female
CA Cancer cell line
//
ID TOV-21G
AC CVCL_3613
SY TOV-21g; TOV21G; TOV21
DR BTO; BTO:0005183
DR CLO; CLO_0009385
DR ATCC; CRL-11730
DR BCRC; 60407
DR BCRJ; 0236
DR BioSample; SAMN03471875
DR CCLE; TOV21G_OVARY
DR Cosmic; 1066220
DR Cosmic; 1102820
DR Cosmic; 1139221
DR Cosmic; 1223320
DR Cosmic; 1305319
DR Cosmic; 1312195
DR Cosmic; 1328069
DR Cosmic; 1434896
DR Cosmic; 1449932
DR Cosmic; 1707558
DR Cosmic; 1708383
DR Cosmic; 2074249
DR Cosmic-CLP; 1240222
DR GDSC; 1240222
DR GEO; GSM289385
DR GEO; GSM289386
DR GEO; GSM289416
DR GEO; GSM289417
DR GEO; GSM313692
DR GEO; GSM659408
DR GEO; GSM784567
DR GEO; GSM851945
DR GEO; GSM887711
DR GEO; GSM888804
DR GEO; GSM1176285
DR GEO; GSM1374965
DR GEO; GSM1670547
DR PRIDE; PXD000901
RX Patent=US5710038;
RX PubMed=10949993;
RX PubMed=11641787;
RX PubMed=22460905;
RX PubMed=22710073;
RX PubMed=23839242;
RX PubMed=24023729;
RX PubMed=25230021;
RX PubMed=25984343;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: KuDOS 95 cell line panel.
CC Part of: MD Anderson Cell Lines Project.
CC Part of: OCCP ovarian cancer cell line panel.
CC Part of: PTEN genetic alteration cell panel (ATCC TCP-1030).
CC Doubling time: 27 hours (PubMed=25984343).
CC Microsatellite instability: Instable (MSI-high) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; Cosmic-CLP; PubMed=25230021; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 13,15
ST D13S317: 11,12
ST D16S539: 10,12
ST D18S51: 12
ST D21S11: 28,34.2
ST D3S1358: 14,16
ST D5S818: 12,13
ST D7S820: 12
ST D8S1179: 13,16
ST FGA: 20,23
ST Penta D: 9
ST Penta E: 17,19 (PubMed=25230021)
ST Penta E: 17,18 (PubMed=25877200)
ST TH01: 7,9.3
ST TPOX: 8,11
ST vWA: 17
DI NCIt; C40078; Ovarian clear cell adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID TOV-2223
AC CVCL_4063
SY TOV-2223G
DR Cosmic; 1122316
RX PubMed=18507860;
WW http://colt.ccbr.utoronto.ca/cancer/get_cellline.pl?cellline=TOV-2223G
DI NCIt; C105555; High grade ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID TOV-2295(R)
AC CVCL_9T18
SY TOV2295(R)
RX PubMed=22931248;
DI NCIt; C105555; High grade ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_9T13 ! OV-2295
OI CVCL_9T14 ! OV-2295(R2)
SX Female
CA Cancer cell line
//
ID TOV-2978G
AC CVCL_9U73
SY TOV2978G
RX PubMed=26622941;
CC Doubling time: 1.87 +- 0.11 days (PubMed=26622941).
CC Omics: Deep exome analysis.
CC Omics: SNP array analysis.
DI NCIt; C105555; High grade ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID TOV-3041G
AC CVCL_9T24
SY TOV3041G
RX PubMed=26622941;
CC Doubling time: 1.33 +- 0.02 days (PubMed=26622941).
CC Omics: Deep exome analysis.
CC Omics: SNP array analysis.
DI NCIt; C105555; High grade ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID TOV-3133D
AC CVCL_9T19
SY TOV3133D
RX PubMed=22931248;
DI NCIt; C105555; High grade ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_9T15 ! OV-3133(R)
OI CVCL_9T16 ! OV-3133(R2)
OI CVCL_4064 ! TOV-3133G
SX Female
CA Cancer cell line
//
ID TOV-3133G
AC CVCL_4064
RX PubMed=22931248;
WW http://colt.ccbr.utoronto.ca/cancer/get_cellline.pl?cellline=TOV-3133G
DI NCIt; C105555; High grade ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_9T15 ! OV-3133(R)
OI CVCL_9T16 ! OV-3133(R2)
OI CVCL_9T19 ! TOV-3133D
SX Female
CA Cancer cell line
//
ID TOV-3291G
AC CVCL_9T25
SY TOV3291G
RX PubMed=26622941;
CC Doubling time: 2.28 +- 0.19 days (PubMed=26622941).
CC Omics: Deep exome analysis.
CC Omics: SNP array analysis.
DI NCIt; C105555; High grade ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID TOV-81D
AC CVCL_A453
RX PubMed=10949993;
RX PubMed=11641787;
CC Omics: Transcriptome analysis.
DI NCIt; C7550; Ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID Tp 242-C
AC CVCL_M419
RX PubMed=6306758;
DI NCIt; C4450; Large cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Tp 362-C
AC CVCL_M420
RX PubMed=6306758;
DI NCIt; C4450; Large cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID TP-1
AC CVCL_S160
SY Tor Putitora-1
RX DOI=10.1016/j.aquaculture.2005.09.021;
CC Group: Fish cell line.
OX NCBI_TaxID=210638; ! Tor putitora
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID TP-3
AC CVCL_J968
DR ATCC; CRL-8761
RX Patent=US4859595;
CC Group: Hybridoma fusion partner cell line.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Discontinued: ATCC; CRL-8761; probable.
OX NCBI_TaxID=9986; ! Oryctolagus cuniculus
CA Transformed cell line
//
ID TP17
AC CVCL_A685
DR BTO; BTO:0002959
RX PubMed=10892885;
DI NCIt; C7712; Uveal melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Tp242MG
AC CVCL_M432
SY TP 242 Mg
RX Patent=US5525626;
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Tp265MG
AC CVCL_A686
SY TP265MG
DR Cosmic; 849854
DR Cosmic; 1610743
RX PubMed=6601641;
RX PubMed=19435942;
CC Characteristics: Has no IDH1 mutation.
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Tp276MG
AC CVCL_A687
SY TP276MG
DR Cosmic; 849848
DR Cosmic; 1610746
RX PubMed=19435942;
CC Characteristics: Has no IDH1 mutation.
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID TP31
AC CVCL_W950
DR Cosmic; 986622
RX PubMed=10892885;
RX PubMed=21647268;
DI NCIt; C7712; Uveal melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Tp336MG
AC CVCL_A688
SY TP336MG; TP 336 MG
DR Cosmic; 851221
DR Cosmic; 1610747
RX Patent=US5525626;
RX PubMed=19435942;
CC Characteristics: Has no IDH1 mutation.
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Tp365MG
AC CVCL_A689
SY TP365MG
DR Cosmic; 849855
DR Cosmic; 1610744
RX PubMed=6601641;
RX PubMed=19435942;
CC Characteristics: Has no IDH1 mutation.
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID TP378MG
AC CVCL_M433
SY Tp-378MG
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Tp410N
AC CVCL_M434
SY TP410N; TP 410 N; Tp-410
RX Patent=US5525626;
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Tp483MG
AC CVCL_A690
SY TP483MG
DR Cosmic; 849846
DR Cosmic; 1610745
RX PubMed=19435942;
CC Characteristics: Has no IDH1 mutation.
DI NCIt; C60781; Astrocytoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID TPA30-4
AC CVCL_H690
RX PubMed=6274452;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [ts30].
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID TPA30-6
AC CVCL_H646
RX PubMed=206898;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [ts30].
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2820 ! 3A(tPA-30-1)
OI CVCL_H645 ! TPWT-2
CA Transformed cell line
//
ID TPC-1
AC CVCL_6298
SY TPC1
DR ChEMBL-Cells; CHEMBL3308064
DR ChEMBL-Targets; CHEMBL613836
DR Cosmic; 686571
DR Cosmic; 686572
DR Cosmic; 686728
DR Cosmic; 849969
DR Cosmic; 931238
DR Cosmic; 1021385
DR Cosmic; 1084277
DR Cosmic; 1132593
DR Cosmic; 1152124
DR Cosmic; 1237448
DR Cosmic; 1239954
DR Cosmic; 1280041
DR Cosmic; 2036695
DR Cosmic; 2054096
DR Cosmic; 2319845
DR TOKU-E; 4065
RX PubMed=2823470;
RX PubMed=17725429;
RX PubMed=17804723;
RX PubMed=18713817;
RX PubMed=19087340;
RX PubMed=21868764;
RX PubMed=22087789;
RX PubMed=23162534;
RX PubMed=23833040;
CC Omics: Transcriptome analysis.
ST Source(s): PubMed=18713817; PubMed=21868764
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 11,12
ST D16S539: 9
ST D18S51: 13,16
ST D21S11: 30,31.2
ST D3S1358: 16,17
ST D5S818: 8,10
ST D7S820: 11
ST D8S1179: 11,17
ST FGA: 20,21
ST TH01: 9
ST TPOX: 11
ST vWA: 14,18
DI NCIt; C4035; Thyroid gland papillary carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID Tpit/E
AC CVCL_U899
DR CLO; CLO_0051605
DR RCB; RCB1692
RX PubMed=11014214;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX NCBI_TaxID=10090; ! Mus musculus
CA Conditionally immortalized cell line
//
ID Tpit/F1
AC CVCL_S513
DR CLO; CLO_0050227
DR RCB; RCB1691
RX PubMed=11014214;
RX PubMed=15541569;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX NCBI_TaxID=10090; ! Mus musculus
CA Conditionally immortalized cell line
//
ID TPK-1
AC CVCL_DE01
SY Transformed Porcine Kidney-1
RX PubMed=14120333;
RX PubMed=14206435;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [777].
OX NCBI_TaxID=9823; ! Sus scrofa
CA Transformed cell line
//
ID TpM(409)
AC CVCL_6D37
SY TpM(D409)
RX PubMed=1979317;
CC Characteristics: Infected by Theileria parva isolate Muguga.
OX NCBI_TaxID=9913; ! Bos taurus
CA Transformed cell line
//
ID TpM(803)
AC CVCL_F840
SY TpM803; T.p. M 803; 803 TPM
RX PubMed=1899385;
RX PubMed=1979317;
RX PubMed=3133661;
CC Characteristics: Infected by Theileria parva isolate Muguga.
OX NCBI_TaxID=9913; ! Bos taurus
CA Transformed cell line
//
ID TPM2-187
AC CVCL_6D25
DR RCB; AES2228
CC Knockout cell: Method=Gene trap; MGI; MGI:1350933; Bcap31.
CC Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_6D29 ! v6.4
SX Male
CA Embryonic stem cell
//
ID TPM5-123
AC CVCL_6D34
DR RCB; AES2486
CC Knockout cell: Method=Gene trap; MGI; MGI:2444748; Chd7.
CC Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_6D29 ! v6.4
SX Male
CA Embryonic stem cell
//
ID TPM6-180
AC CVCL_6D35
DR RCB; AES2641
CC Knockout cell: Method=Gene trap; MGI; MGI:2142330; Ppm1n.
CC Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_6D29 ! v6.4
SX Male
CA Embryonic stem cell
//
ID TPM6-360
AC CVCL_6D36
DR RCB; AES2764
CC Knockout cell: Method=Gene trap; MGI; MGI:1313312; Khdrbs3.
CC Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_6D29 ! v6.4
SX Male
CA Embryonic stem cell
//
ID TPS
AC CVCL_4328
SY Trout Pronephric Stroma
DR CLO; CLO_0009390
DR ECACC; 96112839
RX DOI=10.1006/fsim.1995.0042;
CC Group: Fish cell line.
OX NCBI_TaxID=8022; ! Oncorhynchus mykiss
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID TPS-2
AC CVCL_M749
SY Trout Pronephric Stroma-2
RX PubMed=22634253;
CC Group: Fish cell line.
OX NCBI_TaxID=8022; ! Oncorhynchus mykiss
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID TPWT-2
AC CVCL_H645
RX PubMed=206898;
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2820 ! 3A(tPA-30-1)
OI CVCL_H646 ! TPA30-6
CA Finite cell line
//
ID TR 310
AC CVCL_9239
DR CLO; CLO_0009391
DR ATCC; HB-219
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID TR-Ag-9-HPRT-
AC CVCL_F740
DR CLO; CLO_0009400
DR CLDB; cl4537
OX NCBI_TaxID=9913; ! Bos taurus
SX Sex undetermined
CA Undefined cell line type
//
ID TR-AST1
AC CVCL_6B51
RX PubMed=11699636;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Conditionally immortalized cell line
//
ID TR-AST2
AC CVCL_6B52
RX PubMed=11699636;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Conditionally immortalized cell line
//
ID TR-AST3
AC CVCL_6B53
RX PubMed=11699636;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Conditionally immortalized cell line
//
ID TR-AST4
AC CVCL_6B54
RX PubMed=11699636;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Conditionally immortalized cell line
//
ID TR-AST5
AC CVCL_6B55
RX PubMed=11699636;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Conditionally immortalized cell line
//
ID TR-BBB1
AC CVCL_5U70
SY TR-BBB 1
RX Patent=US20020045254;
RX PubMed=11328662;
RX PubMed=11520047;
RX PubMed=17233813;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX NCBI_TaxID=10116; ! Rattus norvegicus
OI CVCL_5U71 ! TR-BBB5
OI CVCL_5U72 ! TR-BBB6
CA Conditionally immortalized cell line
//
ID TR-BBB11
AC CVCL_5U73
SY TR-BBB 11
RX Patent=US20020045254;
RX PubMed=11328662;
RX PubMed=11520047;
RX PubMed=17233813;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX NCBI_TaxID=10116; ! Rattus norvegicus
OI CVCL_5U74 ! TR-BBB13
CA Conditionally immortalized cell line
//
ID TR-BBB13
AC CVCL_5U74
SY TR-BBB 13
RX Patent=US20020045254;
RX PubMed=11328662;
RX PubMed=11520047;
RX PubMed=17233813;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX NCBI_TaxID=10116; ! Rattus norvegicus
OI CVCL_5U73 ! TR-BBB11
CA Conditionally immortalized cell line
//
ID TR-BBB5
AC CVCL_5U71
SY TR-BBB 5
RX Patent=US20020045254;
RX PubMed=11328662;
RX PubMed=11520047;
RX PubMed=17233813;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX NCBI_TaxID=10116; ! Rattus norvegicus
OI CVCL_5U70 ! TR-BBB1
OI CVCL_5U72 ! TR-BBB6
CA Conditionally immortalized cell line
//
ID TR-BBB6
AC CVCL_5U72
SY TR-BBB 6
RX Patent=US20020045254;
RX PubMed=11328662;
RX PubMed=11520047;
RX PubMed=17233813;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX NCBI_TaxID=10116; ! Rattus norvegicus
OI CVCL_5U70 ! TR-BBB1
OI CVCL_5U71 ! TR-BBB5
CA Conditionally immortalized cell line
//
ID TR-BE
AC CVCL_6C36
RX PubMed=16773315;
RX PubMed=17233813;
CC Transfected with: UniProtKB; P42212; GFP.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Conditionally immortalized cell line
//
ID TR-BME clone 2
AC CVCL_5U63
RX PubMed=11336358;
RX PubMed=11520047;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX NCBI_TaxID=10116; ! Rattus norvegicus
OI CVCL_5U64 ! TR-BME clone 3
OI CVCL_5U65 ! TR-BME clone 8
SX Female
CA Conditionally immortalized cell line
//
ID TR-BME clone 3
AC CVCL_5U64
RX PubMed=11336358;
RX PubMed=11520047;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX NCBI_TaxID=10116; ! Rattus norvegicus
OI CVCL_5U63 ! TR-BME clone 2
OI CVCL_5U65 ! TR-BME clone 8
SX Female
CA Conditionally immortalized cell line
//
ID TR-BME clone 8
AC CVCL_5U65
RX PubMed=11336358;
RX PubMed=11520047;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX NCBI_TaxID=10116; ! Rattus norvegicus
OI CVCL_5U63 ! TR-BME clone 2
OI CVCL_5U64 ! TR-BME clone 3
SX Female
CA Conditionally immortalized cell line
//
ID TR-CSFB1
AC CVCL_F923
SY TR-CSFB 1
RX Patent=US20020045254;
RX PubMed=11336348;
RX PubMed=11520047;
RX PubMed=17233813;
RX PubMed=18162136;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX NCBI_TaxID=10116; ! Rattus norvegicus
OI CVCL_F924 ! TR-CSFB2
OI CVCL_F925 ! TR-CSFB3
OI CVCL_F926 ! TR-CSFB4
OI CVCL_F927 ! TR-CSFB5
CA Conditionally immortalized cell line
//
ID TR-CSFB2
AC CVCL_F924
SY TR-CSFB 2
RX Patent=US20020045254;
RX PubMed=11336348;
RX PubMed=11520047;
RX PubMed=17233813;
RX PubMed=18162136;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX NCBI_TaxID=10116; ! Rattus norvegicus
OI CVCL_F923 ! TR-CSFB1
OI CVCL_F925 ! TR-CSFB3
OI CVCL_F926 ! TR-CSFB4
OI CVCL_F927 ! TR-CSFB5
CA Conditionally immortalized cell line
//
ID TR-CSFB3
AC CVCL_F925
SY TR-CSFB 3
RX Patent=US20020045254;
RX PubMed=11336348;
RX PubMed=11520047;
RX PubMed=17233813;
RX PubMed=18162136;
CC Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-6508.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX NCBI_TaxID=10116; ! Rattus norvegicus
OI CVCL_F923 ! TR-CSFB1
OI CVCL_F924 ! TR-CSFB2
OI CVCL_F926 ! TR-CSFB4
OI CVCL_F927 ! TR-CSFB5
CA Conditionally immortalized cell line
//
ID TR-CSFB4
AC CVCL_F926
SY TR-CSFB 4
RX Patent=US20020045254;
RX PubMed=11336348;
RX PubMed=11520047;
RX PubMed=17233813;
RX PubMed=18162136;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX NCBI_TaxID=10116; ! Rattus norvegicus
OI CVCL_F923 ! TR-CSFB1
OI CVCL_F924 ! TR-CSFB2
OI CVCL_F925 ! TR-CSFB3
OI CVCL_F927 ! TR-CSFB5
CA Conditionally immortalized cell line
//
ID TR-CSFB5
AC CVCL_F927
SY TR-CSFB 5
RX Patent=US20020045254;
RX PubMed=11336348;
RX PubMed=11520047;
RX PubMed=17233813;
RX PubMed=18162136;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX NCBI_TaxID=10116; ! Rattus norvegicus
OI CVCL_F923 ! TR-CSFB1
OI CVCL_F924 ! TR-CSFB2
OI CVCL_F925 ! TR-CSFB3
OI CVCL_F926 ! TR-CSFB4
CA Conditionally immortalized cell line
//
ID TR-iBRB2
AC CVCL_J379
RX Patent=US20020045254;
RX PubMed=11161732;
RX PubMed=11520047;
RX PubMed=17233813;
CC Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-6507.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX NCBI_TaxID=10116; ! Rattus norvegicus
OI CVCL_5U66 ! TR-iBRB4
OI CVCL_5U67 ! TR-iBRB6
OI CVCL_5U68 ! TR-iBRB8
OI CVCL_5U69 ! TR-iBRB9
CA Conditionally immortalized cell line
//
ID TR-iBRB4
AC CVCL_5U66
RX Patent=US20020045254;
RX PubMed=11161732;
RX PubMed=11520047;
RX PubMed=17233813;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX NCBI_TaxID=10116; ! Rattus norvegicus
OI CVCL_J379 ! TR-iBRB2
OI CVCL_5U67 ! TR-iBRB6
OI CVCL_5U68 ! TR-iBRB8
OI CVCL_5U69 ! TR-iBRB9
CA Conditionally immortalized cell line
//
ID TR-iBRB6
AC CVCL_5U67
RX Patent=US20020045254;
RX PubMed=11161732;
RX PubMed=11520047;
RX PubMed=17233813;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX NCBI_TaxID=10116; ! Rattus norvegicus
OI CVCL_J379 ! TR-iBRB2
OI CVCL_5U66 ! TR-iBRB4
OI CVCL_5U68 ! TR-iBRB8
OI CVCL_5U69 ! TR-iBRB9
CA Conditionally immortalized cell line
//
ID TR-iBRB8
AC CVCL_5U68
RX Patent=US20020045254;
RX PubMed=11161732;
RX PubMed=11520047;
RX PubMed=17233813;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX NCBI_TaxID=10116; ! Rattus norvegicus
OI CVCL_J379 ! TR-iBRB2
OI CVCL_5U66 ! TR-iBRB4
OI CVCL_5U67 ! TR-iBRB6
OI CVCL_5U69 ! TR-iBRB9
CA Conditionally immortalized cell line
//
ID TR-iBRB9
AC CVCL_5U69
RX Patent=US20020045254;
RX PubMed=11161732;
RX PubMed=11520047;
RX PubMed=17233813;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX NCBI_TaxID=10116; ! Rattus norvegicus
OI CVCL_J379 ! TR-iBRB2
OI CVCL_5U66 ! TR-iBRB4
OI CVCL_5U67 ! TR-iBRB6
OI CVCL_5U68 ! TR-iBRB8
CA Conditionally immortalized cell line
//
ID TR-LCC-1
AC CVCL_IU63
RX PubMed=28104015;
CC Doubling time: 201.2 hours (PubMed=28104015).
DI NCIt; C4044; Laryngeal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID TR-LE
AC CVCL_6C37
RX PubMed=16773315;
RX PubMed=17233813;
CC Transfected with: UniProtKB; P42212; GFP.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Conditionally immortalized cell line
//
ID TR-MUL1
AC CVCL_5U77
RX PubMed=12898700;
RX PubMed=17233813;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Conditionally immortalized cell line
//
ID TR-MUL2
AC CVCL_5U78
RX PubMed=12898700;
RX PubMed=17233813;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Conditionally immortalized cell line
//
ID TR-MUL3
AC CVCL_5U79
RX PubMed=12898700;
RX PubMed=17233813;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Conditionally immortalized cell line
//
ID TR-MUL4
AC CVCL_5U80
RX PubMed=12898700;
RX PubMed=17233813;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Conditionally immortalized cell line
//
ID TR-MUL5
AC CVCL_J380
RX PubMed=12898700;
RX PubMed=17233813;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Conditionally immortalized cell line
//
ID TR-PCT1
AC CVCL_6B56
RX PubMed=11998866;
RX PubMed=17233813;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Conditionally immortalized cell line
//
ID TR-rPCT1
AC CVCL_J381
RX PubMed=12951435;
RX PubMed=17233813;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Conditionally immortalized cell line
//
ID TR-rPCT2
AC CVCL_5U75
RX PubMed=12951435;
RX PubMed=17233813;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Conditionally immortalized cell line
//
ID TR-rPCT3
AC CVCL_J382
RX PubMed=12951435;
RX PubMed=17233813;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Conditionally immortalized cell line
//
ID TR-rPCT4
AC CVCL_J383
RX PubMed=12951435;
RX PubMed=17233813;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Conditionally immortalized cell line
//
ID TR-rPCT5
AC CVCL_5U76
RX PubMed=12951435;
RX PubMed=17233813;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Conditionally immortalized cell line
//
ID TR-SIE1
AC CVCL_6C38
RX PubMed=15499194;
RX PubMed=17233813;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Conditionally immortalized cell line
//
ID TR-SIE2
AC CVCL_6C39
RX PubMed=15499194;
RX PubMed=17233813;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Conditionally immortalized cell line
//
ID TR-TBT 18d-1
AC CVCL_6B14
RX PubMed=12384998;
RX PubMed=17233813;
RX PubMed=18329095;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX NCBI_TaxID=10116; ! Rattus norvegicus
OI CVCL_6B15 ! TR-TBT 18d-2
OI CVCL_6B16 ! TR-TBT 18d-3
OI CVCL_6B17 ! TR-TBT 18d-4
SX Female
CA Conditionally immortalized cell line
//
ID TR-TBT 18d-2
AC CVCL_6B15
RX PubMed=12384998;
RX PubMed=17233813;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX NCBI_TaxID=10116; ! Rattus norvegicus
OI CVCL_6B14 ! TR-TBT 18d-1
OI CVCL_6B16 ! TR-TBT 18d-3
OI CVCL_6B17 ! TR-TBT 18d-4
SX Female
CA Conditionally immortalized cell line
//
ID TR-TBT 18d-3
AC CVCL_6B16
RX PubMed=12384998;
RX PubMed=17233813;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX NCBI_TaxID=10116; ! Rattus norvegicus
OI CVCL_6B14 ! TR-TBT 18d-1
OI CVCL_6B15 ! TR-TBT 18d-2
OI CVCL_6B17 ! TR-TBT 18d-4
SX Female
CA Conditionally immortalized cell line
//
ID TR-TBT 18d-4
AC CVCL_6B17
RX PubMed=12384998;
RX PubMed=17233813;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX NCBI_TaxID=10116; ! Rattus norvegicus
OI CVCL_6B14 ! TR-TBT 18d-1
OI CVCL_6B15 ! TR-TBT 18d-2
OI CVCL_6B16 ! TR-TBT 18d-3
SX Female
CA Conditionally immortalized cell line
//
ID TR126
AC CVCL_J955
SY TR 126
RX DOI=10.1016/B978-0-12-333530-2.50007-1;
RX PubMed=2413234;
CC Doubling time: 21 hours (PubMed=2413234).
DI NCIt; C4648; Tongue squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID TR131
AC CVCL_J954
SY TR 131
RX DOI=10.1016/B978-0-12-333530-2.50007-1;
RX PubMed=2413234;
CC Doubling time: 34 hours (PubMed=2413234).
DI NCIt; C4044; Laryngeal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID TR138
AC CVCL_J953
SY TR 138; TR-138
RX DOI=10.1016/B978-0-12-333530-2.50007-1;
RX PubMed=2413234;
CC Doubling time: 22 hours (PubMed=2413234).
DI NCIt; C4044; Laryngeal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID TR14
AC CVCL_B474
SY TR-14
DR Cosmic; 1109113
DR Cosmic; 1518080
DR Cosmic; 1526657
DR Cosmic; 2239466
DR GEO; GSM692868
RX PubMed=6144383;
RX PubMed=6861117;
RX PubMed=7838528;
RX PubMed=9516836;
RX PubMed=22213050;
CC Omics: Transcriptome analysis.
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID TR146
AC CVCL_2736
SY Tr146; TR-146; TR 146
DR BTO; BTO:0002718
DR Cosmic; 948039
DR Cosmic; 2131857
DR ECACC; 10032305
DR Ximbio; 151425
RX DOI=10.1016/B978-0-12-333530-2.50007-1;
RX PubMed=2413234;
RX PubMed=21868764;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: 22 hours (PubMed=2413234).
CC Omics: Protein expression by reverse-phase protein arrays.
CC Derived from metastatic site: Neck lymph node.
ST Source(s): ECACC; PubMed=21868764
ST Amelogenin: X
ST CSF1PO: 11,13
ST D13S317: 11,14
ST D16S539: 13
ST D5S818: 10,11
ST D7S820: 10,12
ST TH01: 9
ST TPOX: 8,9
ST vWA: 15,18
DI NCIt; C4040; Buccal mucosa squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID TR170
AC CVCL_B475
SY TR-170
RX PubMed=3804493;
DI NCIt; C5228; Ovarian cystadenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID TR175
AC CVCL_B476
SY TR-175
DR Cosmic; 991331
DR Cosmic; 1524351
DR GEO; GSM459651
RX PubMed=3804493;
DI NCIt; C5228; Ovarian cystadenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID TR33B
AC CVCL_4329
DR CLO; CLO_0009392
DR CLDB; cl4538
DR ECACC; 85040102
RX PubMed=1093176;
CC Transformant: ChEBI; CHEBI:23995; N-ethyl-N-nitrosourea (ENU).
CC Breed/subspecies: Wistar Furth.
DI NCIt; C60461; Rat malignant oligodendroglioma
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Cancer cell line
//
ID TR6.1/52b
AC CVCL_V133
DR CLO; CLO_0009393
DR CLDB; cl4539
DR IHW; IHW8133
CC Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC Selected for resistance to: ChEBI; CHEBI:472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC Breed/subspecies: C3H/An.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4536 ! L-M(TK-)
SX Male
CA Spontaneously immortalized cell line
//
ID TR6Bc1
AC CVCL_4330
DR CLO; CLO_0009394
DR CLDB; cl4540
DR ECACC; 85042301
CC Breed/subspecies: C3H/He.
DI NCIt; C21997; Mouse schwannoma
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID TR9-7
AC CVCL_IM77
DR GEO; GSE7101
RX PubMed=7667317;
RX PubMed=16966095;
CC Characteristics: Express wild-type TP53 under the control of a tetracycline-regulated promoter.
CC Transfected with: HGNC; 11998; TP53.
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Omics: Transcriptome analysis.
DI NCIt; C3476; Li-Fraumeni syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_E212 ! MDAH041
CA Cancer cell line
//
ID TRA-147
AC CVCL_1B65
RX DOI=10.1093/jmedent/18.2.140;
CC Group: Insect cell line.
OX NCBI_TaxID=46208; ! Toxorhynchites amboinensis
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID TRA-171
AC CVCL_Z235
SY Tra-171; TRA171
DR CLO; CLO_0009399
DR CLDB; cl4543
DR ATCC; CRL-1591
DR ECACC; 90120514
RX DOI=10.1007/BF02619328;
RX PubMed=6126465;
RX PubMed=6137452;
CC Group: Insect cell line.
OX NCBI_TaxID=46208; ! Toxorhynchites amboinensis
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID TRA-272
AC CVCL_1B66
RX DOI=10.1093/jmedent/18.2.140;
CC Group: Insect cell line.
OX NCBI_TaxID=46208; ! Toxorhynchites amboinensis
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID TRA-284
AC CVCL_Z986
SY Tra-284; TRA 284; TRA284
RX DOI=10.1093/jmedent/18.2.140;
RX PubMed=2861916;
RX PubMed=6130104;
CC Group: Insect cell line.
OX NCBI_TaxID=46208; ! Toxorhynchites amboinensis
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID TRA-284-SF
AC CVCL_Z987
RX PubMed=2861916;
RX PubMed=6130104;
CC Group: Insect cell line.
OX NCBI_TaxID=46208; ! Toxorhynchites amboinensis
HI CVCL_Z986 ! TRA-284
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID TRA-293
AC CVCL_1B67
RX DOI=10.1093/jmedent/18.2.140;
CC Group: Insect cell line.
OX NCBI_TaxID=46208; ! Toxorhynchites amboinensis
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID TRACHT
AC CVCL_E856
DR dbMHC; 49047
DR IHW; IHW9350
DR IMGT/HLA; 11494
WW http://bioinformatics.hsanmartino.it/ecbr/cl350.html
CC Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID TRAMA
AC CVCL_W398
RX CelloPub=CLPUB00019;
RX PubMed=10936422;
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID TRAMP-C1
AC CVCL_3614
DR BTO; BTO:0005112
DR CLO; CLO_0009401
DR ATCC; CRL-2730
RX PubMed=9269988;
CC Breed/subspecies: C57BL/6-TgN(TRAMP)8247Ng.
DI NCIt; C21732; Carcinoma of the mouse prostate gland
OX NCBI_TaxID=10090; ! Mus musculus
OI CVCL_3615 ! TRAMP-C2
OI CVCL_3616 ! TRAMP-C3
SX Male
CA Cancer cell line
//
ID TRAMP-C1A
AC CVCL_H593
SY TRAMP C1A; C1A
DR ChEMBL-Cells; CHEMBL3307772
DR ChEMBL-Targets; CHEMBL614367
RX PubMed=11063747;
CC Breed/subspecies: C57BL/6-TgN(TRAMP)8247Ng.
DI NCIt; C21732; Carcinoma of the mouse prostate gland
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3614 ! TRAMP-C1
SX Male
CA Cancer cell line
//
ID TRAMP-C1D
AC CVCL_H594
SY C1D
RX PubMed=11063747;
CC Breed/subspecies: C57BL/6-TgN(TRAMP)8247Ng.
DI NCIt; C21732; Carcinoma of the mouse prostate gland
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3614 ! TRAMP-C1
SX Male
CA Cancer cell line
//
ID TRAMP-C2
AC CVCL_3615
DR BTO; BTO:0005114
DR CLO; CLO_0009402
DR ATCC; CRL-2731
RX PubMed=9269988;
CC Breed/subspecies: C57BL/6-TgN(TRAMP)8247Ng.
DI NCIt; C21732; Carcinoma of the mouse prostate gland
OX NCBI_TaxID=10090; ! Mus musculus
OI CVCL_3614 ! TRAMP-C1
OI CVCL_3616 ! TRAMP-C3
SX Male
CA Cancer cell line
//
ID TRAMP-C2D
AC CVCL_H596
SY C2D; TR-C2D
DR ChEMBL-Cells; CHEMBL3307920
DR ChEMBL-Targets; CHEMBL614368
CC Breed/subspecies: C57BL/6-TgN(TRAMP)8247Ng.
DI NCIt; C21732; Carcinoma of the mouse prostate gland
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3615 ! TRAMP-C2
SX Male
CA Cancer cell line
//
ID TRAMP-C2G
AC CVCL_H595
SY C2G
DR ChEMBL-Cells; CHEMBL3307817
DR ChEMBL-Targets; CHEMBL613541
RX PubMed=11063747;
CC Breed/subspecies: C57BL/6-TgN(TRAMP)8247Ng.
DI NCIt; C21732; Carcinoma of the mouse prostate gland
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3615 ! TRAMP-C2
SX Male
CA Cancer cell line
//
ID TRAMP-C2H
AC CVCL_H591
SY C2H
DR ChEMBL-Cells; CHEMBL3307609
DR ChEMBL-Targets; CHEMBL614369
CC Breed/subspecies: C57BL/6-TgN(TRAMP)8247Ng.
DI NCIt; C21732; Carcinoma of the mouse prostate gland
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3615 ! TRAMP-C2
SX Male
CA Cancer cell line
//
ID TRAMP-C2N
AC CVCL_H592
SY C2N
CC Breed/subspecies: C57BL/6-TgN(TRAMP)8247Ng.
DI NCIt; C21732; Carcinoma of the mouse prostate gland
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3615 ! TRAMP-C2
SX Male
CA Cancer cell line
//
ID TRAMP-C3
AC CVCL_3616
DR BTO; BTO:0005113
DR CLO; CLO_0009403
DR ATCC; CRL-2732
RX PubMed=9269988;
CC Breed/subspecies: C57BL/6-TgN(TRAMP)8247Ng.
DI NCIt; C21732; Carcinoma of the mouse prostate gland
OX NCBI_TaxID=10090; ! Mus musculus
OI CVCL_3614 ! TRAMP-C1
OI CVCL_3615 ! TRAMP-C2
SX Male
CA Cancer cell line
//
ID TRD-1
AC CVCL_6B63
RX PubMed=21802454;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Conditionally immortalized cell line
//
ID TRD-10
AC CVCL_6B66
RX PubMed=21802454;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Conditionally immortalized cell line
//
ID TRD-12
AC CVCL_6B67
RX PubMed=21802454;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Conditionally immortalized cell line
//
ID TRD-14
AC CVCL_6B68
RX PubMed=21802454;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Conditionally immortalized cell line
//
ID TRD-15
AC CVCL_6B69
RX PubMed=21802454;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Conditionally immortalized cell line
//
ID TRD-17
AC CVCL_6B70
RX PubMed=21802454;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Conditionally immortalized cell line
//
ID TRD-19
AC CVCL_6B71
RX PubMed=21802454;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Conditionally immortalized cell line
//
ID TRD-22
AC CVCL_6B72
RX PubMed=21802454;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Conditionally immortalized cell line
//
ID TRD-24
AC CVCL_6B73
RX PubMed=21802454;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Conditionally immortalized cell line
//
ID TRD-27
AC CVCL_6B74
RX PubMed=21802454;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Conditionally immortalized cell line
//
ID TRD-29
AC CVCL_6B75
RX PubMed=21802454;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Conditionally immortalized cell line
//
ID TRD-3
AC CVCL_6B64
RX PubMed=21802454;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Conditionally immortalized cell line
//
ID TRD-33
AC CVCL_6B76
RX PubMed=21802454;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Conditionally immortalized cell line
//
ID TRD-34
AC CVCL_6B77
RX PubMed=21802454;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Conditionally immortalized cell line
//
ID TRD-35
AC CVCL_6B78
RX PubMed=21802454;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Conditionally immortalized cell line
//
ID TRD-38
AC CVCL_6B79
RX PubMed=21802454;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Conditionally immortalized cell line
//
ID TRD-4
AC CVCL_6B65
RX PubMed=21802454;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Conditionally immortalized cell line
//
ID TRD-41
AC CVCL_6B80
RX PubMed=21802454;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Conditionally immortalized cell line
//
ID TRD-42
AC CVCL_6B81
RX PubMed=21802454;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Conditionally immortalized cell line
//
ID TRD-43
AC CVCL_6B82
RX PubMed=21802454;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Conditionally immortalized cell line
//
ID TRD-44
AC CVCL_6B83
RX PubMed=21802454;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Conditionally immortalized cell line
//
ID TRD-45
AC CVCL_6B84
RX PubMed=21802454;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Conditionally immortalized cell line
//
ID TRD-49
AC CVCL_6B85
RX PubMed=21802454;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Conditionally immortalized cell line
//
ID TRD-52
AC CVCL_6B86
RX PubMed=21802454;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Conditionally immortalized cell line
//
ID TRD-58
AC CVCL_6B87
RX PubMed=21802454;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Conditionally immortalized cell line
//
ID TRD-60
AC CVCL_6B88
RX PubMed=21802454;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Conditionally immortalized cell line
//
ID TRD-61
AC CVCL_6B89
RX PubMed=21802454;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Conditionally immortalized cell line
//
ID TRD-62
AC CVCL_6B90
RX PubMed=21802454;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Conditionally immortalized cell line
//
ID TRD-72
AC CVCL_6B91
RX PubMed=21802454;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Conditionally immortalized cell line
//
ID Tree92
AC CVCL_M659
SY Tree 92
RX PubMed=8683996;
RX PubMed=8704258;
RX PubMed=8847894;
RX PubMed=9454894;
RX PubMed=12967475;
CC Characteristics: EBV-negative.
CC Omics: Transcriptome analysis.
DI NCIt; C2912; Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID Trex1-/- MEF
AC CVCL_5A06
SY Trex1 KO cells; Trex1 KO
DR ECACC; 12021509
DR Ximbio; 151558
RX PubMed=15254239;
RX PubMed=18045533;
CC Knockout cell: Method=Gene-targeted KO mouse; MGI; MGI:1328317; Trex1.
CC Breed/subspecies: 129P2/OlaHsd.
OX NCBI_TaxID=10090; ! Mus musculus
CA Spontaneously immortalized cell line
//
ID TRFK-1
AC CVCL_D152
SY TRFK 1
RX PubMed=2970507;
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID TRFK-2
AC CVCL_D153
SY TRFK 2
RX PubMed=2970507;
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID TRFK-4
AC CVCL_D154
SY TRFK 4
DR BCRJ; 0237
RX PubMed=2970507;
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID TRFK-5
AC CVCL_D155
SY TRFK 5
DR BCRJ; 0238
RX PubMed=2970507;
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID TRI-C3H
AC CVCL_5902
DR CLS; 400359/p956_TRI-C3H
CC Breed/subspecies: C3H.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Cancer cell line
//
ID TRK-1
AC CVCL_T282
SY Transformed Rabbit Kidney-1
DR ATCC; CCL-143
RX PubMed=14120333;
RX PubMed=14206435;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [777].
CC Discontinued: ATCC; CCL-143; probable.
CC Breed/subspecies: New Zealand white.
OX NCBI_TaxID=9986; ! Oryctolagus cuniculus
CA Transformed cell line
//
ID TRK-36
AC CVCL_6F03
SY TRK36; Transformed Rabbit Keratocytes-36
RX PubMed=8985637;
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pSV3-neo].
OX NCBI_TaxID=9986; ! Oryctolagus cuniculus
CA Transformed cell line
//
ID TRK-43
AC CVCL_4385
SY TRK43; Transformed Rabbit Keratocytes-43
DR BTO; BTO:0003224
RX PubMed=8985637;
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pSV3-neo].
OX NCBI_TaxID=9986; ! Oryctolagus cuniculus
CA Transformed cell line
//
ID TRK-73
AC CVCL_D541
SY Transformed Rabbit Kidney cells-73
RX PubMed=4124406;
RX PubMed=4150020;
RX PubMed=4150021;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9986; ! Oryctolagus cuniculus
CA Transformed cell line
//
ID TRL-01
AC CVCL_W777
RX PubMed=16875930;
DI NCIt; C8252; Therapy-related acute myeloid leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID TRLEC-03
AC CVCL_F715
CC From: Tsurufuji S.; Institute of Cytosignal Research; Tokyo; Japan.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Transformed cell line
//
ID TRM-1
AC CVCL_G709
RX PubMed=9040956;
CC Transfected with: HGNC; 5173; HRAS (with V-12).
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID TRM-6
AC CVCL_G708
RX PubMed=9193600;
CC Transfected with: HGNC; 5173; HRAS (with V-12).
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID TRM-6/PDX-1
AC CVCL_0562
DR MCCL; MCC:0000464
RX PubMed=10847584;
CC Transfected with: HGNC; 6107; PDX1.
CC Transfected with: HGNC; 5173; HRAS (with V-12).
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_G708 ! TRM-6
CA Transformed cell line
//
ID Troja 1
AC CVCL_D877
RX PubMed=10098769;
DI NCIt; C2955; Colorectal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Troja 2
AC CVCL_D878
RX PubMed=10098769;
DI NCIt; C2955; Colorectal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID TRP3
AC CVCL_W908
RX PubMed=24853805;
CC Transfected with: HGNC; 11730; TERT.
DI NCIt; C35064; Hereditary hemorrhagic telangiectasia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Telomerase immortalized cell line
//
ID tRPE
AC CVCL_DF64
RX PubMed=19413901;
OX NCBI_TaxID=9913; ! Bos taurus
CA Spontaneously immortalized cell line
//
ID TRSC-1
AC CVCL_D540
SY Transformed Rabbit Spleen Cell line-1
RX PubMed=4150020;
RX PubMed=4150021;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9986; ! Oryctolagus cuniculus
CA Transformed cell line
//
ID TRSC-1-8
AC CVCL_J952
RX PubMed=7021164;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9986; ! Oryctolagus cuniculus
HI CVCL_D540 ! TRSC-1
CA Transformed cell line
//
ID TRT-HU1
AC CVCL_M720
RX PubMed=21136194;
CC Transfected with: HGNC; 11730; TERT.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Telomerase immortalized cell line
//
ID TRT-HU2
AC CVCL_9S98
RX PubMed=21136194;
CC Transfected with: HGNC; 11730; TERT.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Telomerase immortalized cell line
//
ID TS 0111
AC CVCL_E294
SY TS0111; Pa29C; PL19
DR Cosmic; 1473049
DR Cosmic; 1509864
RX PubMed=22753594;
CC From: Johns Hopkins University School of Medicine; Baltimore; USA.
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID TS 0129
AC CVCL_E295
SY TS0129; Pa22C; Pa022C; PL21
DR Cosmic; 1509874
RX PubMed=22753594;
CC From: Johns Hopkins University School of Medicine; Baltimore; USA.
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID TS 0226
AC CVCL_E296
SY TS0226; Pa112C; PL22
DR Cosmic; 1473077
DR Cosmic; 1509881
RX PubMed=22753594;
CC From: Johns Hopkins University School of Medicine; Baltimore; USA.
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID TS 10-7
AC CVCL_V442
DR ATCC; CRL-2835
RX PubMed=12734101;
CC Transformant: Ad-SV40.
CC Discontinued: ATCC; CRL-2835; true.
DI NCIt; C84578; Autosomal dominant polycystic kidney disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_V443 ! WT 10-7
SX Female
CA Transformed cell line
//
ID TS 106
AC CVCL_F788
SY TS106
DR CLO; CLO_0009404
DR ATCC; HB-12497
RX Patent=US5998151;
CC Monoclonal antibody target: UniProtKB; P04818; Human TYMS.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID TS 9-7
AC CVCL_V444
DR ATCC; CRL-2831
DR BioSample; SAMN03471800
RX PubMed=12734101;
CC Transformant: Ad-SV40.
CC Discontinued: ATCC; CRL-2831; true.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 8,11
ST D16S539: 11,12
ST D5S818: 11,12
ST D7S820: 8,11
ST TH01: 6
ST TPOX: 8
ST vWA: 19
DI NCIt; C84578; Autosomal dominant polycystic kidney disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_K231 ! WT 9-7
OI CVCL_V445 ! WT 9-9
OI CVCL_K230 ! WT 9-12
SX Female
CA Transformed cell line
//
ID TS-2
AC CVCL_A323
RX PubMed=9494609;
DI NCIt; C3167; Acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID TS-ED
AC CVCL_Y122
DR ATCC; CRL-1406
CC Discontinued: ATCC; CRL-1406; true.
DI NCIt; C125699; Ehlers-Danlos syndrome, type IV
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID TS-RM-1
AC CVCL_W501
SY TS-RM1
DR Cosmic; 1718362
DR Cosmic; 2356031
RX PubMed=7669751;
RX PubMed=23882450;
DI NCIt; C8971; Embryonal rhabdomyosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID TS/A
AC CVCL_F736
SY TSA; TS/A-pc
DR BTO; BTO:0004282
DR CLO; CLO_0009405
DR CLDB; cl4545
DR ChEMBL-Cells; CHEMBL3308478
DR ChEMBL-Targets; CHEMBL615017
DR Lonza; 103
RX PubMed=3455746;
RX PubMed=6546207;
RX PubMed=7989764;
CC Breed/subspecies: BALB/cAnNCrlBR.
DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Cancer cell line
//
ID TS/A clone E1
AC CVCL_L871
SY E1
DR CLO; CLO_0002857
DR CLDB; cl1121
RX PubMed=6543703;
CC Breed/subspecies: BALB/cAnNCrlBR.
DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_F736 ! TS/A
SX Female
CA Cancer cell line
//
ID TS/A clone E2
AC CVCL_L872
SY E2
DR CLO; CLO_0002860
DR CLDB; cl1123
RX PubMed=6543703;
CC Breed/subspecies: BALB/cAnNCrlBR.
DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_F736 ! TS/A
SX Female
CA Cancer cell line
//
ID TS/A clone E3
AC CVCL_L873
SY E3
DR CLO; CLO_0002861
DR CLDB; cl1124
RX PubMed=6543703;
CC Breed/subspecies: BALB/cAnNCrlBR.
DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_F736 ! TS/A
SX Female
CA Cancer cell line
//
ID TS/A clone F1
AC CVCL_L874
SY F1
DR CLO; CLO_0002960
DR CLDB; cl1187
RX PubMed=6543703;
CC Breed/subspecies: BALB/cAnNCrlBR.
DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_F736 ! TS/A
SX Female
CA Cancer cell line
//
ID TS/A clone F2
AC CVCL_L875
SY F2
DR CLO; CLO_0002972
DR CLDB; cl1192
RX PubMed=6543703;
CC Breed/subspecies: BALB/cAnNCrlBR.
DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_F736 ! TS/A
SX Female
CA Cancer cell line
//
ID TS/A clone F5
AC CVCL_L876
SY F5
DR CLO; CLO_0002983
DR CLDB; cl1195
RX PubMed=6543703;
CC Breed/subspecies: BALB/cAnNCrlBR.
DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_F736 ! TS/A
SX Female
CA Cancer cell line
//
ID TS.10.1
AC CVCL_6E16
SY TS10.1
RX PubMed=10706684;
WW http://www.umass.edu/vetimm/catfish/CC41-UMC-Poster.pdf
CC Group: Fish cell line.
OX NCBI_TaxID=7998; ! Ictalurus punctatus
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID TS.32.15
AC CVCL_6E17
SY TS32.15
RX PubMed=10706684;
RX PubMed=18824023;
CC Group: Fish cell line.
OX NCBI_TaxID=7998; ! Ictalurus punctatus
OI CVCL_6E20 ! TS.32.5
OI CVCL_6E18 ! TS.32.17
OI CVCL_6E19 ! TS.32.32
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID TS.32.17
AC CVCL_6E18
SY TS32.17
RX PubMed=10706684;
RX PubMed=18824023;
CC Group: Fish cell line.
OX NCBI_TaxID=7998; ! Ictalurus punctatus
OI CVCL_6E20 ! TS.32.5
OI CVCL_6E17 ! TS.32.15
OI CVCL_6E19 ! TS.32.32
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID TS.32.32
AC CVCL_6E19
RX PubMed=10706684;
CC Group: Fish cell line.
OX NCBI_TaxID=7998; ! Ictalurus punctatus
OI CVCL_6E20 ! TS.32.5
OI CVCL_6E17 ! TS.32.15
OI CVCL_6E18 ! TS.32.17
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID TS.32.5
AC CVCL_6E20
RX PubMed=10706684;
CC Group: Fish cell line.
OX NCBI_TaxID=7998; ! Ictalurus punctatus
OI CVCL_6E17 ! TS.32.15
OI CVCL_6E18 ! TS.32.17
OI CVCL_6E19 ! TS.32.32
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID TS.75.2
AC CVCL_6E21
RX PubMed=10706684;
CC Group: Fish cell line.
OX NCBI_TaxID=7998; ! Ictalurus punctatus
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID TS1/18.1.2.11
AC CVCL_F789
DR CLO; CLO_0009406
DR ATCC; HB-203
CC Monoclonal antibody target: UniProtKB; P05107; Human ITGB2/CD18.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID TS1/22.1.1.13
AC CVCL_F790
DR CLO; CLO_0009407
DR ATCC; HB-202
CC Monoclonal antibody target: UniProtKB; P20701; Human ITGAL/CD11a.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID TS10
AC CVCL_E857
DR IHW; IHW1005
WW http://bioinformatics.hsanmartino.it/ecbr/cl379.html
CC Part of: 9th International Histocompatibility Workshop (9IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID TS2/16.2.1
AC CVCL_F791
DR CLO; CLO_0009408
DR ATCC; HB-243
CC Monoclonal antibody target: UniProtKB; P05556; Human ITGB1/CD19.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID TS2/18.1.1
AC CVCL_F792
DR CLO; CLO_0009409
DR ATCC; HB-195
CC Monoclonal antibody target: UniProtKB; P06729; Human CD2.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID TS2/4.1.1
AC CVCL_F793
DR CLO; CLO_0009410
DR ATCC; HB-244
CC Monoclonal antibody target: UniProtKB; P20701; Human ITGAL/CD11a.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID TS2/7.1.1
AC CVCL_F794
DR CLO; CLO_0009411
DR ATCC; HB-245
CC Monoclonal antibody target: UniProtKB; P56199; Human ITGA1/CD49a.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID TS2/9.1.4.3
AC CVCL_F795
SY TS2/9.1.1.4.3
DR CLO; CLO_0009412
DR ATCC; HB-205
CC Monoclonal antibody target: UniProtKB; P19256; Human CD58.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID Ts20
AC CVCL_D594
SY TS-20
DR BTO; BTO:0005283
RX PubMed=2995094;
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0184 ! BALB/3T3 clone A31
CA Spontaneously immortalized cell line
//
ID ts3b2
AC CVCL_C568
SY ts 3b-2
RX PubMed=6683997;
CC Transformant: ChEBI; CHEBI:34342; 3-methylcholanthrene (MCA).
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_0386 ! L6E9
CA Transformed cell line
//
ID ts485
AC CVCL_C567
RX PubMed=3043175;
CC Transformant: ChEBI; CHEBI:34342; 3-methylcholanthrene (MCA).
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_C568 ! ts3b2
CA Transformed cell line
//
ID TS9;22
AC CVCL_A691
SY TS9:22; TS9-22; TS 9:22
DR CGH-DB; 9347-4
DR Cosmic; 996326
DR Cosmic; 998758
DR Cosmic; 1037678
DR Cosmic; 1012126
DR Cosmic; 2089678
RX PubMed=7808006;
RX PubMed=16408098;
RX PubMed=23955599;
DI NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID tsa-N11
AC CVCL_5V12
RX PubMed=201774;
RX PubMed=214570;
CC Transformant: NCBI_TaxID; 1891730; Murine polyomavirus (MPyV) [Pytsa].
CC Breed/subspecies: Fischer.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_C691 ! FR3T3
CA Transformed cell line
//
ID tsA201
AC CVCL_2737
SY tsA-201
DR BTO; BTO:0004232
DR ECACC; 96121229
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/t/cell-lines-detail-339.html
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
ST Source(s): ECACC
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 12
ST D16S539: 9,13
ST D5S818: 8,9
ST D7S820: 11
ST TH01: 7,9.3
ST TPOX: 11
ST vWA: 16,19
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID TSA8
AC CVCL_A799
SY TSA-8
DR CLO; CLO_0050773
DR RCB; RCB2852
DR TKG; TKG 0370
RX PubMed=2835222;
RX PubMed=6574510;
CC Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV).
CC Breed/subspecies: DBA/2.
DI NCIt; C21895; Mouse erythroid leukemia
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID tsAM5D
AC CVCL_6B20
RX PubMed=12753072;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: C57BL/6J SV40-tsA58 transgenic.
OX NCBI_TaxID=10090; ! Mus musculus
CA Conditionally immortalized cell line
//
ID tsAM5NE
AC CVCL_F706
RX PubMed=21029049;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: C57BL/6J SV40-tsA58 transgenic.
OX NCBI_TaxID=10090; ! Mus musculus
CA Conditionally immortalized cell line
//
ID tsBN2
AC CVCL_U467
DR CLO; CLO_0051408
DR RCB; RCB1264
RX PubMed=694723;
RX PubMed=1851087;
OX NCBI_TaxID=10036; ! Mesocricetus auratus
HI CVCL_1915 ! BHK-21 clone 13
SX Male
CA Spontaneously immortalized cell line
//
ID tsBN250
AC CVCL_U468
SY BN250
DR CLO; CLO_0051405
DR RCB; RCB1272
RX PubMed=6891837;
OX NCBI_TaxID=10036; ! Mesocricetus auratus
HI CVCL_1915 ! BHK-21 clone 13
SX Male
CA Spontaneously immortalized cell line
//
ID tsBN269
AC CVCL_U469
DR CLO; CLO_0051406
DR RCB; RCB1273
OX NCBI_TaxID=10036; ! Mesocricetus auratus
HI CVCL_1915 ! BHK-21 clone 13
SX Male
CA Spontaneously immortalized cell line
//
ID tsBN462
AC CVCL_U470
SY BN462
DR CLO; CLO_0051404
DR RCB; RCB1268
RX PubMed=6891837;
OX NCBI_TaxID=10036; ! Mesocricetus auratus
HI CVCL_1915 ! BHK-21 clone 13
SX Male
CA Spontaneously immortalized cell line
//
ID tsBN51
AC CVCL_U471
DR CLO; CLO_0051410
DR RCB; RCB1270
RX PubMed=694723;
OX NCBI_TaxID=10036; ! Mesocricetus auratus
HI CVCL_1915 ! BHK-21 clone 13
SX Male
CA Spontaneously immortalized cell line
//
ID tsBN67
AC CVCL_U472
DR CLO; CLO_0051411
DR RCB; RCB1271
RX PubMed=694723;
OX NCBI_TaxID=10036; ! Mesocricetus auratus
HI CVCL_1915 ! BHK-21 clone 13
SX Male
CA Spontaneously immortalized cell line
//
ID tsBN7
AC CVCL_U473
DR CLO; CLO_0051409
DR TOKU-E; 3992
DR RCB; RCB1267
RX PubMed=694723;
OX NCBI_TaxID=10036; ! Mesocricetus auratus
HI CVCL_1915 ! BHK-21 clone 13
SX Male
CA Spontaneously immortalized cell line
//
ID tsBN75
AC CVCL_U474
DR CLO; CLO_0051407
DR RCB; RCB1269
RX PubMed=694723;
OX NCBI_TaxID=10036; ! Mesocricetus auratus
HI CVCL_1915 ! BHK-21 clone 13
SX Male
CA Spontaneously immortalized cell line
//
ID tsc2 ang1
AC CVCL_6784
SY tsc2ang1
DR CLO; CLO_0009414
DR ATCC; CRL-2620
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID tsDC
AC CVCL_4331
SY ts DC
DR ECACC; 01081609
RX PubMed=8921940;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX NCBI_TaxID=10090; ! Mus musculus
CA Conditionally immortalized cell line
//
ID TSE
AC CVCL_0563
DR MCCL; MCC:0000465
DI NCIt; C4872; Breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID TSF19
AC CVCL_W807
RX PubMed=19448741;
CC Breed/subspecies: Texel.
OX NCBI_TaxID=9940; ! Ovis aries
SX Male
CA Finite cell line
//
ID TSFAT-3
AC CVCL_1N76
RX PubMed=1071084;
CC Breed/subspecies: DDD.
DI NCIt; C21604; Mouse leukemia
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_1N75 ! SFAT-3
SX Male
CA Cancer cell line
//
ID TSFAT-3.fl
AC CVCL_F500
DR CLO; CLO_0050782
DR RCB; RCB0562
RX PubMed=1071084;
CC Breed/subspecies: DDD.
DI NCIt; C21604; Mouse leukemia
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_1N76 ! TSFAT-3
SX Male
CA Cancer cell line
//
ID TSG11
AC CVCL_B477
SY TSG-11
DR Cosmic; 848378
RX CelloPub=CLPUB00145;
RX PubMed=15767549;
WW http://www.lib.yamagata-u.ac.jp/medical/ymj/19-2-4.html
CC Part of: JFCR45 cancer cell line panel.
CC Misspelling: 'TGS-11' in PubMed=15767549.
DI NCIt; C4004; Gastric adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID TSG6
AC CVCL_S861
RX PubMed=8054813;
DI NCIt; C5250; Signet ring cell gastric adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID TSGH-8301
AC CVCL_A342
SY TSGH8301; TSGH 8301
DR Cosmic; 755397
RX PubMed=3352272;
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID TSGH-8302
AC CVCL_N030
SY TSGH8302; TSGH 8302
DR ChEMBL-Cells; CHEMBL3307472
DR ChEMBL-Targets; CHEMBL615019
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID TSGH-9201
AC CVCL_5379
SY TSGH9201; TSGH 9201
DR BCRC; 60146
DR ChEMBL-Cells; CHEMBL3307708
DR ChEMBL-Targets; CHEMBL614787
RX PubMed=7823569;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=TSGH9201
ST Source(s): BCRC
ST Amelogenin: X,Y
ST CSF1PO: 11
ST D13S317: 11
ST D16S539: 11
ST D5S818: 11
ST D7S820: 11,12
ST TH01: 9
ST TPOX: 8,9
ST vWA: 17
DI NCIt; C5250; Signet ring cell gastric adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID TSHC
AC CVCL_DE15
SY Tongue Sole Heart Cell line
RX DOI=10.1111/are.12813;
CC Group: Fish cell line.
OX NCBI_TaxID=244447; ! Cynoglossus semilaevis
SX Female
CA Spontaneously immortalized cell line
//
ID TSHKC
AC CVCL_R877
SY Tong Sole Head Kidney Cell line
RX PubMed=22660891;
CC Group: Fish cell line.
OX NCBI_TaxID=244447; ! Cynoglossus semilaevis
SX Female
CA Spontaneously immortalized cell line
//
ID TSHR-R5T-34
AC CVCL_F796
DR CLO; CLO_0009416
DR ATCC; CRL-2683
RX PubMed=1570295;
CC Monoclonal antibody target: UniProtKB; P16473; Human TSHR.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID TSHR-R5T-44
AC CVCL_F797
DR CLO; CLO_0009417
DR ATCC; CRL-2681
RX PubMed=1570295;
CC Monoclonal antibody target: UniProtKB; P16473; Human TSHR.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID TSHR-T3-365
AC CVCL_F798
SY T3-356
DR CLO; CLO_0009418
DR ATCC; CRL-2684
RX PubMed=1570295;
CC Monoclonal antibody target: UniProtKB; P16473; Human TSHR.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID TSHR-T5-51
AC CVCL_F799
SY T5-51
DR CLO; CLO_0009419
DR ATCC; CRL-2680
RX PubMed=1570295;
CC Monoclonal antibody target: UniProtKB; P16473; Human TSHR.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID TSHR-T5U-317
AC CVCL_F800
SY T5-317
DR CLO; CLO_0009420
DR ATCC; CRL-2682
RX PubMed=1570295;
CC Monoclonal antibody target: UniProtKB; P16473; Human TSHR.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID tsJT16
AC CVCL_L709
SY tsJT16(3Y1)
DR JCRB; JCRB0153.2
DR JCRB; NIHS0233.2
RX PubMed=6692850;
CC Discontinued: JCRB; NIHS0233.2; true.
CC Breed/subspecies: Fischer 344.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_E147 ! 3Y1-B clone 1-6
SX Female
CA Transformed cell line
//
ID tsJT60
AC CVCL_L710
SY tsJT60(3Y1)
DR JCRB; JCRB0153.3
DR JCRB; NIHS0233.3
RX PubMed=6692850;
CC Discontinued: JCRB; NIHS0233.3; true.
CC Breed/subspecies: Fischer 344.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_E147 ! 3Y1-B clone 1-6
SX Female
CA Transformed cell line
//
ID tsJT663
AC CVCL_L711
SY tsJT663(3Y1)
DR JCRB; JCRB0153.1
DR JCRB; NIHS0233.1
RX PubMed=8082723;
CC Discontinued: JCRB; NIHS0233.1; true.
CC Breed/subspecies: Fischer 344.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_E147 ! 3Y1-B clone 1-6
SX Female
CA Transformed cell line
//
ID TSM1
AC CVCL_U157
SY TSM
DR BTO; BTO:0004762
RX PubMed=8793865;
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID TSMK-1
AC CVCL_DE04
SY Transformed Swiss Mouse Kidney-1
RX PubMed=14120333;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [777].
CC Breed/subspecies: NIH Swiss.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID TSS
AC CVCL_M750
SY Trout Splenic Stroma
RX PubMed=22634253;
CC Group: Fish cell line.
OX NCBI_TaxID=8022; ! Oncorhynchus mykiss
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID tST-14
AC CVCL_GS38
SY transformed Swine Testicle-clone 14
RX PubMed=2175590;
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pSV3-neo].
OX NCBI_TaxID=9823; ! Sus scrofa
OI CVCL_GS40 ! tST-3
OI CVCL_GS39 ! tST-18
SX Male
CA Transformed cell line
//
ID tST-18
AC CVCL_GS39
SY transformed Swine Testicle-clone 18
RX PubMed=2175590;
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pSV3-neo].
OX NCBI_TaxID=9823; ! Sus scrofa
OI CVCL_GS40 ! tST-3
OI CVCL_GS38 ! tST-14
SX Male
CA Transformed cell line
//
ID tST-3
AC CVCL_GS40
SY transformed Swine Testicle-clone 3
RX PubMed=2175590;
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pSV3-neo].
OX NCBI_TaxID=9823; ! Sus scrofa
OI CVCL_GS38 ! tST-14
OI CVCL_GS39 ! tST-18
SX Male
CA Transformed cell line
//
ID TSt-4
AC CVCL_B973
SY Tst-4
DR RCB; RCB2116
RX DOI=10.4051/ibc.2010.2.4.0014;
RX PubMed=1535830;
CC Caution: Not from strain C57BL/6 as originally published but from strain BALB/c (DOI 10.4051/ibc.2010.2.4.0014).
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
CA Adult stem cell
//
ID TSt-4/G
AC CVCL_B974
DR RCB; RCB2117
RX DOI=10.4051/ibc.2010.2.4.0014;
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).
CC Caution: Not from strain C57BL/6 as originally published but from strain BALB/c (DOI 10.4051/ibc.2010.2.4.0014).
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_B973 ! TSt-4
CA Adult stem cell
//
ID TSt-4/G-DLL1
AC CVCL_B975
SY TSt-4/DL1
DR RCB; RCB2118
RX DOI=10.4051/ibc.2010.2.4.0014;
RX PubMed=15728456;
CC Transfected with: MGI; MGI:104659; Dll1.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).
CC Caution: Not from strain C57BL/6 as originally published but from strain BALB/c (DOI 10.4051/ibc.2010.2.4.0014).
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_B973 ! TSt-4
CA Adult stem cell
//
ID TSt-4/N
AC CVCL_B976
DR RCB; RCB2119
RX DOI=10.4051/ibc.2010.2.4.0014;
CC Transfected with: HGNC; 7809; NGFR.
CC Caution: Not from strain C57BL/6 as originally published but from strain BALB/c (DOI 10.4051/ibc.2010.2.4.0014).
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_B973 ! TSt-4
CA Adult stem cell
//
ID TSt-4/N-DLL1
AC CVCL_B977
DR RCB; RCB2120
RX DOI=10.4051/ibc.2010.2.4.0014;
CC Transfected with: HGNC; 7809; NGFR.
CC Transfected with: MGI; MGI:104659; Dll1.
CC Caution: Not from strain C57BL/6 as originally published but from strain BALB/c (DOI 10.4051/ibc.2010.2.4.0014).
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_B973 ! TSt-4
CA Adult stem cell
//
ID tsTM18
AC CVCL_J507
RX PubMed=2237640;
RX PubMed=15878348;
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Transformed cell line
//
ID tsTM4
AC CVCL_J617
RX PubMed=2237640;
RX PubMed=9272869;
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Transformed cell line
//
ID TSU
AC CVCL_8763
DR CGH-DB; 360-2
DR ChEMBL-Cells; CHEMBL3308092
DR ChEMBL-Targets; CHEMBL613973
DR Cosmic; 850416
DR Cosmic; 876397
DR Cosmic; 930338
DR Cosmic; 1046038
DR Cosmic; 1123043
RX PubMed=8704650;
RX PubMed=12632084;
RX PubMed=17052259;
RX PubMed=17599052;
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID TSU-1621MT
AC CVCL_A455
SY TSU1621MT; TSU-1621-MT
DR Cosmic; 787482
DR Cosmic; 975306
DR Cosmic; 1106591
DR Cosmic; 1281357
RX PubMed=10354136;
DI NCIt; C9154; Adult acute myeloid leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID TSU-Pr1
AC CVCL_4014
SY Tsu-Pr1; TSU-PR1; TSUpr1
DR BTO; BTO:0001065
DR BioSample; SAMN03151952
DR Cosmic; 704847
DR Cosmic; 869158
DR Cosmic; 921049
DR Cosmic; 922552
DR Cosmic; 923958
DR Cosmic; 948073
DR Cosmic; 1218867
DR Cosmic; 2444243
RX PubMed=3586177;
RX PubMed=9018337;
RX PubMed=10972993;
RX PubMed=11522622;
RX PubMed=12725112;
RX PubMed=16271951;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a T24 derivative (PubMed=11522622, PubMed=20143388). Originally thought to originate from a prostate carcinoma.
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0554 ! T24
SX Female
CA Cancer cell line
//
ID TSU-Pr1-B1
AC CVCL_M904
RX PubMed=16086232;
CC Problematic cell line: Contaminated. Parent cell line (TSU-Pr1) has been shown to be a T24 derivative.
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_4014 ! TSU-Pr1
SX Female
CA Cancer cell line
//
ID TSU-Pr1-B2
AC CVCL_M905
RX PubMed=16086232;
CC Problematic cell line: Contaminated. Grand-parent cell line (TSU-Pr1) has been shown to be a T24 derivative.
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_M904 ! TSU-Pr1-B1
SX Female
CA Cancer cell line
//
ID tsU19-5
AC CVCL_5H92
RX PubMed=1628212;
CC Breed/subspecies: Sprague-Dawley.
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Transformed cell line
//
ID TsuGK27
AC CVCL_M134
SY TSUGK27; TSUGK-27
RX PubMed=9365544;
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_4014 ! TSU-Pr1
SX Female
CA Cancer cell line
//
ID TSUS-1
AC CVCL_W865
RX PubMed=6587762;
DI NCIt; C7729; Squamous cell carcinoma of the penis
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID TT
AC CVCL_1774
SY MTC-TT
DR BTO; BTO:0003074
DR CLO; CLO_0009421
DR EFO; EFO_0002382
DR CLDB; cl4547
DR CLDB; cl4901
DR ATCC; CRL-1803
DR BCRC; 60346
DR BCRJ; 0259
DR BioSample; SAMN03471250
DR CCLE; TT_THYROID
DR CCRID; 3111C0001CCC000268
DR CCRID; 3131C0001000700078
DR CCRID; 3142C0001000000072
DR ChEMBL-Cells; CHEMBL3308145
DR ChEMBL-Targets; CHEMBL2366083
DR Cosmic; 796049
DR Cosmic; 796731
DR Cosmic; 930299
DR Cosmic; 1005455
DR Cosmic; 1094763
DR Cosmic; 1175889
DR Cosmic; 1239955
DR Cosmic; 1608835
DR Cosmic; 1612901
DR Cosmic; 1699419
DR Cosmic; 1876248
DR Cosmic; 2036697
DR Cosmic; 2050374
DR Cosmic-CLP; 930299
DR ECACC; 92050721
DR GDSC; 930299
DR GEO; GSM887714
DR GEO; GSM888807
DR GEO; GSM1374966
DR GEO; GSM1670548
DR ICLC; HTL98004
DR IGRhCellID; TT
DR KCB; KCB 201301YJ
DR Lonza; 1097
RX CelloPub=CLPUB00116;
RX DOI=10.1016/B978-0-12-333530-2.50007-1;
RX PubMed=3467830;
RX PubMed=7736432;
RX PubMed=7864888;
RX PubMed=22460905;
RX PubMed=22538498;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; Cosmic-CLP; ECACC; ICLC
ST Amelogenin: X
ST CSF1PO: 10,13
ST D13S317: 11
ST D16S539: 12,13
ST D21S11: 29,32.2
ST D5S818: 12,13
ST D7S820: 10,12
ST TH01: 6,9
ST TPOX: 8,11
ST vWA: 16,18
DI NCIt; C46099; Hereditary thyroid gland medullary carcinoma
DI NCIt; C6432; Multiple endocrine neoplasia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID TT-D6
AC CVCL_6B95
RX PubMed=12837285;
RX PubMed=17233813;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX NCBI_TaxID=10090; ! Mus musculus
CA Conditionally immortalized cell line
//
ID TT-E4
AC CVCL_6B96
RX PubMed=12837285;
RX PubMed=17233813;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX NCBI_TaxID=10090; ! Mus musculus
CA Conditionally immortalized cell line
//
ID TT-G11
AC CVCL_6B97
RX PubMed=12837285;
RX PubMed=17233813;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX NCBI_TaxID=10090; ! Mus musculus
CA Conditionally immortalized cell line
//
ID TT0111
AC CVCL_8Y78
DR ECACC; 90062721
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID TT0112
AC CVCL_8Y79
DR ECACC; 90062722
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID TT0113
AC CVCL_8Y80
DR ECACC; 90062723
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID TT0114
AC CVCL_8Y81
DR ECACC; 90062724
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C84717; Fragile X syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID TT0115
AC CVCL_8Y82
DR ECACC; 90062725
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C84717; Fragile X syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID TT0122
AC CVCL_8Y83
DR ECACC; 90081619
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C84717; Fragile X syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID TT0148
AC CVCL_8Y84
DR ECACC; 91012408
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C84717; Fragile X syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID TT0150
AC CVCL_8Y85
DR ECACC; 91012410
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C84717; Fragile X syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID TT0151
AC CVCL_8Y86
DR ECACC; 91012411
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C84717; Fragile X syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID TT0153
AC CVCL_8Y87
DR ECACC; 91012413
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C84717; Fragile X syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID TT0154
AC CVCL_8Y88
DR ECACC; 91012414
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C84717; Fragile X syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID TT0155
AC CVCL_8Y89
DR ECACC; 91012415
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C84717; Fragile X syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID TT0164
AC CVCL_8Y90
DR ECACC; 91020701
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C84717; Fragile X syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID TT0165
AC CVCL_8Y91
DR ECACC; 91020702
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C84717; Fragile X syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID TT0201
AC CVCL_8Y92
DR ECACC; 91032620
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C84717; Fragile X syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID TT0202
AC CVCL_8Y93
DR ECACC; 91032621
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C84717; Fragile X syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID TT0208
AC CVCL_8Y94
DR ECACC; 91042501
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID TT0209
AC CVCL_8Y95
DR ECACC; 91042502
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID TT0210
AC CVCL_8Y96
DR ECACC; 91042503
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID TT0211
AC CVCL_8Y97
DR ECACC; 91042504
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID TT0212
AC CVCL_8Y98
DR ECACC; 91042505
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID TT0237
AC CVCL_8Y99
DR ECACC; 91062105
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID TT0252
AC CVCL_8Z00
DR ECACC; 91080908
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C84717; Fragile X syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID TT1 [Human alveolar type 1]
AC CVCL_G005
SY Transformed type 1
RX PubMed=18539954;
RX PubMed=19199008;
CC Transfected with: HGNC; 11730; TERT.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID TT1 [Human ovarian adenocarcinoma]
AC CVCL_G001
DR Cosmic; 1021386
DR Cosmic; 1113280
RX PubMed=12429618;
DI NCIt; C7700; Ovarian adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID Tt1.Th
AC CVCL_S389
SY Tt1th
DR ATCC; CRL-6553
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6553; true.
OX NCBI_TaxID=9801; ! Tapirus terrestris
SX Sex undetermined
CA Finite cell line
//
ID TT1TKB
AC CVCL_8764
DR CLO; CLO_0051401
DR BioSample; SAMN03472173
DR RCB; RCB1185
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 9,12
ST D16S539: 9
ST D5S818: 11,13
ST D7S820: 8
ST TH01: 7,9
ST TPOX: 8,11
ST vWA: 18,19
DI NCIt; C9383; Rectal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID TT2
AC CVCL_C318
SY TT2 ES; ES-TT2
DR BTO; BTO:0004639
DR EFO; EFO_0005485
DR ENCODE; ENCBS317ENC
DR GEO; GSM450274
DR GEO; GSM450284
DR RCB; AES0014
DR RCB; RCB2077
RX PubMed=8250257;
RX PubMed=9353641;
CC Part of: ENCODE project mouse cell lines.
CC Discontinued: RCB; RCB2077; true.
CC Breed/subspecies: C57BL/6 x CBA.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Embryonic stem cell
//
ID TT2609-A02
AC CVCL_A594
RX PubMed=11716037;
DI NCIt; C8054; Thyroid gland follicular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_A595 ! TT2609-B02
OI CVCL_2218 ! TT2609-C02
SX Male
CA Cancer cell line
//
ID TT2609-B02
AC CVCL_A595
RX PubMed=11716037;
DI NCIt; C8054; Thyroid gland follicular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_A594 ! TT2609-A02
OI CVCL_2218 ! TT2609-C02
SX Male
CA Cancer cell line
//
ID TT2609-C02
AC CVCL_2218
SY TT2609-CO2
DR BioSample; SAMN03473513
DR CCLE; TT2609C02_THYROID
DR Cosmic; 1995660
DR Cosmic; 2054095
DR Cosmic-CLP; 1240223
DR DSMZ; ACC-510
DR GDSC; 1240223
DR GEO; GSM887712
DR GEO; GSM888805
DR GEO; GSM1670550
RX PubMed=11716037;
RX PubMed=18713817;
RX PubMed=22460905;
RX PubMed=23833040;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: ~60-80 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; DSMZ; PubMed=18713817
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 11,13
ST D16S539: 9,11
ST D18S51: 14
ST D21S11: 28,30
ST D3S1358: 16
ST D5S818: 12
ST D7S820: 8,10
ST D8S1179: 12,13
ST FGA: 22,25
ST TH01: 8,9.3
ST TPOX: 8,12
ST vWA: 17,18
DI NCIt; C8054; Thyroid gland follicular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_A594 ! TT2609-A02
OI CVCL_A595 ! TT2609-B02
SX Male
CA Cancer cell line
//
ID TT3E
AC CVCL_9808
DR EFO; EFO_0002868
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID TTA-1
AC CVCL_6297
SY TTA1; TTA-I
DR BTO; BTO:0004965
DR CGH-DB; 46-1
DR Cosmic; 1152125
DR Cosmic; 1239984
DR Cosmic; 2054119
RX Patent=US8029793;
RX PubMed=8121182;
RX PubMed=8176927;
RX PubMed=9177455;
RX PubMed=16924234;
RX PubMed=18713817;
RX PubMed=23833040;
CC Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-7523.
ST Source(s): PubMed=18713817
ST Amelogenin: X
ST D13S317: 12
ST D18S51: 15
ST D21S11: 30
ST D3S1358: 15
ST D5S818: 12,13
ST D7S820: 11,12
ST D8S1179: 13,15
ST FGA: 23
ST vWA: 17
DI NCIt; C3878; Thyroid gland undifferentiated (anaplastic) carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID TTA-2
AC CVCL_9570
SY TTA2; TTA-II
DR CGH-DB; 47-1
RX Patent=US8029793;
RX PubMed=8121182;
RX PubMed=9177455;
RX PubMed=16924234;
CC Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-7527.
DI NCIt; C3878; Thyroid gland undifferentiated (anaplastic) carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID TTA-3
AC CVCL_9571
SY TTA3; TTA-III
DR CGH-DB; 48-1
RX PubMed=8121182;
RX PubMed=9177455;
RX PubMed=16924234;
DI NCIt; C3878; Thyroid gland undifferentiated (anaplastic) carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID TTC-1240
AC CVCL_8002
SY TTC1240; TTC 1240
DR Cosmic; 801772
DR Cosmic; 802055
DR Cosmic; 2144783
RX PubMed=10602515;
RX PubMed=24418192;
CC From: Triche T.J.; Children's Hospital of Los Angeles; Los Angeles; USA.
CC Misspelling: 'TTC1204' in Cosmic 801772.
DI NCIt; C8715; Rhabdoid tumor of the kidney
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID TTC-1318
AC CVCL_AQ33
RX PubMed=19887553;
RX PubMed=23665679;
ST Source(s): COG
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 11,12
ST D16S539: 12,13
ST D18S51: 12,15
ST D19S433: 14,15
ST D21S11: 32.2
ST D2S1338: 20,24
ST D3S1358: 15,17
ST D5S818: 11
ST D7S820: 9,12
ST D8S1179: 13,14
ST FGA: 20,24.2
ST TH01: 9,9.3
ST TPOX: 8,9
ST vWA: 17,18
DI NCIt; C8971; Embryonal rhabdomyosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID TTC-442
AC CVCL_B255
SY TTC442; TC-442; TU-442; A91
DR Cosmic; 802050
RX PubMed=7882340;
RX PubMed=19887553;
RX PubMed=23665679;
RX PubMed=23882450;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Omics: Protein expression by reverse-phase protein arrays.
ST Source(s): COG
ST Amelogenin: X,Y
ST CSF1PO: 11
ST D13S317: 11,12
ST D16S539: 11,14
ST D18S51: 15,24
ST D19S433: 13,16.2
ST D21S11: 29
ST D2S1338: 20,21
ST D3S1358: 16,18
ST D5S818: 10,11
ST D7S820: 10,13
ST D8S1179: 11,14
ST FGA: 27
ST TH01: 9
ST TPOX: 8,11
ST vWA: 14,17
DI NCIt; C8971; Embryonal rhabdomyosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID TTC-445
AC CVCL_8003
SY TTC445
RX PubMed=10602515;
RX PubMed=23665679;
CC From: Triche T.J.; Children's Hospital of Los Angeles; Los Angeles; USA.
DI NCIt; C3359; Rhabdomyosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID TTC-466
AC CVCL_A444
SY TTC466
DR Cosmic; 759889
DR Cosmic; 1081765
DR Cosmic; 2294590
DR GEO; GSM510014
RX PubMed=16631476;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Omics: Protein expression by reverse-phase protein arrays.
DI NCIt; C4817; Ewing sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_M152 ! CHLA-25
SX Female
CA Cancer cell line
//
ID TTC-475
AC CVCL_IW46
SY TTC475
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC From: Triche T.J.; Children's Hospital of Los Angeles; Los Angeles; USA.
CC Omics: Protein expression by reverse-phase protein arrays.
DI NCIt; C4817; Ewing sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID TTC-487
AC CVCL_B256
SY TTC487; TC-487; TU-487; TU 487; CHLA 37
RX PubMed=7882340;
DI NCIt; C3749; Alveolar rhabdomyosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID TTC-516
AC CVCL_8004
SY TTC516; TC-516; TU-516; A995
DR Cosmic; 802051
RX PubMed=7882340;
RX PubMed=10602515;
RX PubMed=19887553;
RX PubMed=23665679;
RX PubMed=23882450;
ST Source(s): COG
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 11,12
ST D16S539: 9,11
ST D18S51: 15,16
ST D19S433: 14
ST D21S11: 27,31.2
ST D2S1338: 19
ST D3S1358: 14,15
ST D5S818: 10,13
ST D7S820: 10,11
ST D8S1179: 13,14
ST FGA: 22,24
ST TH01: 9
ST TPOX: 9
ST vWA: 17,19
DI NCIt; C8971; Embryonal rhabdomyosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID TTC-547
AC CVCL_7152
SY TTC547; TC-547; TU-547
DR Cosmic; 1091072
DR Cosmic; 2228247
RX PubMed=7882340;
RX PubMed=25010205;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Omics: Deep RNAseq analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
DI NCIt; C3749; Alveolar rhabdomyosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID TTC-549
AC CVCL_8005
SY TTC549
DR EFO; EFO_0005700
DR Cosmic; 801776
DR Cosmic; 802052
DR Cosmic; 1063888
DR Cosmic; 2144784
DR ENCODE; ENCBS258AAA
RX PubMed=10602515;
RX PubMed=11557780;
RX PubMed=16557275;
RX PubMed=24418192;
WW http://genome.ucsc.edu/ENCODE/protocols/cell/human/MRTTTC549_Crawford_protocol.pdf
CC Part of: ENCODE project common cell types; tier 3.
DI NCIt; C6586; Extrarenal rhabdoid tumor
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID TTC-633
AC CVCL_B257
SY TTC633
DR Cosmic; 1081766
CC From: Triche T.J.; Children's Hospital of Los Angeles; Los Angeles; USA.
DI NCIt; C4817; Ewing sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID TTC-642
AC CVCL_8006
SY TTC642
DR Cosmic; 801774
DR Cosmic; 802053
DR Cosmic; 2144785
RX PubMed=10602515;
RX PubMed=24418192;
DI NCIt; C6586; Extrarenal rhabdoid tumor
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID TTC-709
AC CVCL_8007
SY TTC709
DR Cosmic; 802054
RX PubMed=10602515;
DI NCIt; C6586; Extrarenal rhabdoid tumor
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID TTCF
AC CVCL_Z506
SY Tor Tor Caudal Fin
RX PubMed=22203177;
WW http://mail.nbfgr.res.in/nrfc/celldetail.php?id=3
CC Group: Fish cell line.
CC Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC003.
OX NCBI_TaxID=464755; ! Tor tor
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID TTD HM 1BR
AC CVCL_W045
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2554 ! LB198
SX Female
CA Finite cell line
//
ID TTD1BR
AC CVCL_W046
RX PubMed=8213812;
ST Source(s): PubMed=11416159
ST Amelogenin: X,Y
ST D18S51: 13,21
ST D21S11: 30,31
ST D8S1179: 11,14
ST FGA: 20,21
ST TH01: 9.3
ST vWA: 17,18
DI NCIt; C4924; Trichothiodystrophy
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2555 ! LB199
SX Male
CA Finite cell line
//
ID TTD4BR
AC CVCL_W052
DI NCIt; C4924; Trichothiodystrophy
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2562 ! LB443
SX Male
CA Finite cell line
//
ID TTE1
AC CVCL_D629
SY TTE-1; TTE 1
DR BTO; BTO:0005187
RX PubMed=11789682;
RX PubMed=15541572;
RX PubMed=17233813;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Conditionally immortalized cell line
//
ID TTE3
AC CVCL_U448
SY TTE 3
RX PubMed=11832784;
RX PubMed=15541572;
RX PubMed=17233813;
RX PubMed=17543550;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Omics: Transcriptome analysis.
CC Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Conditionally immortalized cell line
//
ID TTF-1 iPS
AC CVCL_IT50
DR PRIDE; PXD000589
RX PubMed=18371336;
RX PubMed=25894527;
CC Omics: Cell surface proteome.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Induced pluripotent stem cell
//
ID TTN-45
AC CVCL_EJ25
SY TTN45
DR Cosmic; 2144786
RX PubMed=24418192;
DI NCIt; C8715; Rhabdoid tumor of the kidney
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID TtT/GF
AC CVCL_S512
DR CLO; CLO_0050271
DR RCB; RCB1279
RX PubMed=1446645;
RX PubMed=8404665;
RX PubMed=15541569;
RX PubMed=23881407;
CC Breed/subspecies: C57BL/6N x C3H/2N.
DI NCIt; C24037; Mouse pituitary gland neoplasms
OX NCBI_TaxID=10090; ! Mus musculus
OI CVCL_U804 ! TtT/M-87
CA Cancer cell line
//
ID TtT/M-87
AC CVCL_U804
SY M-87
DR CLO; CLO_0050272
DR RCB; RCB0531
RX DOI=10.2220/biomedres.9.367;
RX PubMed=8133800;
CC Breed/subspecies: C57BL/6N x C3H/2N.
DI NCIt; C24037; Mouse pituitary gland neoplasms
OX NCBI_TaxID=10090; ! Mus musculus
OI CVCL_S512 ! TtT/GF
CA Cancer cell line
//
ID Tu 113
AC CVCL_4831
SY Tu-113; Tu113
DR BTO; BTO:0004880
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Tu 132
AC CVCL_4909
SY TU 132; Tu-132; Tu132
DR BTO; BTO:0004879
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Tu 138
AC CVCL_4910
SY Tu-138; Tu138
DR BioSample; SAMN03151956
RX PubMed=8033080;
RX PubMed=21868764;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. T404, T406, Tu 138, Tu 158LN, Tu 159, Tu 182, Tu 212 and Tu 212LN have been shown to be identical (PubMed=21868764).
ST Source(s): PubMed=21868764
ST Amelogenin: X
ST CSF1PO: 12,13
ST D13S317: 12
ST D16S539: 8,9
ST D5S818: 12
ST D7S820: 10
ST TH01: 8
ST TPOX: 10,11
ST vWA: 15,16
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1T20 ! T404
OI CVCL_1T19 ! T406 [Human HNSCC]
OI CVCL_1T17 ! Tu 158LN
OI CVCL_4911 ! Tu 159
OI CVCL_4914 ! Tu 182
OI CVCL_4915 ! Tu 212
OI CVCL_1T18 ! Tu 212LN
CA Cancer cell line
//
ID Tu 140
AC CVCL_W956
SY Tu-140; Tu140
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Tu 158LN
AC CVCL_1T17
SY Tu-158LN
DR BioSample; SAMN03151957
RX PubMed=21868764;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. T404, T406, Tu 138, Tu 158LN, Tu 159, Tu 182, Tu 212 and Tu 212LN have been shown to be identical (PubMed=21868764).
ST Source(s): PubMed=21868764
ST Amelogenin: X
ST CSF1PO: 12,13
ST D13S317: 12
ST D16S539: 8,9
ST D5S818: 12
ST D7S820: 10
ST TH01: 8
ST TPOX: 10,11
ST vWA: 15,16
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1T20 ! T404
OI CVCL_1T19 ! T406 [Human HNSCC]
OI CVCL_4910 ! Tu 138
OI CVCL_4911 ! Tu 159
OI CVCL_4914 ! Tu 182
OI CVCL_4915 ! Tu 212
OI CVCL_1T18 ! Tu 212LN
CA Cancer cell line
//
ID Tu 159
AC CVCL_4911
SY TU 159; Tu-159; Tu159; TU159
DR BioSample; SAMN03151958
RX PubMed=21868764;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. T404, T406, Tu 138, Tu 158LN, Tu 159, Tu 182, Tu 212 and Tu 212LN have been shown to be identical (PubMed=21868764).
ST Source(s): PubMed=21868764
ST Amelogenin: X
ST CSF1PO: 12,13
ST D13S317: 12
ST D16S539: 8,9
ST D5S818: 12
ST D7S820: 10
ST TH01: 8
ST TPOX: 10,11
ST vWA: 15,16
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1T20 ! T404
OI CVCL_1T19 ! T406 [Human HNSCC]
OI CVCL_4910 ! Tu 138
OI CVCL_1T17 ! Tu 158LN
OI CVCL_4914 ! Tu 182
OI CVCL_4915 ! Tu 212
OI CVCL_1T18 ! Tu 212LN
CA Cancer cell line
//
ID Tu 167
AC CVCL_4912
AS CVCL_1Q87
SY Tu-167; TU-167; Tu167; TU167; T167; T-167
DR BioSample; SAMN03151992
DR Cosmic; 1530763
DR Cosmic; 1530765
DR Cosmic; 2043887
RX PubMed=12907203;
RX PubMed=18234965;
RX PubMed=21868764;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a UM-SCC-1 derivative (PubMed=21868764).
ST Source(s): PubMed=21868764
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 8,11
ST D16S539: 12,13
ST D5S818: 10,13
ST D7S820: 9,12
ST TH01: 6
ST TPOX: 8,11
ST vWA: 15,18
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_7707 ! UM-SCC-1
SX Male
CA Cancer cell line
//
ID Tu 177
AC CVCL_4913
SY Tu-177; Tu177
RX PubMed=8033080;
DI NCIt; C4044; Laryngeal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Tu 182
AC CVCL_4914
SY Tu-182; Tu182
DR BioSample; SAMN03151959
RX PubMed=21868764;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. T404, T406, Tu 138, Tu 158LN, Tu 159, Tu 182, Tu 212 and Tu 212LN have been shown to be identical (PubMed=21868764).
ST Source(s): PubMed=21868764
ST Amelogenin: X
ST CSF1PO: 12,13
ST D13S317: 12
ST D16S539: 8,9
ST D5S818: 12
ST D7S820: 10
ST TH01: 8
ST TPOX: 10,11
ST vWA: 15,16
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1T20 ! T404
OI CVCL_1T19 ! T406 [Human HNSCC]
OI CVCL_4910 ! Tu 138
OI CVCL_1T17 ! Tu 158LN
OI CVCL_4911 ! Tu 159
OI CVCL_4915 ! Tu 212
OI CVCL_1T18 ! Tu 212LN
CA Cancer cell line
- 公告/新闻
